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ABSTRACT 
 
The lumpfish, Cyclopterus lumpus L. is an emerging and most promising aquaculture 
fish currently used for a biological control against sea lice in salmonids. However, the 
lumpfish is prone to a number of bacterial diseases including vibriosis, atypical 
furunculosis and pasteurellosis. The use of vaccines in aquaculture has been one of 
the best prophylactic measures against fish bacterial diseases; vaccines can protect 
the lumpfish from bacterial diseases. Thus, it is essential to investigate the adaptive 
humoral immune response of the lumpfish in order to develop protective vaccines 
against the bacterial diseases. 
This work is the first to study the adaptive humoral immune response of the lumpfish 
in response to immunization with formalin inactivated whole bacteria (WB) antigens 
and challenge with different Gram-negative bacteria after vaccination or without 
vaccination. Immunization was conducted against two atypical A. salmonicida, V. 
anguillarum O2, Pasteurella spp. and V. ordalii. Analysis of the different lumpfish 
antisera using sonicated WB antigens by ELISA and western blot revealed the 
presence of strong specific or cross-reactive antibodies two weeks post immunization. 
The antisera to both atypical A. salmonicida strains had antibodies that detected 
common antigenic components directed to ca. 10, 13, 20, 22, 28, 50 and 55 kDa 
proteins. However, antibodies to one of the atypical strains (8546) did not recognize 
the 50-kDa protein from the heterogeneous antigen (AL20460) on the western blot. 
The absence of the 50-kDa protein in one of the atypical A. salmonicida may contribute 
to differences in the level of specific antibody response. 
 Antibodies to strain AL122 (V. anguillarum O2) reacted strongly with a 14-kDa 
antigenic component of heterogeneous antigens from strains 8752 (V. anguillarum O1) 
and strain 8657 (V. ordalii). The Pasteurella spp. induced the highest level of antibodies 
directed to 100 and 20 kDa proteins of a homogeneous antigen. Moreover, antibodies 
to Pasteurella spp. reacted with 100, 73, 37 and 20 kDa protein components of a 
heterogeneous antigen from P. skyensis. However, V. ordalii induced the lowest 
antibody response; no specific antibodies were detected in antisera to V. ordalii by the 
western blot analysis. 
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The lumpfish’s specific humoral immune system showed strong antibody response to 
vaccination post challenge (i.p.) with strains 8546 (atypical A. salmonicida), AL20460 
(atypical A. salmonicida), 8752 (V. anguillarum) and Pasteurella spp. The trivalent and 
the commercial AMM3 vaccines against atypical furunculosis showed higher antibody 
levels after challenge with strain 8546 (atypical A. salmonicida) than challenge with 
strain AL20460 (atypical A. salmonicida). The monovalent vaccines had similar effect 
on antibody levels after challenging with either of the atypical A. salmonicida strains. 
The trivalent and monovalent vaccines against Vibriosis induced similar amount of 
antibodies post challenge with strain 8752 (V. anguillarum). However, the non-
vaccinated groups, in general, displayed low antibody levels post challenge with post 
challenge with strains of the atypical A. salmonicida, 8752 (V. anguillarum O1), and 
Pasteurella spp. by any of the challenge exposures (bath, i.p., or cohabitation). These 
results indicate that the use of the vaccines in the lumpfish may play a protective role 
against some of the bacterial diseases; however, further studies are needed.  
Moreover, total serum IgM in the lumpfish was quantified by single radial 
immunodiffusion assay. The mean total IgM (mg/ml) post immunization for the different 
groups was estimated at the range of 1.02 to 0.41 mg/ml, which is in the range also 
found in other fish species.  
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1. INTRODUCTION 
 
1.1 The lumpfish, Cyclopterus lumpus L. 
The lumpsucker or lumpfish, Cyclopterus lumpus L. (Linnaeus, 1758) is one of the 28 fish 
species identified under the family of Cyclopteridae (Mecklenburg and Sheiko, 2003). It is 
the sole species in genus Cyclopterus (Davenport, 1985). They are marine, mostly 
benthos inhabiting continental shelves and upper slopes. Females lay their eggs in 
shallow coastal waters or may migrate hundreds of miles; the males protect the eggs 
after spawning. Benthic organisms such as polychaetes, crustaceans and molluscs are 
major food sources for the lumpfish, while some feed on slow moving pelagic organisms 
such as medusae and ctenophores (Mecklenburg and Sheiko, 2003). The Cyclopterus 
lumpus L. has an extensive range of distribution along the coasts of the Arctic Ocean, 
northern sections of the North Pacific and North Atlantic oceans (Davenport, 1985, 
Mecklenburg and Sheiko, 2003, Mecklenburg et al., 2011). Fig. 1 (Davenport, 1985) 
shows a map of the lumpfish distribution in the northern part of the Atlantic Ocean. In 
many western North Atlantic countries, Cyclopterus lumpus L. is an important 
commercial fish, in which female lumpfish are caught for caviar production (Mecklenburg 
and Sheiko, 2003). Recently, the lumpfish has become an emerging and most promising 
cleaner fish to be used for biological control against sea lice, Lepeophteirus salmonis 
Krøyer, in salmonid aquaculture.  
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Fig. 1. A map of the lumpfish, Cyclopterus lumpus L., distribution. The small black dots 
indicate for the lumpfish’s breeding ground (Davenport, 1985).  
 
The salmon louse is a cause of serious environmental, welfare and economic problems 
that may compromise the sustainability of the salmon aquaculture industry (Jimenez et 
al., 2012, Denholm et al., 2002). For many years, the industry has relied on topical and 
oral administration of chemotherapeutants for the control of salmon lice (Torrissen et al., 
2013). However, increased use of chemicals has led to the development of resistant lice 
(Jimenez et al., 2012). Thus, such concerns coupled with public preference to high 
quality fish product and immediate necessity for effective and sustainable sea lice control 
have prompted the industry to use environmentally friendly cleaner fish as biological 
control against sea lice infestation (Treasurer, 2002). At present, the principal cleaner fish 
in use for biological sea lice control include Ballan wrasse (Labrus bergylta), goldsinny 
wrasse (Ctenolabrus rupestris L.) and the lumpfish (Cyclopterus lumpus L.). The wrasses 
are not without limitations; they are incapable of tolerating low temperature less than 6 ⁰C 
making them unsuitable candidates in cold regions (Sayer and Reader, 1996), like in 
Northern Norway. The lumpfish, however, can tolerate low water temperature (Imsland et 
al., 2014). According to the 2013 report on statistics of fish farming by the Norwegian 
Department of Fisheries (Fiskeridirektoratet), the farming of lumpfish in Norway has been 
growing since 2011; the lumpfish constituted 95% of all the cleaner fish produced in 2013. 
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In the same year, 1.95 million farmed lumpfish were sold for delousing in sea cages of 
Atlantic salmon (Salmo salar L.) and rainbow trout (Oncorhynchus mykiss W.) 
(Fiskeridirektoratet, 2014).  
 
1.2 Bacterial diseases in lumpfish 
However, like any other animal husbandry, the lumpfish are also prone to a number of 
bacterial pathogens. It has been reported that several bacterial pathogens have been 
isolated and identified in both wild and captive lumpfish, including atypical Aeromonas 
salmonicida (A. salmonicida), Pseudomonas anguilliseptica (P. anguilliseptica), 
Pasteurella species (Pasteurella spp.) and diverse species of vibrio bacteria such as 
Vibrio anguillarum (V. anguillarum), Vibrio ordalii (V. ordalii), Vibrio splendidus (V. 
splendidus), Vibrio tapetis (V. tapetis), Vibrio wodanis (V. wodanis) and Vibrio logeli (V. 
logeli) (Nilsen et al., 2014). According to Nilsen et al., (2014), 310,043 (33%) mortalities 
were registered out of the total 934,935 cleaner fish stocked in 17 marine sites within a 
period of six months in 2013. The most serious mortality episode after transfer to sea 
cages was related to acute outbreak of bacterial infections by atypical A. salmonicida, V. 
anguillarum or Pasteurella spp. The rate of mortality (32 – 48%) was highest for the 
lumpfish (Nilsen et al., 2014).   
 
Atypical frunculosis: A. salmonicida is one of the destructive bacterial fish pathogens 
responsible for great economic losses in several fish farms in the world (Diamanka et al., 
2014). It is a facultative, gram negative, anaerobic, immobile, fermentative and 
rod-shaped bacterium (Gudmundsdottir, 1998). According to Bergey’s manual of 
systematic bacteriology, there are five subspecies (subsp.) of A. salmonicida, which 
include subsp. salmonicida, subsp. achromogenes, subsp. masoucida, subsp. smithia 
and subsp. pectinolytica (Martin-Carnahan and Joseph, 2005). The A. salmonicida spp. 
salmonicida is the aetiological agent of typical frunculosis in salmonids and mentioned as 
typical, whereas the other subsp. including many other strains that do not fall into the 
taxonomic category of A. salmonicida spp. salmonicida are described as atypical A. 
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salmonicida (Gudmundsdottir, 1998, Wiklund and Dalsgaard, 1998). Unlike the typical A. 
salmonicida spp. salmonicida, the atypical A. salmonicida strains are heterogeneous 
showing wide variations with respect to their biochemical, molecular and virulence 
features (Austin et al., 1998). The atypical A. salmonicida are responsible for profound 
and extensive ulcers and systemic infections in a wide range of farmed and wild fish 
species in both freshwater and marine ecosystems (Gudmundsdottir, 1998, Wiklund and 
Dalsgaard, 1998). Different strains of the atypical A. salmonicida have been identified in 
more than 20 farmed and 30 wild fish species (Wiklund and Dalsgaard, 1998). These 
bacteria affect particularly fish in the Northern hemisphere such as in Canada, USA, 
Japan, and central and northern Europe including the Scandinavian countries (Wiklund 
and Dalsgaard, 1998). The atypical strains have also been isolated from Norwegian 
farmed and wild fish species with the subsp. achromogenes being the most abundantly 
scattered in Norway and perhaps globally (Sorum et al., 2000). They are regarded as the 
most significant pathogens of cleaner fish, including lumpfish, causing chronic diseases 
with granulomas in internal organs and ulcerative lesions (Johansen, 2013). Like many 
gram-negative bacteria, the virulence factor of atypical A. salmonicida is possibly 
associated with various cellular components found in its membrane, which is composed 
of a peptidoglycan and an outer membrane (OM) (Gudmundsdottir, 1998). At the surface 
of the OM is a protein layer known as A–layer, which is believed to be a virulent factor. 
Strains without the A-layer display reduced virulence (Noonan and Trust, 1995). The 
A-layer plays an important role in defending the pathogen from phagocytosis (Trust et al., 
1996), proteolytic actions (Chu et al., 1991), serum effects and accelerates the binding of 
immunoglobulins (Ig), porphyrins and a number of extracellular proteins (Trust et al., 
1996). The Lipopolysaccharide (LPS), which molecularly and physically shields the cell, 
is made up of lipid A, a central oligosaccharide and the O-antigen or O-chain 
polysaccharide subunits. Unlike the typical strain, the O-chain polysaccharide subunits in 
the atypical strain is incomplete with either absence or presence of an O-acetyl group 
(Wang et al., 2007). The O-antigen is located at the outermost surface; hence, it is a 
region where specific interaction occurs with antibodies (Gudmundsdottir, 1998). 
Moreover, metallo-caseinase (AsaP1), a 20-kilodalton (kDa) exotoxin isolated from 
extracellular product (ECP) of some atypical strains including ssp. achromogenes is 
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deadly to fish. AsaP1 may induce protection against the atypical furunculosis 
(Gudmundsdottir and Magnadottir, 1997).  
 
Vibriosis: The lumpfish are also susceptible to a group of bacteria belonging to genus 
Vibrio, which cause a disease condition known as vibriosis (Woo et al., 2011). The vibrio 
species are found everywhere in the aquatic environment (Haenen et al., 2014). Within 
the family of Vibrionaceae the vibrio that result in devastating economic loss in 
mariculture are V. anguillarum, Vibrio salmonicida (V. salmonicida), V. ordalii and V. 
vulnificus. The disease associated with V. anguillarum infection is referred to as classical 
vibriosisis, which is characterized by a typical haemorrhagic septicaemia in a number of 
economically important cold- and warm-water species of fish. Fish with classical vibriosis 
display symptoms of extensive septicaemia with bleeding on fins, protrusion of the eyes, 
corneal opacity, anorexia with discolored gills, which is a reflection of serious anaemia, 
and oedematous injuries in the hypodermis (Toranzo et al., 2005). Chemical, physical 
and biological stressors can trigger epidemics of vibriosis (Frans et al., 2011). V. 
anguillarum is a gram-negative, curved rod shaped (0.5x1.5 µm), motile with the help of a 
single polar flagellum, non-spore-forming, halophilic and facultative anaerobic bacterium, 
which grows in a medium containing 1.5 – 2% NaCl at a temperature of 20 – 30 ⁰C (Frans 
et al., 2011, Austin and Austin, 2007).  
 
The virulence factors in V. anguillarum are perhaps linked to ECP exotoxins with 
proteolytic or haemolytic activities, LPS (O-antigen), siderophore and flagellum (Frans et 
al., 2011). The ECP exotoxins such as hemolysins can breakdown the host’s erythrocyte 
membranes and hence, discharge of iron-binding proteins such as hemoglobin, 
transferrin and lactoferrin (Zhang and Austin, 2005). Another ECP exotoxin produced by 
the bacterium is a 36-kDa zinc metalloprotease (EmPA). EmpA is an essential virulence 
factor and involves in penetration and degradation of the mucus membrane (Norqvist et 
al., 1990, Denkin and Nelson, 2004). Afterwards, the infection becomes systemic, 
damaging vital organs such as the kidneys and liver (Frans et al., 2011). V. anguillaurm 
has a single flagellum made up of five subunits, in which one of the five subunits known 
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as flagellin A (flaA) is a virulent factor required for traversing the fish integument following 
invasion (Milton et al., 1996). The immune system of fish utilizes iron binding proteins 
such as transferrin, lactoferrin and ferritin making iron - a limiting growth factor - 
inaccessible for pathogens (Frans et al., 2011). However, V. anguillarum utilizes iron in 
iron-restricted environment by producing plasmid-mediated high-affinity iron chelating 
compounds known as siderophores. Genes contained inside plasmid pMJ1 of V. 
anguillarum encode proteins that facilitate biosynthesis of siderophore anguibactin and 
uptake of ferri-siderephore into the cytosol (Stork et al., 2002).  
 
V. anguillarum has been considered as a very heterogeneous species (Kühn et al., 1996) 
comprising 23 O serotypes (O1 – O23) (Pedersen et al., 1999), however, only serotypes 
O1 or O2 and to a smaller degree serotype O3 have been related to vibriosis (Pedersen 
et al., 1999, Sørensen and Larsen, 1986). Serotypes O1 and O2 have worldwide 
distribution causing serious economic damage to several aquaculture farms, whereas, 
the other serotypes are considered as environmental isolates from sediments and water 
(Pedersen et al., 1999, Toranzo et al., 2005). Unlike serotype O1, which displays 
antigenic similarity, serotypes O2 and O3 show antigenic heterogeneities, each having 
two subgroups called O2a and O2b, and O3A and O3B, respectively. The serotype O3A 
is isolated from diseased fish, mostly from eel and ayu, while, O3B consists of 
environmental variants. The subgroup O2a can be detected from both salmonids and 
other fish species; whereas, subgroup O2b has been isolated from marine fishes only 
(Toranzo et al., 2005).  According to the 2013 report regarding the status of fish health in 
Norwegian aquaculture, serotypes O1 and O2b had been spotted from diseased lumpfish 
in 2012 (Johansen, 2013). 
 
V. ordalii is another causative agent of fish vibriosis. Initially, the bacterium was 
categorized as a strain belonging to V. anguillarum biotype 2 (Schiewe and Crosa, 1981). 
Like V. anguillarum, V. ordalii is also gram-negative, fermentative, curved rod-shaped 
(2.5-3.0x1.0 µm) and motile by a single polar flagellum. V. ordalii can be cultured in 
seawater agar and Thiosulfate-citrate-bile salts sucrose (TCBS) agar at 15 – 25 °C giving 
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creamy and circular (1-2mm) colonies after 4 – 6 days of incubation (Austin and Austin, 
2007). Contrary to V. anguillarum, V. ordalii show antigenic homogeneity (Toranzo et al., 
2005) based on plasmid profiling, ribotyping and serogrouping (Austin and Austin, 2007). 
Moreover, the vibriosis caused by V. ordalii is also characterized as haemorrhagic 
septicaemia, but with some pathological differences with the vibriosis caused by V. 
anguillarum (Austin and Austin, 2007, Toranzo et al., 2005). In the case of infections by V. 
ordalii, the bacteraemia grows slower than infections with V. anguillarum. Primarily, the 
bacterium was considered as causative agent of vibriosis in wild and farmed fish from 
USA, Japan and Australia (Woo et al., 2011); it has also been isolated from farmed 
Atlantic salmon in Chile (Toranzo et al., 2005). According to the Norwegian fish health 
report, V. ordalii has been diagnosed in many of the Norwegian lumpfish farms in 2013 
(Johansen, 2013).  
 
Pasteurellosis: Although diseases caused by the previously discussed bacteria have 
been well recognized for several years, some bacteria that belong to genus Pasteurella - 
a member of a family Pasteurellaceae - have emerged recently and have been affecting 
the fish farming industry (Birkbeck et al., 2002, Toranzo et al., 2005). Pasteurella 
skyensis (P. skyensis) was isolated from kidneys of farmed Atlantic salmon following 
disease outbreaks in Scotland and suggested as a causative agent of Pasteurellosis 
(Birkbeck et al., 2002). Affected fish displayed substantial cataracts, loss of weight, 
empty stomach and distinct white focal lesions in the kidney, spleen and heart. Besides, 
examination of peritoneal organs and swim bladder revealed the presence of pericarditis 
and peritonitis with granuloma and false membranes (Jones and Cox, 1999). Based on 
16S rRNA and rpoB gene partial sequencing, two different serotypes (serotype 1 and 2) 
of P. skyensis have been isolated. Recently, several isolates with 97% resemblance in 
the 16SrRNA to the Scotish P. skyensis serotype 1 (strain 95A1T) have also been 
detected in Norway (Reid and Birkbeck, 2014). The Norwegian isolate causes unusual 
disease in salmon known as ‘varracalbmi’ (Lapp for blood-eye). In the years 1989 – 2012, 
the bacterium had been intermittently found over a wide area extending from Hordaland 
in the south to Troms in the north (Johansen, 2014). In 2013, lumpfish in 16 separate 
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aquaculture facilities were diagnosed with systemic infections caused by a Pasteurella – 
spp. (Alarcón et al., 2014). Subclinical infections coupled with stress related to 
vaccination, transport or transfer to a new environment might exacerbate the rate of 
lumpfish mortality, and the mortality may reach 100% (Johansen, 2014). The isolates 
from the lumpfish have close phenotypic relations with the unspeciated Pasteurella spp., 
however, phenotypically different from the P. skyensis isolated from the diseased Atlantic 
salmon in Scotland. The placement of the Norwegian isolates as new species or 
subspecies within the family Pasteurellaceae has still been unknown (Alarcón et al., 
2014).  
 
1.3 Vaccination in fish 
We have seen that the fish farming industry has suffered ravaging economic losses due 
to the different bacterial diseases. Consequently, the industry must take some measures 
to control the disease or prevent disease introduction into the facilities so that the industry 
would enjoy economic sustainability. One measure of disease control commonly 
employed by fish farmers would be to rely on using antibacterial drugs. With 
intensification of the Norwegian salmonid aquaculture in around 1980’s, bacterial 
diseases, particularly vibriosis, cold-water vibriosis and furunculosis, were major 
problems. Thus, at the time where fish vaccines were not available, a maximum of 
approximately 50 tons of antibiotic drugs had been used in 1987 (Håstein et al., 2005) (fig. 
2, (Harvest, 2015)). Meanwhile, the total fish production was only ca. 56,000 tones. 
However, following the introduction of effective vaccines in 1994 coupled with good 
aquaculture practices, the amount of drugs used dropped significantly to 1.4 tones, while 
at the same time fish production increased by almost three folds (Harvest, 2015). Now, 
annual fish production has continued to increase and 1.25 million tons of fish were 
produced in 2012, which was a 96% increase since 1987. Simultaneously, antibiotic use 
has decreased by 99.8% per ton of trout and salmon produced (Pharmaq, 2015). 
Therefore, the Norwegian success story clearly demonstrates that vaccination is an 
economically, ecologically and ethically preventive measure against fish diseases 
(Tafalla et al., 2013).  
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Fig. 2. Amount of antibacterial drugs used in Norwegian aquaculture due to outbreak of 
bacterial diseases in the 1980s and fish production from 1980 to 2012. Despite low levels 
of antibiotic use, the industry has enjoyed tremendous production increment since 1994 
thanks to vaccination and some good husbandry practices (Harvest, 2015). 
 
Nowadays, more than 17 species of fish in more than 40 countries are protected against 
22 bacterial diseases and 6 viral diseases (Brudeseth et al., 2013). Most of the bacterial 
vaccines contain inactivated products (antigens) of the disease causing agents in oil 
adjuvants (Håstein et al., 2005). Vaccines can be delivered to the fish in three ways, 
namely injection mainly via intraperitoneal injection (i.p.), immersion by dipping or bath 
and oral administration (Gudding et al., 1999, Håstein et al., 2005). Each method has its 
own advantage or disadvantage with regard to the degree of protection, adverse side 
effects, practicality and cost (Gudding et al., 1999). In general, injectable vaccines 
provide the best protection against fish diseases (Håstein et al., 2005). According to 
PHARMAQ AS, around 2 billion salmonids in Norway have so far received oil based 
injectable vaccines containing formalin-inactivated antigens. To understand how 
vaccination or immunization protects the fish against the bacterial fish pathogens, it is 
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necessary to explore the fish immune system with particular focus on the stimulation of 
the specific humoral immunity (antibody production).  
 
1.4 The immune system of fish 
Most of the scientific knowledge concerning the fish immune system is limited to teleost 
fish; since the lumpfish is a new emerging species, there is very limited scientific review 
or research paper done with respect to their immune system. Therefore, this introductory 
review, as a whole, will discuss the immune system of fish based on information obtained 
from teleost fish and mammalian immunity. The fish immune system is physiologically 
comparable to that of advanced vertebrates, despite some dissimilarities. Besides, the 
fish immune system contains antigen receptors (immunoglobulins and T cell receptors), 
major histocompatibility complexes (MHC) and gene rearranging proteins (rag genes) 
(Fletcher and Secombes, 2010). However, fish lack lymphatic nodules and bone marrow 
(Zapata et al., 2006), which are the principal sources of blood cells in higher animals 
(Murphy, 2012); hence, other organs such as the kidney, spleen and thymus serve as 
major lymphoid organs. For instance, the head kidney, also called pronephros, in teleost 
fish is comparable to the bone marrow in mammals and is the chief spot for 
hematopoiesis (Zapata et al., 2006). Moreover, the head kidney is responsible for 
phagocytosis (Dannevig et al., 1994), antigen processing, antibody production (Brattgjerd 
and Evensen, 1996, Kaattari and Irwin, 1985) and immunological memory (Herraez and 
Zapata, 1986, Tsujii and Seno, 1990). The head kidney contains mostly B lymphocytes 
and macrophages combined in structures known as melanomacrophage centres (Press 
et al., 1994). The thymus is involved in production of T – lymphocytes that are engaged in 
allograft rejection, in prompting phagocytic activities by other cells of the immune system 
and antibody production by B lymphocytes (Bowden et al., 2005, Zapata and Amemiya, 
2000). The main function of the spleen is to filter blood and process antigens (Espenes et 
al., 1995). Cells in the walls of the spleen participate in antigen phagocytosis by 
macrophage cells. Besides, antigens either in the form of antibody or metabolic products 
are stored in the spleen and play an essential role in immunological memory (Uribe et al., 
2011). In general, the fish immune response, like in higher animals, is composed of 
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innate (non-specific) and adaptive immune (specific) responses (Magnadóttir, 2006); 
however, the adaptive immune response in fish is less advanced than that of higher 
animals (Warr, 1995). The primary function of the innate immune system is to protect the 
host against infection by controlling the disease causing microbes that have distinctive 
molecular structures on their cell walls or that trigger interferons and other general 
immune defenses (Murphy, 2012). The innate immune system in fish is composed of 
physical barriers (skin, epithelial tissue lines and mucus layers), cellular (macrophages, 
granulocytes, natural killer cells, etc.) and humoral elements (lysozyme, agglutinin, 
lectins, opsonins, antibacterial lytic enzymes, transferrin, etc.) (Magnadóttir, 2006, Swain 
and Nayak, 2009). The cells of the innate immune system have germline-encoded 
receptors known as pathogen recognition receptors (PRR) such as Toll like receptors 
(TLR), which are specialized to distinguish certain molecular structures, but not usually 
present in multicellular organisms. These molecular structures are collectively referred to 
as pathogen associated molecular patterns (PAMPs), which include polysaccharides, 
LPS, peptidoglycans and deoxyribonucleic acid (DNA) of bacteria or viral ribonucleic acid 
(RNA). In addition, the PRRs play a key role in the initiation of the adaptive immune 
system (Murphy, 2012).  
 
Specific humoral immune response: The adaptive immune response takes place through 
interaction of intricate and highly specialized cells, proteins, genes and biochemical 
reactions that equip the host to communicate effectively with antibodies and effector cells 
in response to antigens with high affinity and specificity (Uribe et al., 2011). The adaptive 
immune system is mediated by T- and B lymphocytes (Fletcher and Secombes, 2010) 
and is comprised of cell - and antibody-mediated humoral responses. Antibody-mediated 
humoral responses occur when B cells are activated in response to antigen in 
cooperation with antigen presenting cells (APCs), specific T lymphocytes and various 
cytokines (fig. 3). Immunoglobulins (Ig) bound to the surface of the B cells act as B cell 
receptors (BCR) and have a wide range of specificities for different antigens derived from 
bacteria, or other pathogens. Antibody synthesis by the B cells can be instigated in two 
ways: either through thymus-independent antigens (TI) or thymus-dependent antigens 
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(TD). TI antigens are mostly products of microbes such as the bacterial LPS, which 
without the presence of T helper cells can directly induce B cells to generate specific 
antibodies, whereas TD antigens need the presence of T helper (TH) cells to activate B – 
cells to make antibodies. Most proteins and peptides are TD antigens because they need 
activation from TH cells in order to provoke an immune response (Weintraub, 2003, 
Möller, 2001). Professional APCs such as macrophages, dendritic cells, or B cells engulf 
and process antigens in their intracellular vesicles and present the peptide fragments on 
the surface in combination with the MHCII so that TH cells would recognize them. The TH 
cells produce interleukins (IL) that signal the B cells to undergo proliferation and clonal 
expansion to become antibody-producing plasma cells (Murphy, 2012). Here, 
collaboration between CD40 ligand (CD40L) or CD154 on the T cell and CD40 on the B 
cell is crucial for the TD responses (Fletcher and Secombes, 2010, Murphy, 2012). 
Before B cell activation, the same specific peptide fragment must trigger the CD4 T cells 
to make TH cells. Each plasma cell or B-lymphocyte clone secretes a specific antibody in 
response to antigen having the same specificity (Murphy, 2012). TD antigen activated B 
and T lymphocytes to generate specific antibodies are considered memory cells because 
they provide long – lasting immune protection (Möller, 2001) and allow the immune 
system to react more quickly, vigorously and efficiently to the same pathogen during 
reinfection and protect the host from disease (Murphy, 2012).  
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Fig. 3. TD cell activation of B cells. Professional APCs phagocytize extracellular 
pathogens (bacteria), process them inside intracellular vesicles and present the peptide 
fragments in combination with MHCII. The T lymphocyte recognizes the peptide-MHCII 
complex through its cell-surface CD4 receptor and divides into TH effector cells. The BCR 
also recognize antigens, internalize and present them with MHCII; the TH recognizes the 
peptide – MHCII complex and produces cytokines (IL-2,4,5) signaling B cells to undergo 
proliferation and clonal expansion (Murphy, 2012). 
 
Structure of antibody, its specificity and antibody – antigen interaction: In understanding 
the specificity of antibodies to antigens, knowledge of the structure of an antibody 
molecule is crucial. A typical antibody molecule is similar to a letter Y, which is 
constructed of four polypeptide chains: two identical light (L) and two identical heavy (H) 
chains connected by disulfide bonds (hinge region) (fig. 4). The L and H chains can be 
divided into two distinctive regions: the variable (V) region found at the tips of each chain 
towards the amino acid terminal and the constant (C) region pointed in the direction of 
the carboxy-terminal. The V and C regions of an antibody molecule perform different 
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functions; the former is involved in recognition and binding of antibodies by its antigenic 
binding site (paratope), while the later has an effector function (Murphy, 2012, Lucas, 
2003). As its name indicates, the amino acid sequences in the V – region differ 
significantly between different antibody molecules. The variability of the amino acid 
sequences is concentrated at the tip of the variable domains particularly in three amino 
acid segments known as hypervariable regions. Both the VL and VH domains constitute 
six hypervariable segments, in which altogether, form the entire antigen-binding site. 
These hypervariable regions are often termed as complementarity-determining regions 
(CDRs); various combinations of these regions decide the antigen specificity of the 
antibody. Uniform residue sequences outside the CDRs, which is called framework, do 
not make bonds with antigens, but control the three – dimensional folding of the Ig, 
provide the bending of the V region and support the structure of the binding-site. 
Moreover, the CDR structures can create different binding shapes in thier surface 
according to the structure of the antigens. The involvement of all binding sites of the 
antibody with the antigen and their combined strength is called avidity (Murphy, 2012, 
Kumagai and Tsumoto, 2001). On the other hand, some antibodies raised against certain 
antigens may often cross react with other closely related antigens or occasionally with 
unrelated antigens (Murphy, 2012). In some cases, greater affinity can be attained for 
antigens other than the original one (Kumagai and Tsumoto, 2001).  
 
 
Fig. 4. Typical structure of an antibody molecule.  
 
 
 
15 
 
 
Although antibodies can virtually recognize any structure as antigen, some antigens fail 
to elicit immune response, i.e. they are not immunogenic. Proteins are good immunogens 
and can provoke entirely advanced adaptive immune responses because they have the 
capability to engage T cells. Some proteins can serve as carriers for carbohydrates, 
nucleic acids and other kinds of molecules (Murphy, 2012). During immunization, the 
immunogenicity of less immunogenic antigens can be enhanced by attaching the 
antigens with protein carriers in the presence of adjuvants (Ellis, 1988, Murphy, 2012). 
Moreover, larger, structurally more complex, aggregated and more distant protein 
antigens are required to provoke entirely advanced specific humoral responses. The 
extent of antibody response is also dependent on antigen dose. Low levels of antigens 
(below threshold level) cannot elicit immune response, but a gradual increase in antibody 
takes place with rising antigen dose until it reaches a plateau. The response starts to 
decline with increasing antigens above the threshold level; the immune response may 
cease following administration of very high antigen concentration (Murphy, 2012). 
 
Fish IgM: So far, only three Ig classes, namely IgD (Wilson et al., 1997), IgT (Danilova et 
al., 2005, Hansen et al., 2005) and IgM (Acton et al., 1971) have been identified in fish. 
The IgM in teleost fish is produced by plasmablasts and plasma-like cells found in the 
anterior kidney and plays a pivotal role in stimulating memory IgM responses (Ye et al., 
2011); it is the most dominant Ig in plasma (Warr, 1997). IgM shows significant structural 
and biochemical diversities among different species (Magnadóttir, 1998). For example, 
higher vertebrates and cartilaginous fish have pentameric IgM (Kunihiko et al., 1984), 
whereas it is hexameric in some amphibians (Hsu and Du Pasquier, 1984). The teleost 
IgM is mainly tetrameric consisting of eight antigenic binding sites (Acton et al., 1971). 
Some fish may contain monomeric IgM in their sera, but tetrameric IgM is more efficient 
than the monomeric one in triggering the complement system due to variations in the 
structure of their Fc portions (Elcombe et al., 1985). Unlike the mammalian IgM, the IgM 
of many fishes lacks the J – chain, a polypeptide responsible for IgM polymerization 
(Magnadóttir, 1998); however, there are some evidences for its presence in catfish 
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(Mestecky et al., 1975) and rainbow trout (Sanchez et al., 1989). The H and L chains of 
each monomer of the tetrameric Ig have a molecular weight of 60 – 77 and 23 – 26 kDa, 
respectively (Van Muiswinkel and Woo, 1995). The amount of serum IgM in fish may 
greatly vary from species to species (Castro et al., 2013). In addition, parameters like 
stress (Cuesta et al., 2004), size, age, water quality and seasonal variations may 
influence the level of Ig in fish (Scapigliati et al., 1999). 
 
Immunization and immune response: The occurrence of specific antibody response can 
be monitored by examining sera of immunized, vaccinated or pathogen challenged fish. 
The magnitude of the specific antibodies increases with successive immunization of the 
animal with the same antigen. The initial response obtained during the first immunization 
is termed as primary antibody response. The primary antibody response is dominated by 
the production of IgM. The immune response can further develop into secondary or 
tertiary antibody responses with subsequent booster immunization at different times (fig. 
5) (Ellis, 1988). A little amount of specific antibody is produced during first immunization 
at time zero. After some days, the antibody builds up until it reaches a peak, and then, 
plateaus and starts to decrease slowly. With the second immunization, very rapid and 
higher amount of antibodies having greater antigen binding affinity are generated. The 
amplified antigen binding affinity is known as affinity maturation (Murphy, 2012). Unlike 
higher vertebrates, affinity maturation does not exist in teleost fish; however, 
immunological memory with increased and improved secondary antibody responses with 
high specificity to antigens has been demonstrated (Fletcher and Secombes, 2010). 
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Fig. 5. Antibody responses during first and second immunization and the formation of 
memory cells (Ellis, 1988). 
 
1.5 Objectives 
Investigation of the specific humoral immune response in the lumpfish is of paramount 
importance in developing an environmentally and welfare friendly protective vaccines 
against diseases caused by bacterial pathogens. Yet, little is known about the specific 
humoral immune response of the lumpfish. Thus, the aim of this study is to: 
 To investigate the presence of specific antibody response in sera of the lumpfish 
after immunization, vaccination and challenge with different bacterial pathogens.  
 To test the occurrence of cross-reactive antibodies between different bacterial 
strains and  
 To estimate total serum IgM in the lumpfish. 
 
 
 
 
 
18 
 
2. MATERIALS AND METHODS  
 
All procedures and methods in this thesis are done according to a protocol used by the 
Fish immunology group at the University of Bergen. The Norwegian Animal Welfare 
Research Authorities approved the challenge experiment that was carried out in the 
lumpfish. 
 
2.1 Fish and rearing conditions 
Lumpfish, Cyclopterus lumpus L., (800 g; 21cm, (n=51)) were used in the immunization 
experiment. The fish were obtained from Fjordforsk AS in Sogndal and kept in a green 
500 liter (1m3) fiberglass tank in the rearing facilities of Industrilaboratoriet (ILAB) in 
Bergen at the High Technology Center (HiB) inside the University of Bergen. The fish 
were reared under normal optimal conditions at a temperature of 12 ºC, salinity of 34 ‰ 
and a photoperiod of 12:12 (light:dark). The fish were fed with a commercial dry feed 
3mm pellet (BioMar) at 2% of their biomass using an automatic feeder. No sign of 
infection or mortality was observed during the experimental period.  
 
2.2 Bacteria and antigens 
Seven different Gram – negative bacterial pathogens listed in table 1 were used in this 
experiment. The bacteria were harvested from late exponential growth phase and grown 
in 50 ml tryptic soy broth (TSB) with or without additional NaCl depending on the growth 
requirement of the different bacteria. They were incubated at 21 ºC with continuous 
shaking at 200 rpm. Bacterial growth was checked and turbidity of the media was 
measured at 600 nm with a spectrophotometer (HITACHI U-1100). The growth for the 
atypical A. salmonicida strains was measured at 340 nm after resuspension in NaOH due 
to the agglutinating nature of this bacterium (Aakre et al., 1994). The bacterial 
suspension was washed three times in Phosphate Buffered Saline (PBS) by 
centrifugation at 2500 x g for 15 minutes following the decanting of the supernatant and 
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addition of PBS. The cells were re-suspended in a drop of distilled water and frozen at 
-20 ºC.  
 
The frozen whole bacterial (WB) cells were freeze – dried; a stock solution of 1 mg/ml 
antigen was prepared by dissolving 2 mg of the freeze-dried bacteria in 2 ml PBS with 5M 
Ethylenediaminetetraacetic acid (EDTA) (pH 7.3). The bacterial solution was sonicated 
three times for 20 seconds each at 40 - 60 Hz by ultrasonic homogenizer (Teknisk 
Kjemisk). The stock solution was divided into aliquots and stored at -20 ºC.  
 
Table 1. List of Gram negative fish bacterial pathogens used for immunization, challenge 
and antigens in ELISA and western blot and for SDS – PAGE profiles.  
 
Id. No. Bacteria Source 
8546 Atypical A. salmonicida Lumpfish 
AL20460 Atypical A. salmonicida Lumpfish 
AL122 Vibrio (Listonella) anguillarum O2 Cod 
8752  Vibrio (Listonella) anguillarum O1 Lumpfish 
8657 V. ordalii  Lumpfish 
 - Pasteurella spp. Lumpfish 
 - P. skyensis Salmon 
 
 
2.3 Immunization 
The fish were starved for 24 hours prior to immunization. For identification of vaccine 
groups the fish were marked with Visible Implant Elastomer, VIE, silicone implants (North 
West Marine Technology, Inc.) on the forehead. Four fluorescent dyes - orange, red, blue 
and green - were used. 
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Immunization was carried out against formalin inactivated WB from strains 8546 (atypical 
A. salmonicida), AL20460 (atypical A. salmonicida), AL122 (V. anguillarum O2), 8657 
Pasteurella spp. and 8657 (V. ordalii). The bacterial strains had been isolated after 
outbreak of disease in the lumpfish, except for AL112 (V. anguillarum O2), which was 
isolated from Atlantic cod. The fish were manually immunized three times with 100 µl of 
the antigen by intraperitoneal (i.p.) injections. The first immunization contained formalin 
inactivated bacteria emulsified in a mineral oil adjuvant (Freud incomplete) while the 
second immunization after four weeks of the first immunization and the third 
immunization after four weeks of the second immunization were conducted without the 
use of adjuvants.  
 
2.4 Sera 
Immunized and non-immunized groups. Sera from immunized (n=49) and 
non-immunized (n=2) groups were collected two weeks post the final immunization. The 
non-immunized sera were collected from fish that were injected with PBS only. The fish 
were sedated using a mixture of Metacaine and Metomidate and stunned to death by a 
blow to the head. Blood was drawn from Vena Caudalis and directly transferred to blood 
collection tubes without additives (BD Vacutainer). The blood samples were placed at 
4ºC overnight to allow blood coagulation. The coagulated blood was centrifuged at 
2500xg (Allerga X – 15R Centrifuge, Beckman Coulter) for 15 minutes at 4ºC. The serum 
fraction was carefully extracted and stored at -20ºC in small aliquots for further analysis.  
 
Non – vaccinated challenged group. Sera from this group were collected from survivals of 
fish post challenge with AL20460 (atypical A. salmonicida), 8546 (atypical A. 
salmonicida), 8752 (V. anguillarum O1) or Pasteurella spp. The fish had been challenged 
by bath, intraperitoneal (i.p.) injection or cohabitation. For bath challenge, the fish had 
been exposed to a bacterial concentration of 2x106 bacteria/ml for 1 h. The cohabitation 
and i.p challenge experiments were carried out in tanks with i.p to cohabitant ratios of 1:1 
or 1:2, respectively. Challenge against strains AL20460 (atypical A. salmonicida), 8546 
(atypical A. salmonicida) and 8752 (V. anguillarum O1) had been performed by 
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cohabitation and i.p. injections of 50 µl of 1x103 or 1x106 bacteria/ml. For challenge 
against the Pasteurella spp., the fish were injected with bacterial suspensions of 5.1x108 
at 1/20, 1/50, 1/100 or 1/1000 dilutions in PBS. The non-challenged control sera were 
collected from non-challenged fish that were injected with PBS only. 
 
Vaccinated challenged group. Sera were collected from survivals of vaccinated fish group 
that were challenged against AL20460 (atypical A. salmonicida), 8546 (atypical A. 
salmonicida) or 8752 (V. anguillarum O1). The fish were i.p. injected (before challenge) 
with vaccines listed in table 2. The vaccinated fish were marked with green (Trivalent), 
blue (Monovalent) or red (Alpha Marine Micro 3) fluorescent dyes. Non-vaccinated 
challenged fish injected with PBS were also included in the experiment and these were 
not marked. The bacterial concentration used for the challenge experiment was based on 
mortality profiles in challenge models of non-vaccinated fish (Rønneseth, 2015).  
 
Table 2. Injectable vaccines used for vaccination of the lumpfish before challenge. Alpha 
Marine Micro 3 is a commercial vaccine developed for Atlantic cod (Gadus morhua) by 
Pharmaq AS, Norway. 
 
Vaccine          Challenge       Content 
 
Monovalent 
8546 (atypical A. salmonicida) Atypical A. salmonicida 
AL20460 (atypical A. salmonicida) Atypical A. salmonicida 
8752 (V. anguillarum O1) V. anguillarum O1 
   
 
Trivalent 
8546 (atypical A. salmonicida) Atypical A. salmonicida, V. anguillarum O1 
& Pasteurella spp. AL20460 (atypical A. salmonicida) 
8752 (V. anguillarum O1) 
   
AMM3  
            
8546 (atypical A. salmonicida) 
AL20460 (atypical A. salmonicida) 
Atypical A. salmonicida and V. anguillarum 
(O2a & O2b) 
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2.5 Enzyme – Linked – Immunosorbent - Assay 
 
 
Figure 6. A diagrammatic description of the ELISA method used. Modified from: 
University of Bergen Fish Immunology Laboratory Journal. 
 
The same ELISA procedure as shown in fig. 6 were employed for all groups. ELISA with a 
flat-bottomed 96 well microtiter plate in an 8x12 format (F96 MAXISORP 
NUNC-IMMUNO PLATE) was used to test for antibody levels in fish sera post 
immunization and challenge with or without vaccination. The ELISA was also used to test 
antibody cross-reactivity between strains 8546 (atypical A. salmonicida) and AL20460 
(atypical A. salmonicida) and also between strains 8752 (V. anguillarum O1) and AL-122 
(V. anguillarum O2). Strain 8752 (V. anguillarum O1) was used for challenge, whereas 
AL-122 (V. anguillarum O2) was included as antigen in the vaccine and for antisera 
production. 
 
 
 
23 
 
First, the concentration of antigen needed for coating the ELISA wells was optimized. 
Concurrently, the effect of 3% skimmed milk blocking solution on antigen was also 
determined. For antigen optimization, 1 mg/ml of antigen from a stock solution was 
diluted in PBS – T to make five final concentrations of 10 µg/ml, 8 µg/ml, 6 µg/ml, 4 µg/ml 
and 2 µg/ml from each bacterium according to a dilution equation (Eq. 1). The antigen 
concentration that gave the highest response in terms of optical density (OD) at 492 nm 
was selected.  
 
                          C1V1 = C2V2                    Eq. 1                
Where 
 C1 = concentration 1 
 C2 = concentration 2 
 V1 = volume 1 
 V2 = volume 2 
 
For testing the effect of blocking solution on antigen, the 96 well ELISA plate was divided 
into two equal parts, one part with a blocking solution (200 µl per well) and the other part 
without a blocking solution. A volume of 200 µl PBS-T per well was added to the 
unblocked part. The wells were coated with 10 µg/ml of WB antigen (150 µl/well). The 
plates were covered with an empty microtiter plate, wrapped in a plastic and incubated at 
4 ºC overnight. Excess unbound antigens were removed by washing with 200 µl 
PBS-Tween per well using a washer (Nunc-ImmunoTMWash 12). The washing, covering 
and wrapping procedures were the same for all the steps. The antigen was not blocked 
with 3% skimmed milk when testing for antibody levels in immunized, non-immunized 
and challenged groups and also for cross reactivity test.  
 
Serum was diluted in PBS – T; different sera dilutions listed in table 3 were used. A 
volume of 100 µl of serum diluted in PBS-T was loaded into the well in duplicates and 
incubated overnight at 4 ºC. The plates were washed and 50 µl of rabbit anti-lumpfish, a 
secondary antibody diluted 1/1000 in PBS-T, was added to each well. The rabbit 
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anti-lumpfish Ig was obtained from the fish immunology group at the University of Bergen. 
The plates were incubated for two hours at room temperature (RT) and after washing the 
plates, 50 µl horseradish peroxidase-conjugated goat anti-rabbit Ig (HPR, DAKO) diluted 
1/1000 in PBS-T was added and incubated for 1 hour. Peroxidase substrate solution was 
prepared and 15 µl hydrogen peroxide (H2O2) (Sigma Aldrich) was added to the substrate 
solution just before loading the substrate into the wells. After final washing, 50 µl of 
peroxidase substrate solution was added to each well resulting in development of colored 
products. The reaction was stopped after six minutes by adding 50 µl 2.5N sulfuric acid 
(H2SO4) into each well. The plates were read by a microplate reader (Tecan) at 492nm. 
The final OD readings were used to compare between different groups. 
 
Table 3. Dilution of sera used for detection of antibodies by ELISA 
       Test       Dilution 
Antigen optimization 1/50 to 1/800 (twofold)  
Specific antibodies (antibody titration) in 
immunized groups 
1/50 to 1/25,600 (twofold) 
Antibody cross reactivity 1/50 
Antibody detection in challenged groups 1/200 & 1/800 
 
 
2.6 Gel electrophoresis of proteins 
Proteins from the sonicated WB antigens were separated using sodium-dodecyl sulfate – 
polyacrylamide gel electrophoresis (SDG-PAGE). The mini-PROTEAN Tetra cell casting 
module (Bio-Rad) was properly assembled and the space in-between the short and 
spacer (0.75mm) glass plates was filled with 12% resolving gel in a mixture with 5 µl 
Tetramethylethylenediamine (TEMED) (Sigma Aldrich) and 50ul 10% ammonium 
persulfate (APS). A little amount of deionized water (Milli-Q) was added on top of the gel. 
After pouring off the water, 4% stacking gel was added on top of the polymerized 
resolving gel. A comb (Mini-PROTEAN® Comb, 10-well, 1.0 mm, 44 μl) was put on top of 
the stacking gel to create wells for sample and standard proteins. The stacking gel was 
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allowed to polymerize at RT for 45 minutes. The comb was removed from the casting 
frame (Mini-PROTEAN® Bio-Rad). The gel together with the glass plates were fastened 
into a Mini-PROTEAN® Tetra Electrode Assembly and immersed into a buffer tank 
(Mini-PROTEAN® Tetra cell, Bio-Rad) filled with 1xTris-Glycine-Sodium-dodecyl-sulfate 
(TGS, pH 8.3) buffer. A concentration of 2 mg/ml freeze-dried sonicated WB from strains 
8752 (V. anguillarum O1), ALL-122 (V. anguillarum O2), AL-20460 (atypical A. 
salmonicida), 8546 (atypical A. salmonicida), 8652 (V. ordalii), Pasteurella spp. and P. 
skynesis were prepared. Equal volumes of the sonicated WB sample and gel-loading 
buffer, also called 2xLaemmli concentrate, containing 2-mercaptoethanol were mixed and 
boiled for 5 minutes at 98ºC using a thermo-mixer (Eppendorf). For silver stain, 10 µl 
unstained low range SDG-PAGE standard (#161-0314, Bio-Rad) diluted 1/20 in the 
gel-loading buffer was used, whereas 5 µl Precision PlusTM KaleidoscopeTM pre-stained 
standard (#161-0324, Bio-Rad) was used in gels for immunoblotting. A volume of 10 µl 
from each sample was pipetted and loaded into their respective wells in the gel. The 
buffer tank was covered with a cell lid attached to power cables (Bio-Rad) and 190 volts 
of electrical current was passed across the gel for 45 minutes. 
 
2.7 Silver staining of proteins 
After protein separation on the SDS-PAGE, the proteins were fixed for 20 minutes with a 
fixative solution. The gel was washed 2x10 minutes in deionized water and stained with 
silver-staining technique (Switzer et al., 1979) for 40 - 45 minutes until clear bands were 
formed. The staining solution was replaced by 5% acetic acid and the gel with the protein 
bands was photographed. The molecular weight of the sample proteins was estimated 
according to a protocol for molecular weight estimation by the Bio-Rad (BIO-RAD, 2015). 
The relative distances (Rf) of the standard and unknown proteins were determined using 
eq. 2. Using the values for the standard proteins, a linear standard curve was developed 
by plotting the logarithm of the molecular weight (logMW) of the standard proteins on the 
y – axis and its Rf value on the x – axis. Then, the molecular weight of the sample was 
estimated by interpolating the Rf values of the sample into the x variable of the linear 
formula obtained from the standard curve.   
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Rf  =  Migration distance of the protein (cm)     Eq. 2 (BIO-RAD, 2015)  
    Migration distance of the dye front  (cm) 
 
 
 
 
 
2.8 Western blot 
The protein gel, a nitrocellulose membrane (0.45µm) (Bio-Rad), blot absorbent 
chromatography papers (Whatman®) and foam pads were soaked in transfer buffer for 
30 minutes. The protein gel and the nitrocellulose were tightly placed together and 
sandwiched in between the moist blot absorbent chromatography papers assembled in a 
gel holder cassette as described by Garfin (2003) (fig. 7). The cassette was submerged 
in transfer buffer in a vertical position inside a buffer tank mounted with positive and 
negative electrodes at the opposite sides of the tank. The tank was covered with a lid 
attached to electrical cables. Identical copies of the proteins in the same pattern as in the 
gel were copied and immobilized on the nitrocellulose membrane by applying a 100 volt 
electrical current across the gel for 1 hour in the presence of ice. After the electrophoretic 
transfer of the proteins, the membrane was removed and unbound protein sites were 
blocked by incubating the membrane in Tris buffered saline (TBS) with 3% skimmed milk 
for 1 hour at RT. The membrane was washed 2x5 minutes in TTBS and the same 
washing procedure was applied in every step of the immuno-detection (fig. 8). The 
protein blot was probed with specific primary antibody by incubating the membrane for 
overnight at 5ºC in antiserum (collected from immunized groups) diluted 1/100 in TTBS 
with 1% skimmed milk (antibody dilution buffer). All the immune-detection procedures 
after this step were conducted at RT. The blot was probed for the second time with rabbit 
anti-lumpfish Ig (secondary Ig) and the third time with enzyme conjugated goat anti-rabbit 
Ig for incubation period of 1 ½ hours each. Both anti-lumpfish Ig and enzyme conjugated 
Ig were diluted 1/500 and 1/1000 in the antibody dilution buffer, respectively. After the 
final washing, the membrane was placed in TBS for 5 minutes just before imaging the 
blots. The membrane was immersed for 5 minutes in a mixture consisting of equal 
volumes of Clarity ECL Western Blotting substrates (Peroxide and luminescence 
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substrates) (Bio-Rad). The best blot was considered by shooting and comparing several 
blot images at different exposure times using Molecular Imager® ChemiDocTM XRS 
system (Bio Rad). The presence of cross reactivity between the samples was checked. 
The molecular weight of the protein bands was estimated from the Kaleidoscope 
Pre-stained Standards (#161-0324, Bio-Rad).  
 
 
 
 
Figure 7. A protein tank electro-transfer device in an exposed view (Garfin, 2003). The 
gel (b) and the membrane (c) in between the moist blot absorbent filter papers and foam 
pads (d) were held by the cassette (a). The cassette (e) was vertically placed in the tank 
(f) filled with the transfer buffer.  
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Figure 8. A diagrammatic description of immuno-detection by western blot modified from 
Bio-Rad Laboratories, Inc. (BioRad, 2015). The lumpfish (primary) antibody (d) was 
specifically bound to the target protein (b) fixed in the nitrocellulose membrane (a). Free 
sites in the membrane were blocked (c) with a blocking solution. The primary antibody 
was probed with rabbit anti-lumpfish (secondary) antibody (e). The specific antibody was 
detected with the help of a goat anti-rabbit (tertiary) antibody (f) conjugated to enzyme (g), 
which acts on the substrate (h) to give a detectable product (i) (BioRad, 2015).  
  
2.9 Bradford protein assay for determination of purified lumpfish IgM concentration 
The concentration of purified lumpfish IgM was determined by generating a standard 
curve according to the Bradford Protein Assay (Bradford, 1976). The purified IgM was 
obtained from the fish immunology group at the University of Bergen. Bovine Serum 
Albumin (BSA) (Bio-Rad Laboratories, Inc.) was used as a standard protein. Initial 
concentration of 1.08 mg/ml of BSA was used to make four final concentrations by 
pipetting 50 µl, 100 µl, 200 µl and 300 µl of the standard protein into 450 µl, 400 µl, 300 µl 
and 200 µl of PBS making a final volume of 500 µl each, respectively. A solution 
containing 1 part Coomassie Brilliant Blue G-250 (Imperial Chemical Industries) and four 
parts distilled water (MilliQ) was also prepared. Four 5 ml test tubes of the known 
samples including two separate test tubes of the unknown and blank samples were filled 
with 1 ml of the solution. A 100 µl of the standard protein and unknown samples was 
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pipetted and added into their respective test tubes. PBS was added into the blank sample. 
After mixing and incubating at room temperature for 5 minutes, the samples were 
transferred to cuvettes and measured by a spectrophotometer at 595 nm to obtain OD. 
The OD’s of the blank samples were subtracted from the OD’s of the standard protein 
and the unknown samples. A standard curve was generated by plotting sample OD’s in 
the y-axis against the concentrations of the standard protein in the x – axis. The 
concentration of the purified IgM was calculated from the standard curve. The purified 
IgM with a known concentration was used as reference IgM for the determination of 
protein content in all immunized fish sera.  
 
2.10 Single Radial Immunodiffusion Assay for determination of total serum IgM 
SRID was used to quantify the total IgM concentrations in in sera of immunized and 
non-immunized groups in reference to the standard proteins. The procedures of the SRID 
assay were the same for all the experiments. Agarose gel was prepared by mixing 0.335 
g agarose 1% (Lonza Group Ltd) and 0.67 g 2% polyethylene glycerol (PEG) 6000 
(Sigma-Aldrich, CO.) in 33.33 ml PBS (pH 7.2, Lonza Group Ltd). The mixture was boiled 
in a microwave oven (Whirlpool) at 930 watt until the crystals were completely 
homogenized. The gel was cooled down to 55⁰C and 134.11 µl rabbit anti-lumpfish IgM 
diluted 1/250 in PBS (pH 7.2, Lonza Group Ltd) was incorporated into the gel. Care was 
taken to avoid denaturation of Ig by the heated mixture. A thin transparent and flexible 
plastic plate, GelBond®film (Pharmacia LKB Biotechnology AB) was used to support the 
agarose gel. The film was laid down on to a clean rectangular 13.5x23x0.4 cm (143.1 cm3) 
hard plastic pre-warmed in an incubator (Termarks AS) at 55 – 60 ⁰C. The gel was 
carefully poured onto the hydrophilic side of the film, making sure that the gel was evenly 
spread. After the gel was polymerized for ca. 15 minutes at RT, small circular wells (4 mm 
in diameter) were cut on the gel surface by punching it with a revolving leather belt hole 
puncher (POWERFIX®).  
 
The purified lumpfish IgM was used as a reference for generating a linear standard curve. 
Six concentrations of the purified IgM ranging from 160 ng/µl to 5 ng/µl twofold dilutions 
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were prepared. A standard curve was included for each group. The standard proteins and 
the sera from the immunized (n=10) and non-immunized groups (n=2) were diluted at 
1/20 in PBS (pH 7.2). Then, 5 µl of the samples including the standard proteins were 
pipetted, loaded in duplicates into their respective wells and incubated in a moist 
chamber for 48 hrs. Afterwards, a 140x270mm filter paper (Struers KEBO LAB AB) 
moistened with PBS was carefully laid down onto the agarose gel. Additional five dry filter 
papers were put on top of the moistened filter paper; the gel was pressed by placing 864 
g of weight on top of the dry filter papers for 5 minutes. The filter papers, including the 
moistened one, were carefully removed from the gel and the gel was immersed in PBS 
for 15 minutes. The PBS was removed from the gel and the pressing procedure was 
repeated followed by washing in PBS for 15 minutes. After the second washing, the gel 
was again pressed with a moistened and five dry filter papers for five minutes and dried in 
an incubator at 40 ºC for 1 hr. The gel was stained with a Coomassie blue solution for 15 
minutes and unstained by Coomassie destaining solution. Circular precipitins were 
observed around the well. The diameter of the precipitins from the standard proteins 
were measured using Adobe Illustrator CS5 software and plotted against the 
concentrations of the purified IgM to make a standard curve with a linear equation and R2 
value. The linear equation (Eq. 3) (Hazewinkel, 2001) from the standard curve was used 
for quantification of IgM concentrations in both immunized and non-immunized groups. 
The y variable was represented by the diameter of the precipitin in millimeter (mm) and x 
variable by IgM concentration in ng/µl. To evaluate the IgM concentration, x variable was 
substituted with the diameter of the precipitin. The final x values were multiplied by the 
dilution factor to find out the serum IgM concentration in mg/ml. The total IgM 
concentrations in both the immunized and unimmunized groups were compared.  
 
y = ax + b     a ≠ 0       Eq. 3 (Hazewinkel, 2001)   
Where,  y = diameter of a ring in mm (dependent variable) 
x = IgM in ng/µl (independent variable) 
b = a constant or value of a dependent variable when x = 0 (y 0 incercept) 
a = a constant or coefficient of independent variable (slope) 
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2.11 Statistics 
 
Data were statistically analyzed by use of GraphPad prism version 5.00 for windows 
(GraphPad, 2007) or R program for statistics (R Core, 2014). GraphPad Prism was used 
to make antibody titration curves. Shapiro-Wilk test (Royston, 1982) and 
Quantile-Quantile plot (Q-Q plot) (Becker et al., 1988) were performed to test for 
normality of the data using R program for statistics (R Core, 2014). Both student t-test 
and a non-parametric Wilcoxon-Mann Whitney test for independent samples were used 
for comparison of means or medians between groups due to non-Gaussian distribution in 
some groups. Comparisons within or between groups were described by boxplots. A 
horizontal line inside the boxplots represents the median. The bottom of the box is the 
first quartile, which is less than or equal to 25% of the data, whereas the top of the box is 
the third quartile, which is less than or equal to 75% of the data. The vertical upper and 
lower whiskers that extend outside the box are highest and lowest data values, 
respectively. Data points elsewhere are outliers (McGill et al., 1978). Statistical inference 
was made based on p values, i.e. observations were considered similar when p > 0.05 
but different when p < 0.05. 
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3. RESULTS 
 
3.1 ELISA 
 
3.1.1 Antigen optimization and the effect of blocking solution on antibody response.  
After a few seconds of adding the OPD substrate to the wells, development of brownish 
colour was observed (not shown), which increased in strength until the reaction was 
stopped at 6 minutes. The OD (492 nm) values were proportional to the amount or 
strength of colour developed, i.e. strong colours were formed at wells with high antigen 
concentrations and low serum dilutions for all groups or vice versa. High antibody 
response with strong colour was observed at 10, 8, or 6 µg/ml of antigen (fig. 9). The 
optimal antigen dilution that could be used to detect specific antibodies was recorded at 
10 µg/ml of antigen. Moreover, blocking had no effect on antibody response (p>0.05).  
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10 µg/ml;  8 µg/ml; 6 µg/ml;  4 µg/ml; 2 µg/ml;  blank 
Fig. 9. Antibody dilution curves at different antigen concentrations in groups immunized 
against formalin inactivated WB antigens of strains 8546 (atypical A. salmonicida) (A), 
AL20460 (atypical A. salmonicida) (B), AL122 (V. anguillarum O2), (C), Pasteurella spp. 
(D), and 8657 (V. ordalii). The ELISA plates were coated with 150 µl freeze-dried, 
sonicated WB Ags. The optimized antigens were homologous, except for group AL122 
(C), which was tested against a heterogeneous antigen from strain 8752. Continuous and 
broken lines indicate for the use and without the use of 3% skimmed milk blocking 
solution in the blocking step, respectively. 
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3.1.2 Response to immunization.  
 
The presence of antigen specific antibody two weeks post-immunization was determined 
by ELISA; the results were described by a sigmoidal curve in a dose-response 
relationship, where OD (response) is a function of the logarithm of serum dilution 
(dose).The level of antigen – antibody reactivity was different between groups; there was 
also large individual variation within groups (fig. 10), i.e. some fish were high responders, 
while others were low responders. The specific antibody response in each group was 
compared at 1/400 serum dilution; antiserum from fish immunized with Pasteurella spp. 
contained the highest specific antibodies followed by AL122 (V. anguillarum O2), 
AL20460 (atypical A. salmonicida), 8546 (atypical A. salmonicida) and 8657 (V. ordalii) 
(fig. 11, table 4). However, no significant difference (p>0.05) in antibody level was 
observed for antiserum from fish immunized against strain 8657 (V. ordalii). 
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Fig. 10. Serum antibody dilution curves for the different immunized groups quantified in 
ELISA. A) Antiserum: 8546 (atypical A. salmonicida); B) Antiserum: AL20460 (atypical A. 
salmonicida); C) Antiserum: AL122 (V. anguillarum O2); D) Antiserum: Pasteurella spp.; 
E) Antiserum: 8657 (V. ordalii). Homologous sonicated WB cells were used as coating 
antigen in ELISA with exception to antiserum to AL122 (V. anguillarum O2), which was 
tested using a heterogeneous antigen from strain 8752 (V. anguillarum O1).   
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Fig. 11. Mean antibody titration curves for each group of immunized fish (A) and 
comparison of specific antibody levels between groups at 1/400 serum dilution (B) by 
ELISA. The arrow in fig. 11A indicates for mean specific antibody levels at 1/400 serum 
dilution. The tests were conducted using homologous sonicated WB cells as antigens in 
ELISA. Antiserum to AL122 was tested using a heterogeneous from strain 8752 (V. 
anguillarum O1). Individual serum dilution curves are shown in fig. 10. *, p<0.05; Non-im, 
non-immunized control. 
 
 
 
37 
 
   
Table 4. Mean specific antibodies at 1/400 serum dilution for immunized and non – 
immunized groups. 
 
Group  N Mean OD (492 nm) ± SD CV 
8546 (atypical A. salmonicida)  10 0.60 ± 0.16 0.28 
AL20460 (atypical A. 
salmonicida) 
 10 0.80 ± 0.17 0.21 
AL122 (V. anguillarum O2)  10 0.94 ± 0.33 0.34 
Pasteurella – spp.   10 1.12 ± 0.15 0.13 
8657 (V. ordalii)  10 0.25 ± 0.15 0.61 
Non – immunized control  2 0.16 ± 0.09 0.59 
 
 
3.1.3 Cross-reactivity test.  
 
Antibody cross – reactivity between strains 8546 (atypical A. salmonicida) and AL20460 
(atypical A. salmonicida) and between strain AL122 (V. anguillarum O2) and 8752 (V. 
anguillarum O1) were tested by ELISA. The antisera to 8546 and AL20460 were reactive 
to one another, showing significantly higher antibodies when compared to 
non-immunized control serum (fig. 12, table 5). The amount of antibody response to the 
heterogeneous and homogeneous antigens was similar (p>0.05).  
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Fig. 12. Analysis of cross reactive antibodies in antisera raised against strains 8546 
(atypical A. salmonicida) and AL20460 (atypical A. salmonicida) to freeze dried sonicated 
WB used as antigens in ELISA. Serum diluted 1/50 in PBS – T. Serum diluted 1/50. 
 
Table 5. Mean antibody levels of antisera (1/50 dilution) when tested for cross-reactivity 
with heterogeneous freeze-dried sonicated WB used as Ag in ELISA.  
 
Antisera Coating antigen N Mean OD (492 nm) ± SD 
8546 (atypical A. salmonicida) 8546 
AL20460 
10 1.04 ± 0.09 
10 0.92 ± 0.11 
 
AL20460 (atypical A. salmonicida) 8546 
AL20460 
10 
10 
0.96 ± 0.11 
1.08 ± 0.08 
 
Non-immunized control  8546/AL20460 2 0.28 ± 0.08 
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Similarly, antiserum to strain AL122 (V. anguillarum O2) had Abs cross reactive to 
freeze-dried sonicated WB antigens from strain 8752 (V. anguillarum O1). Elevated 
levels of antibodies were detected to either homogeneous or heterogeneous antigens 
compared to the non-immunized control serum (fig. 13, table 6). The level of antibodies to 
homogeneous and heterogeneous antigens were the same (p>0.05). However, high 
levels of antibodies were also detected in one of the non-immunized control sera. 
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Fig. 13. Analysis of cross-reactive antibodies by ELISA in antiserum raised against strain 
AL122 (V. anguillarum O2). For cross-reactivity test, the ELISA wells were coated with 
heterogeneous sonicated WB cells of strain 8752 (V. anguillarum O1) and compared to 
the level of antibodies to the homologous antigen in ELISA. Serum diluted 1/50; ns, 
p>0.05.  
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Table 6. Mean antibody levels of antiserum to strain AL122 (V. anguillarum O2) (1/50 
dilution) when tested for cross-reactivity with heterogeneous freeze-dried sonicated WB 
used as antigen in ELISA.  
 
Antiserum Coating antigen N Mean (OD) ± SD 
AL122 (V. anguillarum 
O2) 
AL122 (V. anguillarum 
O2) 
5 1.35 ± 0.12 
 8752 (V. anguillarum O1) 5 1.27 ± 0.13  
Non-immunized control 8752/AL122 2 0.57 ± 0.33 
 
 
 
3.1.4 Response to non-vaccinated challenged group.  
 
Sera from challenge survivals were collected 35, 49, 43 and 11 days post challenge 
against strains 8546 (atypical A. salmonicida), AL20460 (atypical A. salmonicida), 8752 
(V. anguillarum) and Pasteurella spp., respectively. ELISA analysis showed that all 
sera from all different challenge groups had low antibody levels. Individual variation in 
antibody levels was also observed in all sera samples analysed by ELISA.  
  
No significant antibody levels were detected in sera of fish survivals that were challenged 
against strain 8546 (atypical A. salmonicida) by bath, cohabitation or i.p. compared to the 
non-challenged control serum (p> 0.05) (fig. 14). For fish challenged by cohabitation, 
only sera collected from fish that were challenged by cohabitation in a 1 to 1 ratio to i.p. 
were analysed for antibody response.  
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Fig. 14. Antibody levels detected by EILSA in sera of non-vaccinated fish 35 days post 
challenge against strain 8546 (atypical A. salmonicida) by different challenge exposures 
(bath, i.p. or cohabitation). Coating antigen: sonicated WB cells of strain 8546 (atypical A. 
salmonicida). Non-cha-c, non-challenged control; i.p., intraperitoneal injection; Co., 
cohabitation; +, 106 bacteria/ml; ++, 106 bacteria/ml.  
 
Higher antibody levels were detected in sera from fish challenged with strain AL20460 
(atypical A. salmonicida) by cohabitation (p<0.05) compared to the non-challenged 
control serum (fig 15). However, no significant antibodies were found in sera from fish 
challenged by i.p. compared to in sera of the non-challenged control group (p>0.05). 
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Fig. 15. Antibody levels detected by ELISA in sera of non-vaccinated fish 49 days post 
challenge with strain AL20460 (atypical A. salmonicida) by different challenge exposures 
(i.p. or cohabitation). Coating antigen: sonicated WB cells of strain AL20460 (atypical A. 
salmonicida). **, p<0.01; ***, p<0.001.   
 
Challenge with strain 8752 (V. anguillarum O1) by i.p. or cohabitation revealed the 
presence of higher amount of antibodies compared to the non-challenged control group 
(p<0.05) (fig. 16). Highest Antibody levels were obtained in sera collected from i.p. 
challenged survivals, but only two fish survived from i.p. challenged group. The 
cohabitation challenge induced higher antibody levels than the bath challenge (p<0.001). 
In fact, the bath challenge did not induce significant antibody levels compared to the 
non-challenged control group (p>0.05).  
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Fig. 16. Antibody levels detected by ELISA in sera of non-vaccinated fish 43 days post 
challenge with strain 8752 (V. anguillarum O1) by different challenge exposures (bath, i.p 
or cohabitation). Coating antigen: sonicated WB cells of strain 8752 (V. anguillarum O1). 
 
Challenge with Pasteurella spp. was carried out by i.p. injection or cohabitation challenge 
at different bacterial concentrations, but only few from those challenged by cohabitation 
survived. Sera were analysed for the presence of specific antibody response 11 days 
post challenge. All sera from fish challenged with different bacterial concentrations 
contained higher antibody levels than sera from the non-challenged control group 
(p<0.001) (fig. 17). The same antibody levels were detected in sera from fish challenged 
with 1/50, 1/100 and 1/1000 bacterial dilutions (p>0.05). However, sera from fish 
challenged with 1/20 bacterial dilution contained the lowest antibody level (p<0.05).  
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Fig. 17. Antibody levels detected by ELISA in sera of non-vaccinated fish 11 days post 
challenge with Pasteurella spp. through cohabitation by different doses of bacteria. 
Coating antigen: sonicated WB cells of Pasteurella spp.   
 
 
3.1.5 Response to vaccinated challenged group 
 
Sera from vaccinated challenged groups were analysed by ELISA for antibody response 
post challenge with strain 8546 (atypical A. salmonicida) and post challenge with strains 
AL20460 (atypical A. salmonicida) and 8752 (V. anguillarum O1). All sera collected from 
the survivals of vaccinated and non-vaccinated challenged (i.p.) groups revealed 
significantly higher antibody levels compared to the non-challenged control group 
(p<0.001). However, the antibody levels in sera of vaccinated challenged groups was 
much higher than that of the non-vaccinated challenged (i.p.) group (p<0.001).  
 
The amount of serum antibody in sera from fish 43 days post challenge with strain 8546 
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(atypical A. salmonicida) were similar between fish that were treated with trivalent and 
AMM3 vaccines (p>0.05) (fig. 18). However, antibody levels in sera from fish vaccinated 
with monovalent vaccines was lower compared to sera from fish treated with trivalent 
vaccine (p<0.05).  
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Fig. 18. Serum antibody levels in fish treated with different vaccines (AMM3, trivalent, or 
monovalent) 43 days post challenge (i.p.) with strain 8546 (atypical A. salmonicida). 
Coating antigen: sonicated WB cells of strain 8546 (atypical A. salmonicida). AMM3: 
Alpha Marine Micro 3; Tri: trivalent; Mono: monovalent; PBS: non-vaccinated (placebo) 
challenged; Non-cha-c: non-vaccinated non-challenged control group.  
 
The antibody levels in fish treated with monovalent and AMM3 vaccines were similar 
(p>0.05) 31 days post challenge with strain AL20460 (atypical A. salmonicida), but sera 
from fish vaccinated with trivalent vaccine had slightly lower antibody levels compared to 
sera from fish treated with monovalent vaccine (p<0.05) (fig. 19). The trivalent and the 
commercial AMM3 vaccines against atypical furunculosis induced better antibody 
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response 43 days post challenge with strain 8546 (atypical A. salmonicida) than 31 days 
post challenge with strain AL20460 (atypical A. salmonicida) (p<0.05). 
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Fig. 19. Serum antibody levels detected by ELISA in fish treated with different vaccines 
(AMM3, trivalent, or monovalent) 31 days post challenge (i.p.) with strain AL20460 
(atypical A. salmonicida). Coating antigen: sonicated WB cells of strain AL20460 (atypical 
A. salmonicida).  
 
Fish challenged with 8752 (V. anguillarum O1) had been treated only with monovalent 
and trivalent vaccines; similar antibody levels were detected between sera from fish 
treated with these vaccines (p>0.05) (fig. 20).   
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Fig. 20. Serum antibody levels detected by ELISA in vaccinated fish 31 days post 
challenge (i.p.) with strain 8752 (V. anguillarum O1). Coating antigen: sonicated WB cells 
of strain 8752 (V. anguillarum O1).  
 
3.2 SDS – PAGE analysis of proteins 
 
Fig. 21 shows a standard curve of low range SDS – PAGE standard protein and silver 
stained SDS – PAGE of different sonicated WB antigens. A wide range of protein bands 
of low and high molecular masses across the SDS – PAGE were observed. The size of 
protein band in each sample was estimated using the linear equation of the standard 
curve for the standard proteins (fig. 21A). All strains with exception to strain AL122 (V. 
anguillarum O2) had several major and minor protein bands visible across the 
SDS-PAGE (fig. 21B). Strain AL122 (V. anguillarum O2) failed to produce a single protein 
band in the SDS-PAGE (fig. 21B, lane 2).  
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The protein profile of each strain varied in band strength, and it appears the two atypical 
A. salmonicida strains (8546 and AL20460) showed slight differences (fig 21B, lanes 4 & 
6). Unlike strain 8546 (atypical A. salmonicida), strain AL20460 (atypical A. salmonicida) 
possessed three clear bands at ca. 37, 40 and 45 kDa and a weak band at ca. 50 kDa (fig. 
21B, lane 6). However, both strains shared similar proteins of high molecular weight 
(HMW) > 63 kDa protein and low molecular weight (LMW) < 32 kDa protein.  
 
P. skyensis and Pasteurella – like spp. also displayed different protein profiles with major 
protein bands of ca. 37 and 35 kDa, respectively (fig. 21B, lanes 1 & 3).  
 
Strains 8752 (V. anguillarum O1) and 8657 (V. ordalii) showed similar LMW protein 
profiles with prominent bands of ≤ 14.5 kDa. However, both strains had different 
molecular masses of major proteins at ca. 38 kDa for strain 8752 (V. anguillarum) and 36 
kDa for strain 8657 (V. ordalii) (fig. 21B, lanes 5 & 7). Moreover, strain 8657 (V. ordalii) 
displayed several closely spaced bands above its major protein band of 36 kDa protein.   
 
 A             B 
  
 
Fig. 21. A) A standard curve for low range SDS – PAGE standard at 12% gel. B) 
Electrophoretic separation and silver staining of proteins in the SDS – PAGE. Numbers in 
the right side of the gel indicate for molecular masses in kDa. Lane 1: antigen P. skyensis; 
Lane 2: antigen AL122 (V. anguillarum O2); Lane 3: antigen Pasteurella – spp.; Lane 4: 
antigen 8546 (atypical A. salmonicida); Lane 5: antigen 8752 (V. anguillarum O1); Lane 6: 
antigen AL20460 (atypical A. salmonicida); Lane 7: antigen 8657 (V. ordalii).; Lane 8: low 
range SDS - PAGE standards (BIO-RAD, 2015). 
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3.3 Western blot 
 
Antiserum from fish immunized with formalin inactivated WB from strain 8546 (atypical A. 
salmonicida) reacted specifically with several components of a homologous antigen, 
having apparent MWs of 10, 13, 20, 22, 28, 50, 55 and 67 kDa (fig. 22A, Lane 2). 
Similarly, the same antiserum recognized similar antigenic components of a 
heterogeneous antigen from strain AL20460 (atypical A. salmonicida) (fig. 22A, Lane 1), 
but failed to recognize the 50-kDa protein, which was observed on the SDS-PAGE in 
strain AL20460 (atypical A. salmonicida) (fig. 21B, lane 6).  
 
Likewise, antiserum to AL20460 (atypical A. salmonicida) reacted with homologous as 
well as heterogeneous antigens in similar pattern as the antiserum to 8546 (atypical A. 
salmonicida) (fig. 22B, Lanes 1 & 2). However, the antibodies to strain AL20460 (atypical 
A. salmonicida) reacted strongly with a 50-kDa protein from its own antigen and 
cross-reacted less strongly with another ca. 50 kDa protein component from strain 8546 
(atypical A. salmonicida). Both antisera to strains 8546 (atypical A. salmonicida) and 
AL20460 (atypical A. salmonicida) had antibodies that cross-reacted weakly with 
antigenic components from other unrelated strains (fig. 22A, lanes 4, 5 & 6).  
 
Specific antibodies raised against strain AL122 (V. anguillarum O2) cross-reacted 
strongly with ca. 14-kDa antigenic component of strain 8752 (V. anguillarum O1) (fig. 22C, 
lane 4) and 8657 (V. ordalii) (fig. 22C, lane 6), but reacted very weakly with similar 14 
kDa protein of a homologous antigen (fig. 22C, lane 7).   
 
The antiserum raised against Pasteurella – spp. contained specific antibodies directed to 
ca. 100 and 20 kDa proteins from a homogenous antigen (fig. 22D, lane 5); the same 
antiserum contained antibodies cross reactive to ca. 73 kDa, 100, 37 and 20 kDa proteins 
from a heterogeneous antigen of P. skyensis (fig. 22D, lane 3). In addition, some weak 
cross – reactions were observed with antigenic components from strains AL20460 
(atypical A. salmonicida) and 8546 (atypical A. salmonicida) (fig. 22D, lanes 1 & 2).  
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Western blot analysis using antisera to strain 8657 (V. ordalii) showed strong specific 
reactivity with ca. 45 kDa protein, but weakly with ca. 14 kDa protein of a homogeneous 
antigen (fig. 22E, lane 6). No cross reactivity was observed with antigens from other 
strains, but the weak 14 kDa protein from strain 8657 made strong cross-reactivity with 
antibodies to strain AL122 (V. anguillarum O2).   
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Fig. 22. Serum antibody specificity and cross – reactivity analysed by western blot. 
Antisera to different formalin inactivated WB antigens were used; the black blots on the 
pictures indicate for serum antibody reactivity with heterogeneous or homogeneous 
sonicated WB antigens of the different bacterial strains. A) Antiserum to 8546 (atypical A. 
salmonicida), B) Antiserum to AL20460 (atypical A. salmonicida), C) Antiserum to AL122 
(V. anguillarum O2), D) Antiserum to Pasteurella spp., and E) Antiserum to 8657 (V. 
ordalii). Lane 1: antigen from AL20460 (atypical A. salmonicida); Lane 2: antigen from 
8546 (atypical A. salmonicida); Lane 3: antigen from P. skyensis; Lane 4: antigen from 
8752 (V. anguillarum O1); Lane 5: antigen from Pasteurella spp.; Lane 6: antigen from 
8657 (V. ordalii); Lane 7: antigen from AL122 (V. anguillarum O2).    
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3.4 Purified lumpfish IgM 
 
The concentration of purified lumpfish IgM was estimated at 0.5 mg/ml based on the 
linear formula of the standard curve of BSA shown in fig. 23. The concentration of the 
sample was equivalent to 0.471 ODs (595 nm).  
 
 
 
Fig. 23. A standard curve for BSA concentration (mg/ml). 
 
3.5 Total serum IgM 
 
Total IgM (mg/ml) in the lumpfish serum two weeks post immunization was determined by 
single radial immuno-diffusion assay (SRID). The rabbit anti-lumpfish Ab bound to IgM in 
lumpfish serum, forming rounded opaque regions (immune complexes), which were 
distinguished by staining with Comassie blue (fig. 24). The increment in the size of the 
circles ceased after all the IgM in test serum was bound to the rabbit anti-lumpfish 
antibody in the gel. The amount of IgM present in the antiserum was directly proportional 
to the diameter of the circle. 
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Fig. 24. Quantification of lumpfish IgM by SRID. A) Purified lumpfish IgM at different 
concentrations. B) IgM in antiserum from immunized groups with unknown IgM 
concentration. C) IgM in serum from non – immunized groups. Serum was diluted 1/20 in 
PBS (Lonza). Numbers inside the rings indicate for samples in duplicates or triplicates. 
Symbols from a1 to a6 indicate for IgM concentrations. a1, 160 ng/µl; a2, 80 ng/µl; a3, 40 
ng/ µl; a4, 20 ng/ µl; a5, 10 ng/µl; a6, 5 ng/µl; b, blank (PBS without IgM).     
 
The total IgM in sera was quantified based on a linear formula of a standard curve for the 
purified lumpfish IgM (fig. 25A). Mean total IgM for the different immunized groups ranged 
from 1.02 mg/ml to 0.41 mg/ml (fig. 25B, table 9). Antisera from fish immunized with 
AL122 (V. anguillarum O1) contained the highest IgM followed by antisera from fish 
immunized with strain 8546 (atypical A. salmonicida), AL20460 (atypical A. salmonicida), 
8657 (V. ordalii) and Pasteurella spp. (table 7); however, the total IgM in sera from 
immunized groups was not different from the total IgM in sera from non – immunized 
group (p>0.05). Moreover, total IgM in sera from another non-immunized fish group was 
also determined by SRID. This group was comprised of smaller and younger fish 
individuals than the other non – immunized group (800 gm, 21 cm), which was used for 
comparison with immunized groups. The total serum IgM in the smaller and younger fish 
was estimated at 0.14 ± 0.10 mg/ml (fig. 25C).  
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   A             B           
 C 
  
Fig. 25. A) A standard curve for purified lumpfish IgM (ng/µl). B) Total serum IgM (mg/ml) 
in immunized and non-immunized groups (800 gm, 21 cm) determined by SRID. C) Total 
serum IgM (mg/ml) in the smaller and younger non – immunized fish. The vertical lines 
indicate for standard deviations. a, 8546 (atypical A. salmonicida); b, AL20460 (atypical A. 
salmonicida); c, AL122 (V. anguillarum O2); d, Pasteurella spp.; e, (v. ordalii); f, non – 
immunized fish (800 gm, 21 cm); g, non-immunized fish.   
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Table 7. Total serum IgM (mg/ml) in the lumpfish two weeks post immunization.  
 
Group N Mean total IgM ± SD(mg/ml) 
8546 (atypical A. salmonicida) 10 0.80 ± 0.50 
AL20460 (atypical A. salmonicida) 10 0.74 ± 0.23 
AL122 (V. anguillarum O2) 10 1.02 ± 0.76 
Pasteurella – spp. 10 0.41 ± 0.15 
8657 (V. ordalii) 9 0.67 ± 0.31 
Non - immunized 2 0.62 ± 0.25 
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4. DISCUSSION 
 
 
The aim of this study is to investigate the presence of specific antibody response in sera 
of the lumpfish after immunization, vaccination and challenge with different bacterial 
pathogens, to test the occurrence of cross-reactive antibodies between different bacterial 
strains and to estimate total serum IgM in the lumpfish. 
 
SDS-PAGE analysis of proteins: Protein profiles of the different sonicated WB antigens 
were carefully examined by 12% SDS – PAGE and silver staining. Strain AL122 (V. 
anguillarum O2) showed no protein bands on the SDS PAGE. The sample was probably 
destroyed during preparation, hence it was not suitable for analysis of protein profiles by 
SDS-PAGE. However, all the other strains displayed very heterogeneous sizes of LMW 
and HMW components across the SDS-PAGE between 97 and 14 kDa (fig. 21B). Several 
noticeable HMW bands (>45 kDa), closely spaced to each other, were also visible on the 
SDS – PAGE for most of the samples. 
 
Strains 8546 (atypical A. salmonicida) and AL20460 (atypical A. salmonicida) had similar 
protein profiles with some differences (fig. 21B, lanes 4 & 6). Both strains produced 
several major protein bands with apparent MWs of 32, 30, 23, 20 and 14 kDa, and also 
had similar band patterns greater than ca. 66 kDa. Unlike strain AL20460 (atypical A. 
salmonicida), strain 8546 (atypical A. salmonicida) lacked a few visible protein bands of 
ca. 37, 40, and 45 kDa and a weak band of ca. 50 kDa. A protein with a MW of 20 kDa 
protein band in strains that belong to atypical A. salmonicida subsp. achromogenes has 
been described as caseinolytic and gelatinolytic extracellular metalloprotease, an 
essential virulent factor (Warr, 1997). However, the proteolytic activity of the 20 kDa in 
strains 8546 (atypical A. salmonicida) and AL20460 (atypical A. salmonicida) was not 
verified by this study. Thus, further studies are needed to confirm the presence of 
extracellular metalloprotease characterized as 20 kDa protein in the atypical A. 
salmonicida strains. A. salmonicida subsp. achromogenes protease 1 (AsaP1), like many 
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of the toxic proteases, is dependent on Zn+2 to perform its toxic effect against the host. 
AsaP1 can be toxic to several fish species including Arctic charr, Atlantic salmon, and 
Atlantic cod (Magnadóttir, 1998). It has been suggested that antibodies directed against 
AsaP1 can induce protection in fish against atypical furunculosis caused by atypical A. 
salmonicida subsp. achromogenes (Kunihiko et al., 1984). Another virulent factor in A. 
salmonicida is the A – layer (Sanchez et al., 1989), a 49 kDa (approx. 50 kDa) 
component of the OM (Hsu and Du Pasquier, 1984). SDS – PAGE analysis on strains 
8546 (atypical A. salmonicida) and AL20460 (atypical A. salmonicida) revealed the 
presence of a faint 50 kDa protein in strain AL20460 (atypical A. salmonicida), which 
could be an A - layer, but absent in strain 8546 (atypical A. salmonicida). It was 
suggested that the genes that encode the synthesis of the A – layer in strain 8546 may 
not be expressed. According to some authors, the gene that expresses the A – layer in 
some isolates of atypical A. salmonicida subsp. achromogenes may undergo irreversible 
changes, distorting the functionality of the A – layer (Gulla et al., 2015, Merino et al., 
2015). However, these isolates remained virulent in spite of losing functional A – layer 
(Gulla et al., 2015). The A – layer is a vital component of the OM; it prevents the 
bacterium from serum effect (Mestecky et al., 1975), proteolytic action (Anderson et al., 
1974) and phagocytosis (Weinheimer et al., 1971). Moreover, it can increase binding to 
some, Ig and many extracellular proteins (Weinheimer et al., 1971). 
 
Strain 8752 (V. anguillarum O1) produced a major protein of ca. 38 kDa, a diffused 
(bulged) band of 21 kDa, and a broad band of ca. 14 kDa (fig. 21B, lane 5). It has been 
described that different serotypes of V. anguillarum have a major outer membrane protein 
(MOMP) with a molecular weight ranging between 35 and 42 kDa (Simon et al., 1996). V. 
anguillarum serotype O2 isolates may possess MOMPs in the range of 35 – 38 kDa 
(Santos et al., 1995). It has been proposed that this MOMP in V. anguillarum is a porin 
(Suzuki et al., 1994). Porins might play an important role in environmental adaptation by 
allowing selective movement of molecules into the cell membrane through their 
hydrophilic channels while the OM forms a barrier to protect the cell from harmful 
substances (Wang et al., 2003). Environmental parameters such as osmotic 
concentration, temperature, nutrient limitation and phosphate can affect the synthesis of 
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porins (Wang et al., 2003). Moreover, porins may play a crucial role in bile resistance and 
biofilm formation, which are critical to the survival of the bacterium inside the fish or in the 
marine environment (Wang et al., 2003).  
 
Likewise, strain 8657 (V. ordalii) had a MOMP with approximate MW of 36 kDa and a 
LMW protein of ca. 14 kDa (fig. 21B, lane 7). The 14 kDa LMW protein was probably 
associated with LMW LPS, but it was not verified in this study. The results from strain 
8657 (V. ordalii) seem to agree with the results from SDS-PAGE analysis on OMP of V. 
ordalii by Akayli et al., (2010). The MOMP, together with the LPS, in V. ordalii is 
considered as a major epitope (Chart and Trust, 1984). Strains 8657 (V. ordalii) and 8752 
(V. anguillarum O1) seemed to share similar OM structures below ca. 31 kDa protein 
band.   
 
SDS – PAGE analysis on sonicated WB antigens of P. skyensis and Pasteurella - ssp. 
revealed the presence of major proteins weighing ca. 37 and 35 kDa, respectively (fig. 
21B, lanes 1 & 3). The nature of these bands is not known as the bacteria are not well 
studied. The P. skyensis and Pasteurella spp. belong to Pasteurellaceae, a family which 
encompasses a diverse group of bacteria (Challacombe and Inzana, 2008) whose 
taxonomic positions have been unresolved (Korczak et al., 2004).       
 
Antibody response to immunization. The lumpfish were immunized three times; the 
antiserum was collected two weeks post immunization. The ELISA results showed that 
immunization of lumpfish against the different formalin inactivated WB antigens induced 
elevated levels of specific antibodies compared to the non-immunized control group (fig. 
10 & 11), revealing adaptive humoral immune response in the lumpfish. The highest 
antibody response was attained by immunization to Pasteurella spp., followed by strain 
AL122 (V. anguillarum), AL20460 (atypical A. salmonicida), 8546 (atypical A. 
salmonicida), and V. ordalii). However, the level of antibody response to strain 8652 (V. 
ordalii) was not significantly different in comparison to the non-immunized control group 
(fig. 11B). The amount of specific antibodies varied within individuals and between 
groups. A number of factors can affect antibody response in fish; some of these factors 
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include antigen dose, type of antigen, adjuvants, route of administration, age, size, 
genetic background, and booster administration (Morrison and Nowak, 2002).  
 
Repeated immunization of the lumpfish could have contributed to the production of 
specific antibodies with the second or third immunization producing specific antibodies of 
superior quality and quantity (Morrison and Nowak, 2002). In higher vertebrates, the high 
affinity binding of specific antibodies is attributed to affinity maturation of the B – cells, a 
mechanism which is not fully understood in many fish species. However, increased and 
improved secondary antibody response with high specificity to antigens has been 
demonstrated in fish (Fletcher and Secombes, 2010). Nevertheless, this study may 
suggest that the demonstration of specific antibodies by ELISA may give an important 
glimpse to further delve into the lumpfish’s specific humoral immune response, 
particularly with respect to protective immunity that involves immunization or vaccination 
and challenge against the different bacterial pathogens. However, it should be noted that 
the presence of specific antibodies in fish should not be always correlated with protection 
against bacterial pathogens (Morrison and Nowak, 2002). 
 
Antibody specificity and cross-reactivity: Western blot analysis revealed that antisera to 
strains 8546 (atypical A. salmonicida) and AL20460 (atypical A. salmonicida) contained 
antibodies reactive to several antigenic components commonly shared by both strains 
(fig. 22A & 22B; lanes 1 & 2). The specificities of the antibodies to both atypical A. 
salmonicida strains were directed to ca. 10, 13, 20, 22, 28, 50, and 55 kDa proteins. The 
cross – reactivity between the two strains were also revealed by ELISA. Unlike in strain 
AL20460 (atypical A. salmonicida), a band of ca. 50 kDa A-layer protein was not 
observed in strain 8546 (atypical A. salmonicida) by SDS-PAGE analysis on sonicated 
WB antigens (fig. 21B, lanes 6 & 4). Moreover, the 50 kDa A-layer protein in strain 
AL20460 (atypical A. salmonicida) was not detected when using antiserum to strain 8546 
(atypical A. salmonicida) by the western blot. According to the results from ELISA, 
immunization with strain AL20460 (atypical A. salmonicida) resulted in relatively higher 
specific antibody response than immunization with strain 8546 (atypical A. salmonicida) 
(p<0.01) (fig 11). Thus, the difference in the level of specific antibodies between these 
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two immunized groups could be attributed to the 50 kDa A – layer protein.  
 
The 50 kDa protein was already described as an A – layer protein and the LMW protein 
bands of less than 20 kDa were perhaps linked to LPS. In some other studies, the A – 
layer was shown to elicit good specific humoral immune response in Atlantic salmon 
(Lund et al., 1991) and rainbow trout (Thuvander et al., 1993). The A – layer in A. 
salmonicida is bound to the LPS (Belland, 1985) and covers almost the whole bacterium 
(Dooley et al., 1989), nonetheless some LPS molecules are found uncovered (Phipps 
and Kay, 1988). Both of these OM structures are important to protect the bacterium from 
inactivation by serum components (Munn et al., 1982), but the A – layer is a more vital 
armour against opsonophagocytosis (Merino et al., 1994). It has been reported that the 
LPS and A-layer proteins of the atypical A. salmonicida can induce specific antibodies in 
salmon (Evenberg et al., 1985), rainbow trout (Hastings and Ellis, 1990), spotted wolfish 
(Anarhichas minor) and halibut (Hippoglossus hippoglossus) (Ingilæ et al., 2000).   
 
Immunoblotting studies using antiserum to AL122 (V. anguillarum O2) displayed strong 
cross-reactivity with strains 8752 (V. anguillarum O1) (fig. 22C, lane 4) directed to ca. 14 
kDa protein. Moreover, elevated levels of antibodies were also demonstrated by ELISA 
due to the cross reactivity of the specific antibodies to strain AL122 (V. anguillarum O2) 
with sonicated WB antigens of strain 8752 (V. anguillarum O1) (fig. 13). The high 
antibody response to strain 8752 (V. anguillarum O1) was possibly attributed to the 14 
kDa protein. However, the level of antibodies due to the cross reactivity were not 
significant compared to the level of antibodies in serum from the non-immunized control 
group (p>0.05). This result was unexpected as one of the sera from the non-immunized 
control group made elevated levels of antibodies against sonicated WB antigen of strain 
8752 (V. anguillarum O1), which was used as a coating antigen. It was proposed that the 
serum from the non-immunized control group might possibly have contained some 
natural antibodies reacting with some components of strain 8752 (V. anguillarum O1). 
Natural antibodies may arise due to contact of the fish with bacterial pathogens in the 
marine or culture environment (Espelid et al., 1991).  
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Similarly, specific antibodies to AL122 (V. anguillarum O2) cross reacted strongly with a 
14 kDa antigenic component of strain 8657 (V. ordalii) (fig. 22C, lane 6). Cross reactivity 
test was not performed by ELISA between the V. anguillarum O2 and V. ordalii strains. A 
number of authors have demonstrated extensive cross reactions with LPS using 
polyclonal antisera against V. ordalii and V. anguillarum O2 (Chart and Trust, 1984, 
Mutharia et al., 1993). However, this study reported no cross-reactivity with sonicated WB 
antigens of strain AL122 (V. anguillarum O2), also with strain 8752 (V. anguillarum O1) 
when using antiserum to 8657 (V. ordalii) (fig. 22E, lanes 4 & 7). 
 
To the contrary, antibodies to AL122 (V. anguillarum O2) reacted very weakly with a 
homogeneous antigen directed to ca. 14 kDa protein (fig. 22C, lane 7) compared to the 
other heterogeneous antigens. No OMP bands were also observed on this strain by 
SDS-PAGE using sonicated WB antigens. Strain AL122 (V. anguillarum O2) was treated 
with formalin because it was supplied as vaccine antigen by PHARMAQ AS.   
 
Western blot analysis using antiserum to strain 8657 (V. ordalii) revealed the presence of 
highly specific antibodies directed mainly to ca. 45 kDa component of a homogeneous 
antigen (fig. 22E, lane 6). Some antibodies were also weakly reactive with ca. 14 kDa 
protein of the homogeneous antigen.   
   
It appears that all the Vibrio strains used in this study seemed to possess a common 14 
kDa protein. This LMW 14 kDa protein was perhaps associated with LMW LPS, but not 
verified by this study. The LPS has been considered as significant antigenic determinant 
of V. ordalii and V. anguillarum (Chart and Trust, 1984); it is usually included during 
vaccine formulation against vibriosis (Colquhoun and Lillehaug, 2014). However, the LPS 
from V. ordalii and V. anguillarum O2 have different antigenic properties (Mutharia et al., 
1993). Vaccines containing bacterins of V. anguillarum O1 and V. ordalii may provoke 
poor protection against vibriosis caused by V. anguillarum O2 (Toranzo et al., 1996).    
 
The antibodies raised against Pasteurella spp. reacted specifically with antigenic 
components of a homologous antigen forming faint bands of ca. 100 kDa and 20 kDa, 
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respectively (fig. 22D; lane 5). Likewise, the same antisera cross-reacted with a 
heterogeneous antigen prepared from P. skyensis (fig 22D; lane 3). Both the homologous 
and heterogeneous antigens shared similar OM proteins of 100 and 20 kDa. Conversely, 
there was a strong and a faint cross reactivity at only ca. 73 kDa and 37 kDa against the 
heterogeneous antigen, respectively. ELISA was not performed for cross – reactivity test 
between Pasteurella spp. and P. skyensis. The OM proteins of both strains that were 
detected by the western blot and SDS – PAGE were not fully understood. However, this 
study revealed that the specific humoral immunity of the lumpfish were capable of 
responding to formalin inactivated whole cells of Pasteurella spp., producing significant 
amount of specific antibodies as determined by ELISA and western blot. Western blot 
analysis showed that antigen – antibody reactivity was stronger with P. skyensis than with 
the homologous antigen. Therefore, Pasteurella spp. from lumpfish induced antibodies to 
P. skyensis. The significance of this regarding bacterial vaccine antigens need to be 
further elucidated. 
 
Furthermore, the extensive weak cross reactions between antibodies to Pasteurella spp. 
and the atypical A. salmonicida strains remained unclear. Sometimes, there is a 
possibility for antibody cross-reactivity between unrelated antigens (Murphy, 2012). In 
one study (Hoel et al., 1998), for example, it was shown that epitopes from V. 
salmonicida and A. salmonicida were cross-reactive and had protective role against 
typical furunculosis, vibriosis and cold water vibriosis in Atlantic salmon. In the case of 
the Pasteurella spp., the fact that the unresolved taxonomic position of the Pasteurella 
spp. may complicate our understanding of its role in the specific humoral immune 
response of the lumpfish.    
 
Antibody response to challenge: Antibody levels in the small lumpfish from the 
non-vaccinated and vaccinated challenged groups were quantified by ELISA; in general, 
it was found that the specific humoral immune response in all non-vaccinated challenged 
groups was poor, evaluated by the presence of almost negligible specific antibody levels. 
The specific immune response of the lumpfish was perhaps suppressed due to challenge 
with the different bacteria, resulting in a low specific antibody response. For example, 
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Magnadóttir et al. (1995) reported poor specific antibody response in Atlantic salmon that 
had been chronically infected with atypical A. salmonicida subsp. achromogenes. 
Another explanation for the low antibody levels after exposure to challenge might be due 
to either formation of antigen – antibody complex, or the utilization of the complexes by 
opsonisation, depleting free antibodies from plasma (Villumsen et al., 2012). The 
mortality data were not included in the present study, and correlation between mortality 
and specific antibody response would possibly justify the occurrence of protection in the 
lumpfish against the different bacterial pathogens.    
 
No significant antibody levels, compared to the non-challenged control group, were found 
in sera from fish challenged with strain 8546 (atypical A. salmonicida) by any of the 
challenge exposures (bath, i.p. or cohabitation) (p>0.05) (fig. 14). However, relatively 
higher antibody levels were detected in sera from fish challenged by cohabitation with 
strain AL20460 (atypical A. salmonicida) compared to the non-challenged control group 
(p<0.01) (fig. 15).  
 
Higher antibody levels were found in sera from fish challenged by cohabitation or i.p. 
against strain 8752 (V. anguillarum O1) (fig. 16) compared to the non-challenged control 
group (p<0.001), but only two fish survived from i.p. challenged group. The bath 
challenge against strain 8752 (V. anguillarum O1) did not induce significant amount of 
specific antibodies (p>0.05). 
 
Challenge with the Pasteurella spp. by cohabitation in 1 to 1 ratio to i.p. at different 
bacterial concentrations induced high antibody levels relative to the non-challenged 
control group (p>0.001). Low antibody response was found in sera from fish challenged 
with the highest challenge dose (1/20). The fish challenged with lowest dilution (1/20) had 
high mortality (Anita R., personal communication) and fish used for serum sample might 
be infected or antibodies were bound in immune complexes. 
 
On the other hand, the amount of specific antibody response in vaccinated, challenged 
groups (i.p.) was much higher than the non-vaccinated challenged (i.p.) and 
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non-challenged control groups (PBS) (fig. 14). However, western blot was not performed 
for these groups to confirm antibody specificity or cross-reactivity. The presence of 
specific antibodies - one of the protective factors – may give an indication of some 
degree of protection in the lumpfish against vibriosis, atypical furunculosis and 
pasteurellosis. Generally, vaccines against vibriosis (Colquhoun and Lillehaug, 2014) and 
pasteurellosis, caused by Photobacterium damselae subsp. Piscicida have been 
effective for many marine fish species. However, there is still challenge for finding 
protective vaccines for infections caused by atypical A. salmonicida (Midtlyng, 2014). 
Nevertheless, the protective role of the specific antibodies due to vaccination of the 
lumpfish should be investigated by comparisons with the relative percent of survival (RPS) 
based on mortality data of vaccinated and non-vaccinated challenge groups. The 
elevated antibody levels in the vaccinated challenged groups was perhaps due to 
high-affinity antibodies induced by the vaccines, though this requires further investigation. 
In one study, it was suggested that vaccines against V. anguillarum resulted in significant 
specific antibody response in zebra fish (Zhang et al., 2013). In another study, 
vaccination of rainbow trout enhanced IgM productivity, resulting in increased specific 
antibody titre and antibody affinity to pathogens (Costa et al., 2012). Furthermore, the 
presence of high specific antibodies in all vaccinated groups could be due to the fact that 
i.p. vaccination might cause marked antibody response (Harrell et al., 1976) that may last 
for several weeks (THUVANDER et al., 1987).  
 
In groups challenged against 8546 (atypical A. salmonicida), lumpfish that were treated 
with trivalent vaccines produced slightly higher specific antibodies than those fish treated 
with monovalent vaccines (p<0.05), but antibody responses did not differ between sera 
from fish that were treated with trivalent and AMM3 vaccines (p>0.05). On the other hand, 
the specific antibody levels within groups that were treated with the different vaccines 
were similar (p>0.05) 31 days post challenge against strains AL20460 (atypical A. 
salmonicida) and 8752 (V. anguillarum O1). The AMM3 and trivalent vaccines against 
atypical furunculosis induced better antibody response 43 days post challenge with strain 
8546 (atypical A. salmonicida) than 31 days post challenge with strain AL20460 (atypical 
A. salmonicida) (p<0.05). This result was in contrary with the ELISA results from the 
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immunization, in which higher antibodies were obtained with immunization to strain 
AL20460 (atypical A. salmonicida) than with strain 8546 (atypical A. salmonicida). The 
difference in the effectiveness of the vaccines in terms of antibody response might be 
linked to antigenic composition of the vaccines, though the exact composition of the 
vaccines is kept confidential by the commercial vaccine producers, also during vaccine 
trial. It has been reported in some studies that inclusion of multiple WB antigens in 
vaccines may have inhibitive (Nikoskelainen et al., 2007) or enhancive (Hoel et al., 1997) 
effects on the specific humoral immune response of fish. Nikoskelainen et al. (2007) 
proposed that the specific humoral immune response of Atlantic salmon (Salmo salar L.) 
to A. salmonicida was more enhanced by oil-adjuvanted polyvalent vaccine that 
incorporated V. salmonicida, V. anguillarum (O1 and O2) and A. salmonicida than a 
monovalent vaccine containing only A. salmonicida; however, immunological 
cross-reaction between V. salmonicida and A. salmonicida was the main factor for the 
enhancement of the humoral immune response in the Atlantic salmon (Nikoskelainen et 
al., 2007). Western blot analysis showed cross-reactions between atypical A. 
salmonicida and V. anguillarum when using antisera to either strains of atypical A. 
salmonicida. Likewise, there were cross reactions between Pasteurella spp. and atypical 
A. salmonicida, but when using antiserum to Pasteurella spp. (fig. 22). No other works 
have reported on cross-reactions between these bacteria. Thus, other studies are 
required to investigate the finding, and their protective role in vaccines for the lumpfish 
should be investigated.  
 
Total serum IgM: Total serum IgM (mg/ml) in lumpfish was determined by SRID; mean 
total serum IgM (mg/ml) for all groups ranged from 1.02 to 0.41 mg/ml (fig. 19B & Table 7). 
No significant differences in total serum IgM (mg/ml) were observed between immunized 
and non-immunized groups (p>0.05). Individual variation in total serum IgM was 
observed. Moreover, the total serum IgM in the small and young fish was estimated at 
0.14 ± 0.10 mg/ml. Total serum IgM (mg/ml) in the lumpfish was relatively low compared 
to other fish species but the results obtained for the lumpfish fell within the range of the 
total serum IgM (mg/ml) for other fish species as reported by Israelson et al., (1991). Total 
serum IgM varies among fish species (Israelson et al., 1991); several factors may affect 
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the level of serum IgM in fish including age or size, environmental conditions (Scapigliati 
et al., 1999), nutrition (immunostimulators) (Cuesta et al., 2004), etc. Based on the 
results by Israelson et a., (1991), Atlantic cod (Gadus morhua) contains 7 – 8 times more 
IgM than the lumpfish but, quantitatively, the total serum IgM between Atlantic salmon 
(Salmo salar L.) and the lumpfish is nearly similar. The variation in the amount of serum 
IgM between fish species may indicate for differences in their specific humoral immune 
responses (Magnadóttir, 1998). For example, salmon is capable of generating highly 
specific antibodies of less diversity, while cod produces high amount of natural antibodies 
of low specificity (Magnadóttir, 1998). 
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5. CONCLUSION 
 
The most important conclusion of this project is that the lumpfish’s adaptive humoral 
immune responses, like many other aquaculture fish species, is capable of responding to 
i.p. immunization or vaccination with formalin inactivated WB antigens and challenge with 
different bacteria by producing high levels of specific antibodies. This indicate that the 
lumpfish can be protected from the most common bacterial pathogens. However, the 
protective role of the specific antibodies in the lumpfish against the different bacteria 
should be thoroughly investigated by further studies with respect to protective immunity, 
involving challenge, mortality and vaccination trials. Moreover, it can be concluded that 
the lumpfish have normal IgM levels comparable to what is found in Atlantic salmon, but 
lower than that of Atlantic do.       
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7. APPENDIX A. List of chemicals and solutions 
 
No. Ingredients            Quantity   Company 
1. Agarose Gel  
 Agarose 1%     0.335 g   Lanzo Group Ltd. 
 PBS (pH =7.2)    33.35 ml  Lanzo Group Ltd. 
 PEG-6000     0. 67 g   Sigma Aldrich, Co.  
2. PBS (pH = 7.2) 
 Na2HPO4x2H2O   0.72 g   Sigma Aldrich, Co. 
 KH2PO4     0.27 g   Sigma Aldrich, Co. 
 NaCl      8.5 g   Sigma Aldrich, Co. 
 Deionized H2O    1000 ml  Milli Q                             
3. PBS-T (100ml) 
 PBS (pH=7.3)    100 ml 
 0.05% Tween 20   50 µl   Sigma Aldrich, Co. 
4. Blocking solution  
 Skim milk powder   3 g    Sigma Aldrich, Co. 
 PBS-T      100 ml 
5. 0.1M Citric acid 
 Citric acid     21 g   Sigma Aldrich, Co. 
 Deionized H2O    1000 ml  MilliQ  
6. 0.2 M Na2HPO4x2H2O 
 Na2HPO4x2H2O   35.3 g   Sigma Aldrich, Co. 
 Deionized H2O    1000 ml  MilliQ   
7. Phosphate citrate buffer, pH = 5.0 
 0.1 M citric acid    24.3 ml   
 0.2M Na2HPO4x2H2O  25.7 ml 
 Deionized H2O     50 ml   MilliQ 
 
List of chemicals and solutions (Continues) 
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8. Peroxidase substrate solution  
 O – phenyleneidamine  
(OPD, P-4664)    15 mg (1 tablet)   Sigma Aldrich, CO. 
 Phosphate citrate buffer  37.5 ml  
 30% H2O2      15 µl         Sigma Aldrich, Co. 
9. PBS with 5M EDTA, pH = 7.3 
 PBS, pH 0 7.3    100 ml 
 EDTA      0.2 g       Merck 
10. TSB with 2% NaCl 
 TSB      30 g    BactoTM 
 NaCl      15 g    Sigma Aldrich, Co. 
 Deionized H2O    1000 ml   MilliQ  
11. 2.5N H2SO4 
 96%  H2SO4    6.94 ml    Merck 
 Deionized H2O    93.06 ml   MilliQ 
12. Coomassie staining solution (1000 ml)  
 98.6% Methanol   400 ml    Sigma Aldrich, Co. 
 98.6% Acetic acid   100 ml    Sigma Aldrich, Co. 
 Commassie Brilliant  
Blue G-250    500 mg    Merck 
 Deionized H2O    500 ml    MilliQ 
13. Commassie destaining (1500 ml) 
 98.6% Methanol   400 ml    Sigma Aldrich, Co.  
 98.6% Acetic acid    100 ml    Sigma Aldrich, Co.   
 Deionized H2O    500 ml    MilliQ 
 Commassie staining  
 solution      500 ml 
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List of chemicals and solutions (Continues) 
14. Resolving gel (12%) 
 Deionized H2O     4.4 ml    MilliQ 
 30% Degassed Acrylamide/Bis 3 ml    Sigma Aldrich, Co. 
 1.5 M Tris-HCl, pH 8.8  
 (Gel buffer)      2.5 ml 
 10 % w/v SDS      100 µl 
 10 % APS       50 µl 
 TEMED       5 µl     Sigma Aldrich, Co. 
15. 10 % SDS 
 SDS       10 g    Sigma Aldrich 
 Deionized H2O      90 ml    MilliQ 
 Total volume brought to 100 ml with deionized H2O 
16. 10% APS 
 Ammonium sulfate    100 mg    Sigma Aldrich, Co. 
 Deionized H2O     1 ml    MilliQ 
17. 1.5 M Tris-HCl, pH 8.8 (150 ml) 
 Tris base      27.23 g    Sigma Aldrich, Co. 
 Deionized H2O     80 ml    MilliQ 
 pH adjusted to 8.8 by adding 6N HCl and total volume brought to 150 ml by 
adding deionized H2O .  
18. Stacking gel (4%) 
 Deionized H2O     6.4 ml    MilliQ 
 30% Degassed acrylamide/Bis 1 ml    Sigma Aldrich, Co. 
 0.5 M Tris-HCl, pH 6.8   2.5 ml 
 10% w/v SDS      100 µl 
 10 % APS      50 µl 
 TEMED      10 µl    Sigma Aldrich, Co.  
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List of chemicals and solutions (Continues) 
19. 0.5 M Tris-HCl pH 6.8 
 Tris base      6 g     Sigma Aldrich, Co. 
 Deionized H2O     60 ml    MilliQ  
 pH adjusted to 6.8 by adding 6N HCl and total volume brought to 100 ml by 
adding deionized H2O.  
20. 10xTGS buffer (1000 ml) 
 Tris base      30.3 g    Sigma Aldrich, Co. 
 Glycine       144 g    Sigma Aldrich, Co.  
 SDS       10 g    Sigma Aldrich, Co. 
 Deionized H2O     1000 ml   MilliQ 
21. 1xTGS buffer (1000 ml) 
 10xTGS buffer     100 ml  
 Deionized H2O     900 ml  
22. Gel-loading buffer  
 Sample buffer      950 µl 
 2-mercaptoethanol    50 µl    Sigma Aldrich, Co. 
23. Fixative solution  
 98.6% Methanol     100 ml    Sigma Aldrich, Co.  
 98.6% Acetic acid    20 ml    Sigma Aldrich, Co. 
 Fixative enhancer concentrate  20 ml    Bio-Rad  
 Deionized H2O     20 ml    MilliQ 
24. Silver staining solution  
 Deionized H2O     45 ml    MilliQ  
 Silver complex solution   5 ml    Bio-Rad 
 Reduction moderator solution 5 ml    Bio-Rad 
 Image development reagent  5 ml    Bio-Rad  
 Development accelerator  
solution      50 ml    Bio-Rad 
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List of chemicals and solutions (Continues) 
25. 5 % Acetic acid (100 ml) 
 98.6% Acetic acid    5 ml    Sigma Aldrich 
 Deionized H2O     95 ml    MilliQ 
26. 10xTransfer buffer without methanol 
 Tris base      15.4 g    Sigma Aldrich, Co. 
 Glycine       72 g    Sigma Aldrich, Co. 
 Deionized H2O     500 ml    MilliQ 
27. 1xTransfer buffer      
 10xTransfer buffer    100 ml 
 Deionized H2O     700 ml    MilliQ 
 98.6% Methanol    200 ml    Sigma Aldrich, Co.   
(Added just before use) 
28. 10xTBS (pH 7.5) 
 Tris base       12.11 g    Sigma Aldrich, Co. 
 NaCl       146.1 g    Sigma Aldrich, Co. 
 Deionized H2O     500 ml    MilliQ 
29. 1xTBS (pH 7.5) 
 10xTBS      100 ml 
 Deionized H2O     900 ml    MilliQ 
30. TTBS 
 1xTBS (pH7.5)     700 ml 
 0.05% Tween-20    350 µl    Sigma Aldrich, Co. 
31. TBS with 3% skimmed milk powder (100ml) 
 1xTBS       100 ml 
 Skim milk powder    3 g     Sigma Aldrich, Co. 
32. Antibody dilution buffer (100ml) 
 TTBS        100 ml 
 Skim milk powder    1 g     Sigma Aldrich, Co. 
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8. APPENDIX B. Silver staining protocol for protein separation on 12% SDS – PAGE.  
 
This is the same protocol used by the Fish Immunology Group at the University of 
Bergen.  
 
1. Fixation of proteins after separation by electrophoresis  
 Fix the proteins in the gel for 20 minutes in a mixture of 100 ml methanol 
(Sigma Aldrich), 20 ml acetic acid (Sigma Aldrich), 20 ml fixative enhancer 
concentrate (BIORAD) and 20 ml deionized water (MilliQ).  
2. Washing 
 Wash the gel in MilliQ for 2 x 10 minutes  
3. Preparation of coloring solution  
 Prepare a coloring solution by adding, in a consecutive order, 5 ml silver 
complex solution (solution1) (BIORAD), 5 ml reduction moderator solution 
(solution2) and 5 ml image development reagent (solution3) into 45 ml 
deionized water (MilliQ). Stir the solution.  
 Finally add 50 ml development accelerator solution (BIORAD) into the 
mixture. Stir the solution.  
4. Staining  
 Stain the proteins in the gel with the coloring solution for ca. 45 minutes. 
Watch the gel continuously, and avoid overexposure. Observe for 
development of brown colored bands on the gel.  
 Stop the reaction by replacing the coloring solution with 5% acetic acid. The 
gel can stay in 5% acetic acid for 24 hours until it is transferred into 
deionized water. 
 Take photos of the protein bands on the gel for documentation.  
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9. APPENDIX C. List of tables of results   
 
TABLE C1.  Antibody response (OD492) to immunization for antigen optimization by 
ELISA using sonicated WB cells from strain 8546 (atypical A. salmonicida) as antigen at 
different concentrations.  
 
Plate Ag  Ab 
Ag blocked with 3% skimmed 
milk Ag not blocked 
No. (µg/ml) Dilution B F 1 F1 F2 F2 B F1 F1 B F2 F2 B 
1 10 
50 0,20 1,23 1,20 1,13 1,12 0,26 1,30 1,27 0,30 1,16 1,14 0,29 
100 0,23 1,19 1,19 0,98 1,05 0,34 1,18 1,16 0,30 1,08 1,01 0,29 
200 0,09 1,08 1,08 0,90 0,91 0,24 1,10 1,07 0,29 0,78 0,90 0,29 
400 0,10 0,76 0,90 0,68 0,75 0,24 0,90 0,91 0,29 0,78 0,72 0,29 
800 0,08 0,67 0,51 0,55 0,62 0,25 0,75 0,74 0,31 0,71 0,69 0,30 
2 8 
50 0,15 1,03 1,01 0,93 0,99 0,17 1,02 0,94 0,19 0,83 0,82 0,19 
100 0,16 0,94 1,00 0,81 0,88 0,17 0,95 0,95 0,12 0,87 0,75 0,18 
200 0,15 0,86 0,87 0,73 0,72 0,18 0,90 0,88 0,19 0,75 0,61 0,20 
400 0,14 0,64 0,81 0,43 0,58 0,16 0,78 0,68 0,20 0,72 0,37 0,20 
800 0,14 0,61 0,62 0,48 0,22 0,39 0,73 0,68 0,28 0,47 0,59 0,17 
3 6 
50 0,15 1,04 1,06 0,90 0,91 0,24 0,85 0,98 0,20 0,99 0,95 0,20 
100 0,16 0,85 0,99 0,84 0,85 0,14 0,79 0,98 0,20 0,91 0,91 0,21 
200 0,16 0,86 0,82 0,72 0,75 0,14 0,82 0,90 0,19 0,77 0,78 0,20 
400 0,16 0,77 0,77 0,59 0,62 0,15 0,80 0,90 0,19 0,70 0,73 0,18 
800 0,14 0,67 0,53 0,48 0,51 0,16 0,67 0,14 0,20 0,66 0,66 0,21 
4 4 
50 0,07 1,02 1,02 0,87 0,87 0,18 1,05 1,03 0,21 0,98 0,95 0,22 
100 0,16 0,90 0,93 0,79 0,84 0,16 0,93 0,96 0,22 0,89 0,86 0,21 
200 0,14 0,72 0,80 0,80 0,60 0,20 0,82 0,81 0,19 0,71 0,75 0,18 
400 0,16 0,86 0,62 0,41 0,62 0,27 0,73 0,73 0,21 0,70 0,53 0,21 
800 0,15 0,63 0,62 0,39 0,44 0,13 0,77 0,65 0,19 0,78 0,53 0,20 
5 2 
50 0,24 0,67 0,76 0,71 0,73 0,15 0,91 0,83 0,17 0,74 0,74 0,18 
100 0,14 0,74 0,75 0,64 0,67 0,32 0,55 0,78 0,15 0,72 0,69 0,17 
200 0,10 0,62 0,67 0,58 0,59 0,15 0,69 0,71 0,36 0,61 0,42 0,17 
400 0,13 0,59 0,48 0,49 0,48 0,15 0,63 0,68 0,16 0,62 0,50 0,15 
800 0,13 0,52 0,56 0,41 0,35 0,15 0,51 0,55 0,08 0,26 0,08 0,07 
Ag, antigen; Ab, antibody (serum); B, blank (PBS); F1, serum from fish 1; F2, serum from 
fish 2.  
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TABLE C2. Antibody response (OD492) to immunization for antigen optimization by 
ELISA using sonicated WB cells from strain AL20460 (atypical A. salmonicida) as antigen 
in ELISA at different concentrations.  
 
Plate Ag Ab Ag blocked with 3% skimmed milk Ag not blocked 
No. (µg/ml) dilution B F1 F1 F2 F2 B F1 F1 B F2 F2 B 
1 10 
50 0,23 1,18 1,17 1,06 1,22 0,24 1,31 1,31 0,26 1,23 1,21 0,27 
100 0,22 1,14 1,19 1,11 0,86 0,23 1,20 1,19 0,27 1,12 1,09 0,26 
200 0,21 0,99 1,00 0,82 0,96 0,23 1,04 0,92 0,26 1,01 0,88 0,18 
400 0,22 0,85 0,82 0,71 0,66 0,23 0,75 0,89 0,26 0,85 0,83 0,27 
800 0,04 0,63 0,61 0,56 0,60 0,24 0,68 0,70 0,26 0,14 0,63 0,05 
2 8 
50 0,11 1,17 1,16 1,05 1,07 0,16 1,06 1,15 0,21 1,00 1,06 0,19 
100 0,05 1,04 0,97 0,94 0,91 0,38 1,05 0,97 0,20 0,96 0,95 0,20 
200 0,06 0,86 0,91 0,79 0,82 0,16 0,97 0,94 0,19 0,92 0,85 0,16 
400 0,05 0,70 0,71 0,64 0,61 0,15 0,79 0,77 0,20 0,75 0,70 0,16 
800 0,05 0,47 0,50 0,49 0,48 0,16 0,10 0,62 0,20 0,57 0,61 0,07 
3 6 
50 0,14 1,06 1,10 0,97 0,95 0,14 1.158 1,16 0,89 0,91 0,96 0,18 
100 0,14 0,97 0,91 0,84 0,78 0,18 1,05 1,00 0,10 0,94 0,89 0,17 
200 0,13 0,85 0,74 0,71 0,73 0,14 0,76 0,82 0,10 0,84 0,67 0,11 
400 0,14 0,65 0,64 0,58 0,59 0,14 0,72 0,70 0,09 0,70 0,68 0,19 
800 0,13 0,37 0,47 0,48 0,46 0,22 0,59 0,57 0,10 0,58 0,55 0,18 
4 4 
50 0,10 0,92 0,95 0,78 0,83 0,10 0,99 0,96 0,15 0,89 0,73 0,16 
100 0,10 0,72 0,89 0,73 0,70 0,10 0,99 0,77 0,15 0,85 0,56 0,16 
200 0,11 0,43 0,70 0,50 0,53 0,12 0,76 0,20 0,16 0,71 0,55 0,17 
400 0,10 0,54 0,50 0,49 0,27 0,11 0,34 0,61 0,16 0,61 0,56 0,16 
800 0,10 0,42 0,31 0,37 0,38 0,12 0,49 0,52 0,15 0,49 0,48 0,16 
5 2 
50 0,09 0,42 0,32 0,54 0,53 0,07 0,57 0,57 0,13 0,38 0,62 0,08 
100 0,09 0,67 0,60 0,48 0,50 0,09 0,65 0,61 0,13 0,48 0,43 0,11 
200 0,08 0,41 0,51 0,36 0,35 0,09 0,55 0,54 0,15 0,54 0,36 0,13 
400 0,09 0,29 0,42 0,31 0,30 0,09 0,45 0,39 0,15 0,46 0,29 0,13 
800 0,10 0,27 0,28 0,24 0,26 0,09 0,39 0,42 0,15 0,37 0,27 0,14 
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TABLE C3. Antibody response (OD492) to immunization for antigen optimization by ELISA 
using sonicated WB cells from strain AL122 (V. anguillarum O2) as antigen at different 
concentrations.  
 
Plate Ag Ab 
Ag blocked with 3% skimmed 
milk Ag not blocked 
no. (µg/ml) dilution B F1 F1 F2 F2 B F1 F1 B F2 F2 B 
1 10 
50 0,17 1,80 1,69 1,66 1,85 0,19 1,95 1,77 0,23 1,85 1,83 0,24 
100 0,17 1,75 1,73 1,66 1,85 0,23 1,70 1,86 0,21 1,82 1,80 0,23 
200 0,20 1,75 1,79 1,38 1,74 0,23 1,82 1,79 0,22 1,73 1,75 0,23 
400 0,16 1,66 1,63 1,63 1,50 0,21 1,71 1,68 0,22 1,40 1,65 0,21 
800 0,17 1,50 1,07 1,01 1,38 0,22 1,54 1,55 0,24 1,53 1,47 0,23 
2 8 
50 0,15 1,77 1,77 1,38 1,84 0,11 1,58 1,86 0,20 1,88 1,81 0,20 
100 0,17 1,72 1,68 1,74 1,73 0,12 1,79 1,83 0,20 1,81 1,74 0,24 
200 0,12 1,56 1,67 1,23 1,71 0,12 1,80 1,79 0,21 1,74 1,58 0,22 
400 0,15 1,58 1,73 1,50 1,48 0,14 1,78 1,66 0,20 1,42 1,59 0,21 
800 0,16 1,40 1,45 1,26 1,33 0,13 1,51 1,49 0,21 1,41 1,30 0,21 
3 6 
50 0,16 1,63 1,74 1,71 1,72 0,16 1,74 1,74 0,22 1,51 1,71 0,22 
100 0,17 1,76 1,76 1,71 1,67 0,17 1,73 1,79 0,20 1,61 1,65 0,20 
200 0,16 1,64 1,72 1,50 1,62 0,13 1,74 1,61 0,22 1,67 1,63 0,23 
400 0,16 1,43 1,39 1,42 1,43 0,13 1,66 1,61 0,21 1,33 1,46 0,23 
800 0,15 1,25 1,13 1,02 1,24 0,17 1,42 1,36 0,20 1,31 1,27 0,23 
4 4 
50 0,16 1,42 1,69 1,70 1,67 0,13 1,76 1,68 0,19 1,69 1,56 0,19 
100 0,17 1,76 1,70 1,62 1,67 0,10 1,66 1,65 0,18 1,63 1,54 0,19 
200 0,16 1,63 1,56 1,55 1,52 0,15 1,70 1,20 0,19 1,56 1,47 0,19 
400 0,15 1,54 1,47 1,38 1,33 0,15 1,53 1,51 0,18 1,34 1,32 0,19 
800 0,16 1,33 1,31 1,15 1,12 0,15 1,38 1,33 0,19 0,90 1,09 0,20 
5 2 
50 0,14 1,38 1,48 1,53 1,62 0,12 1,67 1,61 0,21 1,66 1,57 0,17 
100 0,15 1,54 1,61 1,55 1,48 0,12 1,63 1,59 0,14 1,58 1,49 0,15 
200 0,13 1,52 1,59 1,41 1,43 0,12 1,58 1,49 0,20 1,34 1,31 0,11 
400 0,14 1,34 1,14 1,15 1,20 0,12 1,34 1,36 0,21 1,00 1,20 0,20 
800 0,15 1,06 0,80 0,93 0,93 0,15 1,18 1,16 0,19 1,01 0,94 0,19 
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Table C4. Antibody response (OD492) to immunization for antigen optimization by ELISA 
using sonicated WB cells from Pasteurella spp. as antigen at different concentrations.  
 
Plate Ag Ab 
Ag blocked with 3% skimmed 
milk Ag not blocked 
No. (µg/ml) Dilutions B F1 F1 F2 F2 B F1 F1 B F2 F2 B 
1 10 
50 0,18 1,34 1,38 1,40 1,47 0,20 1,59 1,48 0,20 1,53 1,48 0,06 
100 0,16 1,29 1,33 1,25 1,23 0,20 1,44 1,41 0,25 1,51 1,49 0,09 
200 0,16 1,26 1,24 1,20 1,51 0,19 1,45 1,45 0,24 1,44 1,46 0,11 
300 0,16 1,12 1,17 1,23 1,19 0,19 1,35 1,40 0,24 1,22 1,23 0,12 
400 0,16 1,01 1,16 1,18 1,31 0,19 1,35 1,36 0,24 1,42 1,18 0,06 
2 8 
50 0,16 1,14 1,15 1,22 1,33 0,15 1,38 1,32 0,21 1,27 0,84 0,21 
100 0,14 1,11 1,11 1,20 1,18 0,13 1,26 1,29 0,21 1,22 1,34 0,21 
200 0,13 1,05 1,01 1,15 1,20 0,17 1,26 1,25 0,21 1,20 1,23 0,23 
300 0,16 0,98 1,00 1,07 1,22 0,17 1,20 1,19 0,21 1,03 1,35 0,21 
400 0,19 0,90 0,79 1,03 1,08 0,17 1,15 1,14 0,21 1,26 1,21 0,25 
3 6 
50 0,14 0,98 1,02 1,07 0,81 0,16 1,23 1,04 0,20 1,15 1,29 0,12 
100 0,14 0,89 0,82 1,05 1,19 0,09 1,17 1,18 0,19 1,28 1,19 0,18 
200 0,14 0,89 0,93 0,93 1,06 0,13 1,03 0,92 0,19 1,07 1,11 0,20 
300 0,14 0,94 0,88 0,96 1,00 0,13 1,00 1,00 0,19 1,18 1,08 0,21 
400 0,12 0,69 0,78 0,88 0,56 0,12 0,84 0,95 0,19 0,55 0,97 0,21 
4 4 
50 0,23 0,90 0,94 1,07 0,96 0,15 0,87 1,04 0,18 1,14 1,02 0,18 
100 0,13 0,84 0,93 0,91 1,09 0,18 0,78 1,02 0,18 1,11 1,00 0,19 
200 0,11 0,89 0,77 0,93 0,85 0,13 0,81 0,98 0,17 1,07 0,89 0,16 
300 0,12 0,78 0,60 0,84 0,79 0,13 0,86 0,91 0,19 1,00 0,92 0,19 
400 0,12 0,71 0,59 0,77 0,86 0,14 0,86 0,87 0,17 0,92 0,87 0,18 
10 2 
50 0,11 0,67 0,61 0,75 0,83 0,11 0,59 0,79 0,14 0,90 0,81 0,13 
100 0,11 0,68 0,58 0,73 0,77 0,11 0,60 0,75 0,13 0,86 0,87 0,12 
200 0,12 0,59 0,66 0,69 0,60 0,12 0,63 0,74 0,11 0,82 0,80 0,13 
300 0,12 0,61 0,52 0,58 0,61 0,12 0,71 0,67 0,14 0,74 0,75 0,13 
400 0,11 0,54 0,47 0,56 0,66 0,13 0,59 0,60 0,14 0,67 0,58 0,14 
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Table C5. Antibody response (OD492) to immunization for antigen optimization by ELISA 
using sonicated WB cells from strain 8657 (V. ordalii) as antigen at different 
concentrations.  
Plate Ag Ab 
Ag blocked with 3% 
skimmed milk Ag not blocked 
no (µg/ml) dilution F1 F1 F2 F2 B F1 F1 B F2 F2 
1 10 
50 1,09 1,10 1,12 1,02 0,17 1,15 1,15 0,19 1,14 1,13 
100 0,99 1,00 0,98 0,98 0,18 1,08 1,06 0,26 1,00 0,94 
200 0,84 0,83 0,84 0,77 0,17 0,95 0,86 0,19 0,84 0,78 
400 0,62 0,77 0,66 0,67 0,19 0,72 0,67 0,18 0,29 0,62 
800 0,44 0,46 0,44 0,46 0,16 0,52 0,50 0,22 0,42 0,46 
2 8 
50 1,11 1,15 1,13 1,16 0,18 1,19 1,19 0,21 1,19 1,17 
100 1,01 1,03 0,95 1,02 0,18 1,11 1,04 0,12 1,08 1,07 
200 0,85 0,88 0,83 0,89 0,18 0,94 0,91 0,30 0,92 0,88 
400 0,68 0,64 0,69 0,69 0,18 0,77 0,65 0,21 0,71 0,69 
800 0,46 0,49 0,48 0,48 0,18 0,55 0,52 0,19 0,52 0,51 
3 6 
50 1,23 1,15 1,23 1,19 0,16 1,07 1,10 0,20 1,06 1,23 
100 1,06 1,04 1,02 1,07 0,17 0,97 1,00 0,20 0,98 0,94 
200 0,88 0,87 0,85 0,81 0,17 0,93 0,96 0,19 0,90 0,83 
400 0,67 0,66 0,59 0,64 0,17 0,79 0,74 0,20 0,68 0,64 
800 0,48 0,47 0,47 0,47 0,18 0,60 0,56 0,18 0,49 0,52 
4 4 
50 1,07 1,09 1,12 1,13 0,16 1,10 1,10 0,19 0,86 0,95 
100 0,98 1,06 0,99 1,02 0,16 1,07 1,00 0,20 0,98 0,87 
200 0,85 0,86 0,85 0,84 0,17 1,05 0,89 0,20 0,84 0,76 
400 0,66 0,66 0,63 0,63 0,17 0,74 0,78 0,19 0,61 0,59 
800 0,46 0,47 0,45 0,44 0,18 0,52 0,53 0,18 0,43 0,45 
5 2 
50 0,87 0,85 0,94 0,94 0,15 1,02 0,96 0,17 0,93 0,87 
100 0,82 0,85 0,82 0,86 0,15 0,85 0,93 0,18 0,89 0,84 
200 0,70 0,72 0,69 0,74 0,15 0,82 0,79 0,18 0,77 0,75 
400 0,57 0,58 0,52 0,57 0,15 0,68 0,65 0,18 0,62 0,61 
800 0,40 0,37 0,40 0,41 0,15 0,55 0,54 0,20 0,47 0,44 
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Table C6. Specific antibody levels two weeks post–immunization with formalin 
inactivated WB cells of strain 8546 (atypical A. salmonicida) detected by ELISA using 
homologous sonicated WB cells as antigens. 
Plate 
No. Sample 
Twofold serum Dilution  
1:50 1:100 1:200 1:400 1:800 1:1600 1:3200 1:6400 1:12800 1:25600 
OD (492 nm) 
1 
F1  1,15 1,10 0,94 0,77 0,63 0,47 0,26 0,14 0,06 0,02 
F1  1,16 1,20 0,94 0,82 0,63 0,45 0,26 0,10 0,07 0,02 
F2 0,88 0,76 0,59 0,45 0,37 0,23 0,13 0,03 0,05 0,02 
F2 0,96 0,67 0,56 0,40 0,33 0,23 0,14 0,06 0,02 0,02 
C2 0,21 0,13 0,08 0,05 0,03 0,03 0,01 0,01 0,00 -0,01 
C2 0,19 0,10 0,07 0,05 0,04 0,03 0,01 0,01 0,00 -0,01 
2 
F3 1,01 0,91 0,59 0,53 0,34 0,23 0,14 0,09 0,00 0,01 
F3 1,03 0,94 0,59 0,57 0,41 0,27 0,17 0,15 0,02 0,00 
F4 0,96 0,66 0,58 0,41 0,25 0,18 0,13 0,09 0,07 0,00 
F4 0,86 0,76 0,52 0,40 0,25 0,18 0,13 0,06 0,03 0,00 
F5 1,04 0,86 0,71 0,55 0,40 0,49 0,16 0,08 0,04 0,00 
F5 1,07 0,92 0,58 0,48 0,34 0,18 0,14 0,06 0,03 0,00 
3 
F6 0,99 0,89 0,58 0,55 0,40 0,18 0,17 0,09 0,06 0,03 
F6 1,01 0,83 0,68 0,52 0,38 0,24 0,17 0,10 0,05 0,02 
F7 1,09 0,90 0,73 0,49 0,34 0,18 0,13 0,08 0,05 0,03 
F7 1,08 0,89 0,70 0,55 0,29 0,19 0,12 0,07 0,04 0,02 
F8 1,11 0,94 0,67 0,53 0,39 0,26 0,17 0,07 0,05 0,05 
F8 1,11 0,95 0,52 0,56 0,30 0,26 0,17 0,12 0,05 0,04 
4 
F9 1,20 1,18 0,96 0,81 0,65 0,47 0,30 0,06 0,10 0,07 
F9 1,25 1,23 1,00 0,78 0,52 0,51 0,31 0,19 0,11 0,03 
F10 1,21 1,02 0,97 0,87 0,64 0,41 0,25 0,15 0,10 0,06 
F10 1,18 1,14 0,99 0,90 0,61 0,40 0,25 0,14 0,09 0,05 
C1 0,50 0,39 0,27 0,20 0,11 0,06 0,02 -0,01 -0,03 -0,04 
C1 0,48 0,36 0,27 0,20 0,08 0,08 0,02 -0,01 -0,03 -0,03 
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Table C7. Specific antibody levels two weeks post–immunization with formalin 
inactivated WB cells of strain AL20460 (atypical A. salmonicida) detected by ELISA using 
homologous sonicated WB cells as antigens. 
 
Plate 
No. Sample 
Twofold serum dilution  
1:50 1:100 1:200 1:400 1:800 1:1600 1:3200 1:6400 1:12800 1:25600 
OD (492 nm) 
1 
F1 1,19 1,01 0,83 0,69 0,43 0,29 0,18 0,10 0,07 0,06 
F1 1,16 1,11 0,83 0,63 0,44 0,30 0,18 0,12 0,06 0,02 
F2 1,01 0,75 0,68 0,51 0,35 0,27 0,15 0,06 0,03 0,02 
F2 1,01 0,86 0,67 0,51 0,37 0,10 0,15 0,05 0,04 0,01 
C2 0,15 0,14 0,12 0,11 0,08 0,07 0,04 0,05 0,03 0,01 
C2 0,17 0,16 0,15 0,13 0,09 0,02 0,06 0,04 0,00 0,04 
2 
F3 1,29 1,22 1,17 1,08 0,96 0,80 0,66 0,46 0,28 0,15 
F3 1,30 1,27 1,14 1,04 0,98 0,84 0,67 0,47 0,29 0,11 
F4 1,22 1,09 0,89 0,73 0,52 0,36 0,21 0,11 0,05 0,01 
F4 1,21 1,11 0,83 0,73 0,55 0,37 0,22 0,12 0,06 0,03 
C2 0,20 0,19 0,19 0,17 0,13 0,09 0,06 0,04 0,03 -0,01 
C2 0,21 0,20 0,18 0,17 0,13 0,10 0,09 0,05 0,05 -0,01 
3 
F5 1,05 1,00 0,87 0,81 0,67 0,66 0,49 0,31 0,19 0,10 
F5 1,10 1,03 0,89 0,83 0,85 0,70 0,51 0,31 0,18 0,10 
F6 1,07 0,95 0,84 0,69 0,51 0,36 0,20 0,10 0,06 0,02 
F6 1,20 1,02 0,85 0,70 0,52 0,33 0,21 0,11 0,06 0,02 
C2 0,21 0,20 0,20 0,18 0,13 0,09 0,07 0,06 0,05 0,03 
C2 0,22 0,19 0,23 0,19 0,15 0,12 0,09 0,06 0,05 0,04 
4 
F7 1,20 1,02 0,85 0,72 0,51 0,37 0,25 0,14 0,09 0,05 
F7 1,17 1,04 0,86 0,72 0,53 0,40 0,25 0,14 0,08 0,04 
F8 1,21 1,18 1,06 0,96 0,79 0,57 0,40 0,21 0,13 0,05 
F8 1,23 1,15 1,08 0,96 0,83 0,59 0,39 0,23 0,13 0,07 
5 
F9 1,21 1,10 0,99 0,92 0,75 0,57 0,35 0,20 0,12 0,06 
F9 1,22 1,11 1,04 0,90 0,74 0,58 0,37 0,18 0,13 0,07 
F10 1,31 1,18 1,08 0,97 0,79 0,60 0,38 0,25 0,05 0,08 
F10 1,35 1,23 1,11 1,00 0,83 0,60 0,39 0,20 0,07 0,10 
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Table C8. Specific antibody levels two weeks post–immunization with formalin 
inactivated WB cells of strain AL122 (V. anguillarum O2) detected by ELISA using 
heterogeneous sonicated WB cells of strain 8752 (V. anguillarum O1) as antigens. 
 
Plate 
No. Sample 
Twofold serum dilution  
1:50 1:100 1:200 1:400 1:800 1:1600 1:3200 1:6400 1:12800 1:25600 
OD (492 nm) 
1 
F1 1,36 1,37 1,27 1,25 0,97 0,70 0,38 0,18 0,11 0,01 
F1 1,38 1,34 1,27 1,14 1,02 0,68 0,39 0,17 0,07 0,00 
F3 1,37 1,33 1,26 1,15 0,92 0,62 0,38 0,19 0,10 0,05 
F3 1,37 1,33 1,24 1,14 0,92 0,65 0,40 0,17 0,10 0,04 
C1 0,76 0,53 0,33 0,21 0,14 0,10 0,07 0,05 0,03 0,01 
C1 0,78 0,52 0,36 0,23 0,10 0,08 0,06 0,04 0,00 0,00 
2 
F4 1,39 1,30 1,12 0,84 0,44 0,23 0,11 0,07 0,03 0,03 
F4 1,40 1,30 1,11 0,92 0,47 0,22 0,12 0,03 0,03 0,03 
F5 1,37 1,28 1,18 0,97 0,63 0,36 0,16 0,10 0,07 0,05 
F5 1,41 1,33 1,16 0,92 0,34 0,35 0,16 0,08 0,08 0,03 
C2 0,11 0,06 0,04 0,01 0,00 -0,02 -0,03 -0,04 -0,10 -0,12 
C2 0,10 0,05 0,03 0,00 -0,01 -0,02 -0,03 -0,05 -0,08 -0,10 
3 
F6 1,04 0,70 0,44 0,34 0,19 0,07 0,05 0,01 0,02 0,02 
F6 1,03 0,74 0,45 0,35 0,18 0,10 0,03 -0,04 0,02 0,02 
F7 1,35 1,25 0,93 0,65 0,33 0,15 0,07 -0,07 0,03 0,02 
F7 1,36 1,22 0,94 0,62 0,29 0,15 0,05 0,06 0,03 0,01 
4 
F8 1,30 1,18 1,10 0,98 0,62 0,39 0,26 0,15 0,10 0,04 
F8 1,30 1,19 1,08 0,89 0,60 0,44 0,24 0,14 0,10 0,06 
F9 1,41 1,44 1,40 1,34 1,22 1,09 0,74 0,35 0,21 0,11 
F9 1,46 1,45 1,38 1,32 1,23 1,07 0,60 0,42 0,22 0,11 
5 
F10 1,41 1,40 1,30 1,38 1,34 1,19 1,01 0,62 0,34 0,14 
F10 1,44 1,40 1,38 1,37 1,34 1,21 0,98 0,58 0,38 0,14 
F11 1,20 1,05 0,76 0,66 0,35 0,22 0,18 0,11 0,07 0,05 
F11 1,20 1,07 0,78 0,62 0,36 0,22 0,17 0,11 0,07 0,05 
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Table C9. Specific antibody levels two weeks post–immunization with formalin 
inactivated WB cells of Pasteurella spp. detected by ELISA using homologous sonicated 
WB cells as antigens. 
Plate 
No. Sample 
Twofold serum dilution  
1:50 1:100 1:200 1:400 1:800 1:1600 1:3200 1:6400 1:12800 1:25600 
OD (492 nm) 
1 
F1 1,40 1,36 1,25 1,19 1,09 0,98 0,85 0,65 0,45 0,20 
F1 1,41 1,35 1,26 1,19 1,10 0,97 0,86 0,65 0,45 0,18 
F2 1,52 1,54 1,44 1,38 1,24 1,21 1,07 0,97 0,89 0,74 
F2 1,54 1,53 1,45 1,37 1,25 1,21 1,05 0,96 0,98 0,73 
C1 0,74 0,48 0,33 0,19 0,16 0,09 0,08 0,01 0,02 0,02 
C1 0,75 0,38 0,32 0,19 0,12 0,09 0,05 0,03 0,02 0,00 
2 
F3 1,54 1,30 1,10 1,09 0,96 0,79 0,53 0,25 0,06 0,02 
F3 1,52 1,10 1,12 1,07 0,94 0,78 0,53 0,27 0,07 0,02 
F4 1,35 1,19 1,18 1,09 1,01 0,88 0,66 0,27 0,20 0,07 
F4 1,34 1,28 1,20 1,07 1,00 0,88 0,66 0,30 0,24 0,09 
C2 0,16 0,09 0,06 0,02 -0,02 -0,03 -0,08 -0,08 -0,07 -0,13 
C2 0,17 0,11 0,06 0,02 -0,04 -0,03 -0,08 -0,08 -0,07 -0,13 
3 
F5 1,45 1,45 1,31 1,25 1,13 1,02 0,89 0,71 0,55 0,51 
F5 1,43 1,45 1,31 1,26 1,13 0,95 0,88 0,72 0,54 0,50 
F6 1,42 1,38 1,23 1,19 1,01 0,91 0,67 0,44 0,37 0,18 
F6 1,38 1,29 1,22 1,19 1,03 0,95 0,66 0,46 0,33 0,19 
4 
F7 1,53 1,33 1,27 1,24 1,12 0,83 0,78 0,66 0,47 0,23 
F7 1,52 1,22 1,27 1,23 1,09 0,82 0,84 0,67 0,47 0,26 
F8 1,36 1,22 1,09 1,03 0,85 0,75 0,60 0,37 0,19 0,06 
F8 1,31 1,20 1,07 1,02 0,81 0,76 0,54 0,37 0,18 0,07 
5 
F9 1,14 1,06 0,99 0,91 0,79 0,67 0,46 0,19 0,10 0,01 
F9 1,15 1,04 1,00 0,91 0,80 0,66 0,43 0,21 0,10 0,01 
F11 1,26 1,18 1,08 0,96 0,87 0,74 0,55 0,33 0,11 0,02 
F11 1,22 1,19 1,09 0,97 0,87 0,73 0,60 0,32 0,12 0,01 
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Table C10. Specific antibody levels two weeks post–immunization with formalin 
inactivated WB cells of strain 8657 (V. ordalii) detected by ELISA using homologous 
sonicated WB cells as antigens. 
Plate 
No. Sample 
Twofold serum dilution  
1:50 1:100 1:200 1:400 1:800 1:1600 1:3200 1:6400 1:12800 1:25600 
OD (492 nm) 
1 
F1 1,06 0,84 0,57 0,35 0,20 0,11 0,07 0,04 0,03 0,02 
F1 1,00 0,83 0,57 0,34 0,20 0,13 0,06 0,03 0,02 0,02 
F2 0,53 0,32 0,17 0,09 0,06 0,06 0,03 0,02 0,02 0,01 
F2 0,53 0,30 0,17 0,10 0,06 0,04 0,04 0,02 0,02 0,01 
C1 0,74 0,58 0,41 0,24 0,13 0,07 0,03 0,03 0,02 0,02 
C1 0,73 0,59 0,40 0,27 0,14 0,07 0,04 0,03 0,04 0,03 
2 
F3 1,07 0,90 0,65 0,25 0,16 0,11 0,08 0,05 0,03 0,00 
F3 1,07 0,91 0,64 0,24 0,19 0,12 0,10 0,05 0,03 0,00 
F4 0,63 0,43 0,34 0,20 0,07 0,06 0,03 0,02 0,02 0,03 
F4 0,61 0,43 0,37 0,19 0,07 0,05 0,02 0,02 0,03 0,01 
C2 0,28 0,19 0,11 0,04 0,04 0,03 0,02 0,02 0,02 0,01 
C2 0,29 0,19 0,10 0,07 0,05 0,05 0,02 0,02 0,02 0,01 
3 
F5 1,18 0,99 0,79 0,55 0,34 0,21 0,13 0,08 0,04 0,03 
F5 1,10 1,03 0,77 0,57 0,33 0,22 0,12 0,05 0,05 0,01 
F6 0,93 0,64 0,39 0,23 0,12 0,07 0,04 0,02 0,01 0,02 
F6 0,92 0,63 0,38 0,23 0,34 0,07 0,04 0,01 0,01 0,02 
4 
F7 0,50 0,29 0,13 0,07 0,03 0,06 0,05 0,05 0,08 0,02 
F7 0,51 0,29 0,09 0,07 0,04 0,01 0,05 0,04 0,02 0,01 
F8 0,96 0,76 0,51 0,32 0,18 0,12 0,09 0,06 0,04 0,04 
F8 0,93 0,75 0,49 0,31 0,19 0,12 0,07 0,04 0,02 0,03 
5 F9 1,09 0,79 0,55 0,44 0,36 0,34 0,32 0,31 0,31 0,31 F9 1,06 0,77 0,54 0,43 0,36 0,34 0,33 0,31 0,31 0,29 
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Table C11. Antibody levels to formalin inactivated WB cells of strain 8546 (atypical A. 
salmonicida) when tested for cross-reactivity using sonicated WB cells of strain AL20460 
(atypical A. salmonicida) as antigens in ELISA. 
 
Antiserum 8546 Antiserum AL20460 
F1 F2 F3 F4 F5 F1 F2 F3 F4 F5 
1.11 1.22 1.39 1.44 1.23 1.40 1.15 1.13 1.03 1.20 
1.31 1.20 1.41 1.43 1.24 1.38 1.12 1.12 1.03 1.21 
F6 F7 F8 F9 F10 F6 F7 F8 F9 F10 
1.27 1.29 1.32 1.26 1.43 1.09 1.03 1.21 1.25 1.26 
1.27 1.28 1.32 1.27 1.43 1.10 1.07 1.23 1.26 1.26 
C2 C2 Blank Blank Blank C1 C1 Blank Blank Blank 
0.48 0.49 0.25 0.26 0.27 0.60 0.61 0.25 0.26 0.27 
0.47 0.48 0.25 0.26 0.26 0.45 0.59 0.28 0.27 0.25 
 
Table C12. Antibody levels to formalin inactivated WB cells of strain AL20460 (atypical A. 
salmonicida) when tested for cross-reactivity using sonicated WB cells of strain 8546 
(atypical A. salmonicida) as antigens in ELISA. 
 
Antiserum 8546 Antiserum AL20460 
F1 F2 F3 F4 F5 F1 F2 F3 F4 F5 
1.46 1.13 1.26 1.09 1.35 1.23 1.31 1.33 1.48 1.39 
1.45 1.28 1.30 1.13 1.34 1.25 1.30 1.48 1.47 1.39 
F6 F7 F8 F9 F10 F6 F7 F8 F9 F10 
1.09 1.38 1.33 1.17 1.36 1.43 1.41 1.45 1.22 1.50 
1.10 1.15 1.31 1.34 1.38 1.40 1.40 1.43 1.42 1.46 
C2 C2 C2 C2 C2 C1 C1 Blank Blank Blank 
0.50 0.54 0.52 0.54 0.55 0.67 0.65 0.31 0.31 0.31 
0.51 0.52 0.53 0.55 0.55 0.70 0.67 0.31 0.33 0.31 
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Table C13. Antibody levels to formalin inactivated WB cells of strain AL20460 (atypical A. 
salmonicida) when tested for cross-reactivity using sonicated WB cells of strain 8546 
(atypical A. salmonicida) as antigens in ELISA. 
 
Antibody response to a homologous antigen 
F5 F6 F8 F10 F11 C2 Blank 
1,647 1,37 1,569 1,549 1,632 0,425 0,119 
1,643 1,355 1,544 1,572 1,67 0,413 0,141 
              
Antibody response to  a heterogeneous antigen 
F5 F6 F8 F10 F11 C1 Blank 
1,469 1,271 1,5 1,478 1,623 0,937 0,263 
1,515 1,257 1,537 1,418 1,642 0,901 0,298 
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Table C14. Antibody levels detected by ELISA in fish 35 days post challenge strain 8546 
(atypical A. salmonicida). 
Tank 
no. Sample Challenge 
OD 492 (nm) 
 1/200 serum dilution 1/800 serum dilution 
 k1-1  
Non-cha-c 
0,14 0,15 0,06 0,08 
   k1-2 0,19 0,17 0,10 0,11 
  1 k1-3 0,12 0,11 0,11 0,11 
 k1-4 0,15 0,15 0,09 0,11 
 k1-5 0,13 0,11 0,08 0,10 
 k8-1 0,09 0,15 0,09 0,10 
 k8-2  0,11 0,09 0,07 0,08 
  8 k8-3 0,05 0,06 0,06 0,06 
 k8-4 0,07 0,05 0,08 0,08 
 k8-5 0,08 0,08 0,08 0,08 
 k5-1ip 
++i.p.  
0,31 0,29 0,12 0,12 
 k5-2ip 0,05 0,06 0,18 0,16 
 k5-3ip 0,06 0,06 0,06 0,07 
5 k5-1 
++Co. (1:1) 
0,16 0,16 0,14 0,13 
   k5-2 0,05 0,04 0,09 0,07 
 k5-3 0,25 0,22 0,20 0,18 
 k5-4 0,12 0,09 0,10 0,11 
 k5-5  0,11 0,12 0,08 0,08 
 k4-1 
++Co. (1:1) 
0,09 0,08 0,08 0,07 
 k4-2 0,07 0,06 0,06 0,05 
 k4-3 0,15 0,13 0,09 0,10 
 4 k4-4 0,05 0,05 0,03 0,04 
 k4-5 0,07 0,07 0,04 0,03 
 k4-1ip ++i.p. 0,08 0,08 0,07 0,05  k4-2ip 0,11 0,11 0,08 0,07 
 k2-1 
++Bath 
0,07 0,06 0,06 0,06 
 k2-2 0,07 0,07 0,07 0,05 
 k2-3 0,07 0,06 0,07 0,05 
 2 k2-4 0,19 0,13 0,15 0,15 
 k2-5 0,06 0,07 0,05 0,05 
 k2-6 0,05 0,05 0,05 0,05 
++, 106 bacteria/ml; i.p., intraperitoneal; Non-cha-c, non-challenged control; 1:1, i.p. to Co. 
ratio. 
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Table C14 (Continues) 
Tank Fish Challenge OD (492 nm) 1/200 serum dilution 1/800 serum dilution 
7 
k7-1 
+Co. (1:1) 
0,14 0,10 0,07 0,08 
k7-2 0,11 0,11 0,08 0,07 
k7-3 0,10 0,12 0,12 0,12 
k7-4 0,10 0,11 0,09 0,10 
k7-5 0,12 0,13 0,06 0,08 
k7-1ip 
+i.p.  
0,09 0,09 0,09 0,11 
k7-2ip 0,19 0,19 0,11 0,11 
k7-3ip 0,05 0,05 0,06 0,09 
k7-4ip 0,07 0,07 0,12 0,08 
k7-5ip 0,10 0,10 0,09 0,07 
3 
k3-1 
+Co. (1:1) 
0,10 0,02 0,10 0,08 
k3-2 0,11 0,10 0,07 0,08 
k3-3 0,10 0,09 0,08 0,07 
k3-4 0,08 0,08 0,08 0,08 
k3-5 0,15 0,15 0,12 0,11 
k3-1ip 
+i.p.  
0,09 0,09 0,11 0,09 
k3-2ip 0,11 0,09 0,09 0,07 
k3-3ip 0,12 0,12 0,11 0,08 
k3-4ip 0,10 0,09 0,12 0,10 
k3-5ip 0,05 0,05 0,07 0,08 
6 
k6-1 
++Bath 
0,12 0,12 0,07 0,09 
k6-2 0,03 0,06 0,07 0,07 
k6-3 0,06 0,07 0,07 0,07 
k6-4 0,11 0,10 0,07 0,06 
k6-5 0,10 0,07 0,07 0,06 
k6-6 0,13 0,12 0,09 0,09 
  +, 103 bacteria/ml;  
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Table 15C. Antibody levels detected by ELISA in fish 49 days post challenge with strain 
AL20460 (atypical A. salmonicida).    
Sample Challenge 
OD (492 nm) 
1/200 serum 
dilution  
1/800 serum 
dilution  
D5 -1  0,16 0,16 0,14 0,14 
D5 -2 ++i.p. 0,16 0,17 0,15 0,16 
D5 -3  0,10 0,12 0,09 0,10 
D5 -4  0,12 0,13 0,10 0,10 
D5 -5  0,14 0,16 0,15 0,17 
D5 -6  0,15 0,16 0,14 0,15 
D5 -7  0,14 0,16 0,12 0,13 
D5 -8 ++Co. (1:1) 0,14 0,14 0,14 0,14 
D5 -9  0,19 0,20 0,17 0,16 
D5 -10  0,14 0,15 0,15 0,15 
D5 -11  0,13 0,14 0,15 0,13 
K1 -1  0,10 0,09 0,05 0,09 
K1 -2  0,09 0,09 0,08 0,09 
K1 -3  0,11 0,10 0,06 0,07 
K1 -4  0,12 0,11 0,08 0,08 
K1 -5 Non-cha-c 0,11 0,14 0,06 0,08 
K8-1  0,10 0,11 0,08 0,12 
K8-2  0,14 0,14 0,07 0,08 
K8-3  0,12 0,12 0,09 0,06 
K8-4  0,12 0,13 0,07 0,07 
K8-5  0,14 0,14 0,06 0,08 
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Table C16. Antibody levels detected by ELISA in fish 43 days post challenge with strain 
8752 (V. anguillarum O1). 
Sample Challenge OD (492 nm) 1/200 serum dilution 1/800 serum dilution  
i.p.1 ++i.p. 0,31 0,31 0,08 0,08 i.p.2 0,21 0,22 0,07 0,08 
Co.1 
++Co. (1:1) 
0,17 0,18 0,05 0,05 
Co.2 0,13 0,13 0,06 0,03 
Co.3 0,15 0,14 0,05 0,05 
Co.4 0,12 0,11 0,05 0,06 
Co.5 0,12 0,12 0,04 0,03 
Co.6 0,17 0,18 0,07 0,06 
Co.7 0,19 0,19 0,08 0,07 
Co.8 0,15 0,11 0,07 0,10 
Co.9 0,12 0,16 0,05 0,06 
Co.10 0,17 0,18 0,05 0,06 
Co.11 0,14 0,12 0,04 0,04 
Co.12 0,16 0,17 0,07 0,04 
Co.13 0,27 0,27 0,08 0,08 
Co.14 0,13 0,13 0,04 0,04 
Co.15 0,17 0,16 0,05 0,06 
Co.16 0,12 0,13 0,03 0,04 
Co.17 0,20 0,19 0,06 0,06 
Co.18 0,15 0,13 0,05 0,05 
Co.19 0,19 0,19 0,06 0,06 
Co.20 0,21 0,20 0,06 0,07 
B1 
++Bath 
0,07 0,07 0,01 0,01 
B2 0,12 0,11 0,03 0,06 
B3 0,05 0,05 0,01 0,00 
B4 0,10 0,11 0,04 0,04 
B5 0,07 0,05 0,03 0,03 
B6 0,08 0,09 0,02 0,03 
B7 0,11 0,07 0,02 0,02 
B8 0,09 0,08 0,02 0,01 
B9 0,11 0,09 0,04 0,02 
B10 0,10 0,11 0,03 0,02 
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Table C16 (Continues).  
 
Sample 
 
Challenge 
OD (492 nm) 
          1/200 serum dilution  1/800 serum dilution   
C1   
 
 
 
 
 
 
 
Non‐cha‐c 
(Placebo) 
 
 
 
 
 
 
 
 
 
 
 
Non‐cha‐c 
0,03  0,03  0,02  0,02 
C2  0,03  0,04  0,01  0,01 
C3  0,11  0,12  0,03  0,04 
C4  0,06  0,07  0,02  0,02 
C5  0,11  0,13  0,03  0,03 
C6  0,08  0,07  0,00  0,01 
C7  0,08  0,08  0,02  0,02 
C8  0,08  0,08  0,03  0,02 
C9  0,11  0,12  0,02  0,02 
C10  0,11  0,11  0,00  0,01 
C11  0,09  0,11  0,01  0,01 
C12  0,14  0,17  0,04  0,03 
C13  0,07  0,08  0,02  0,02 
C14  0,06  0,07  0,04  0,05 
C15  0,02  0,04  0,04  0,08 
C16  0,05  0,05  0,08  0,12 
C17  0,07  0,06  0,09  0,14 
C18  0,04  0,04  0,04  0,07 
C19  0,01  0,04  0,05  0,06 
C20  0,04  0,04  0,03  0,06 
C21  0,01  0,01  0,04  0,03 
C22  0,04  0,02  0,03  0,09 
C23  0,03  0,04  0,02  0,02 
C24  0,05  0,06  0,06  0,06 
C25  0,02  0,03  0,02  0,01 
C26  0,11  0,04  0,04  0,01 
C27  0,02  0,03  0,03  0,02 
C28  0,04  0,06  0,05  0,06 
C29  0,03  0,03  0,02  0,01 
 
 
 
 
 
 
 
 
 
 
 
100 
 
Table C17. Antibody levels detected by ELISA in fish 11 days post challenge with 
Pasteurella spp. by cohabitation in a 1:1 ratio to i.p. at four different concentrations. 
 
Sample 
Bacterial dilution in 
PBS for challenge 
OD (492 nm) 
1/200 dilution 1/800 dilution 
1 
1/20  
0,26 0,28 0,06 0,06 
2 0,19 0,24 0,06 0,08 
3 0,08 0,09 0,03 0,04 
4 0,16 0,19 0,03 0,06 
5 0,25 0,27 0,10 0,15 
6 0,24 0,31 0,10 0,09 
7 0,11 0,13 0,04 0,04 
8 0,10 0,15 0,05 0,05 
1 
1/50  
0,28 0,31 0,17 0,18 
2 0,32 0,41 0,15 0,22 
3 0,26 0,35 0,12 0,16 
4 0,33 0,40 0,18 0,23 
5 0,24 0,26 0,13 0,15 
6 0,34 0,36 0,12 0,23 
7 0,23 0,26 0,14 0,15 
8 0,31 0,33 0,15 0,26 
1 
1/100  
0,21 0,36 0,17 0,18 
2 0,21 0,31 0,16 0,17 
3 0,31 0,43 0,18 0,21 
4 0,18 0,31 0,14 0,16 
5 0,13 0,26 0,13 0,14 
6 0,32 0,48 0,11 0,20 
7 0,10 0,19 0,13 0,11 
8 0,17 0,19 0,09 0,12 
9 0,30 0,30 0,13 0,20 
10 0,26 0,31 0,14 0,20 
1 
1/1000  
0,33 0,34 0,15 0,18 
2 0,29 0,32 0,14 0,21 
3 0,43 0,51 0,12 0,24 
4 0,20 0,22 0,11 0,11 
5 0,27 0,42 0,14 0,13 
6 0,28 0,31 0,14 0,17 
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Table C18. Antibody levels detected by ELISA in vaccinated fish 43 days post challenge 
with strain 8546 (atypical A. salmonicida).  
Serum 
dilution Vaccine 
Sera Samples 
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
OD (492 nm) 
1/200. 
AMM3 1,08 1,24 0,79 0,94 1,09 1,20 1,33 1,36 0,96 NA 1,13 1,21 0,76 1,00 1,02 1,22 1,32 1,41 0,95 NA 
Trivalent 1,59 1,41 1,62 1,05 1,53 1,05 1,16 1,46 1,35 1,12 1,60 1,42 1,58 1,07 1,50 1,10 1,19 1,47 1,33 1,14 
Monovalent 1,33 1,34 0,89 1,07 0,89 1,01 0,89 0,92 1,58 0,89 1,35 1,31 0,86 1,07 0,88 1,00 0,88 0,91 1,55 0,91 
Non-vacc-cha 
(PBS) 
0,71 0,56 0,74 0,52 0,64 0,60 0,58 0,57 0,61 0,61 
0,65 0,55 0,75 0,51 0,64 0,62 0,57 0,55 0,60 0,62 
Non-cha-c 
(Placebo) 
0,29 0,29 0,28 0,31 0,30 0,30 0,31 0,31 NA NA 
0,29 0,30 0,28 0,33 0,30 0,30 0,31 0,31 NA NA 
0,30 0,31 0,31 0,34 0,33 0,33 0,30 0,33 NA NA 
0,31 0,32 0,31 0,36 0,34 0,33 0,39 0,34 NA NA 
0,28 0,30 0,29 0,34 0,31 0,31 0,31 0,30 NA NA 
0,30 0,30 0,28 0,31 0,30 0,32 0,31 0,30 NA NA 
0,29 0,29 0,29 0,32 0,34 0,31 0,31 0,30 NA NA 
0,30 0,35 0,29 0,32 0,30 0,30 0,31 0,30 NA NA 
1/800. 
AMM3 0,83 0,96 0,46 0,67 0,75 0,74 0,70 0,94 0,62 NA 0,81 0,90 0,48 0,66 0,77 0,74 0,76 0,92 0,59 NA 
Trivalent 1,33 1,09 1,43 0,53 1,12 0,61 0,82 1,02 0,69 0,63 1,31 1,06 1,40 0,50 0,95 0,64 0,79 1,26 0,72 0,63 
Monovalent 0,90 0,79 0,53 0,69 0,49 0,59 0,53 0,47 1,27 0,53 0,88 0,81 0,51 0,62 0,54 0,53 0,56 0,51 1,22 0,52 
Non-vacc-cha 
(PBS) 
0,48 0,43 0,49 0,43 0,48 0,43 0,44 0,38 0,40 0,39 
0,47 0,42 0,49 0,42 0,48 0,44 0,44 0,38 0,38 0,42 
Non-cha-c 
(Placebo) 
0,29 0,29 0,31 0,31 0,30 0,33 0,31 0,32 NA NA 
0,30 0,29 0,28 0,31 0,29 0,30 0,29 0,29 NA NA 
0,28 0,29 0,28 0,29 0,29 0,29 0,28 0,28 NA NA 
0,29 0,28 0,28 0,30 0,28 0,31 0,30 0,31 NA NA 
0,30 0,29 0,29 0,31 0,28 0,30 0,29 0,28 NA NA 
0,31 0,30 0,30 0,33 0,31 0,32 0,31 0,31 NA NA 
0,30 0,28 0,30 0,36 0,36 0,31 0,31 0,30 NA NA 
0,31 0,29 0,29 0,34 0,29 0,30 0,29 0,28 NA NA 
Blank 
0,30 0,29 0,29 0,28 0,28 0,28 0,31 0,30 0,28 0,27 
0,28 0,30 0,30 0,28 0,28 0,28 0,31 0,30 0,29 0,28 
0,29 0,28 0,28 0,27 0,29 0,28 0,30 0,28 NA NA 
0,28 0,28 0,31 0,29 0,29 0,28 0,28 0,28 NA NA 
NA, not available; Non-challenged control (placebo); Non-vacc-cha, Non-vaccinated challenged 
(injected with PBS); AMM3, Alpha Marine Micro 3. F1 – F10; individual sera samples.   
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Table C19. Antibody levels detected by ELISA in vaccinated fish 31 days post challenge 
with strain AL20460 (atypical A. salmonicida). 
 
Serum 
dilution Vaccine 
Sera samples  
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
OD (492 nm) 
1/200 
AMM3 0,84 1,52 0,53 0,98 0,91 0,90 1,31 0,68 0,75 0,95 0,97 1,58 0,55 1,06 0,90 0,96 1,36 0,70 0,76 1,01 
Trivalent 0,77 0,68 0,79 0,84 0,74 0,87 0,71 0,86 0,86 NA 0,76 0,72 0,83 0,84 0,75 0,89 0,73 0,83 0,87 NA 
Monovalent 0,93 0,75 0,81 1,13 0,80 0,80 1,43 0,96 1,16 1,41 1,00 0,77 0,84 1,15 0,82 0,77 1,45 0,99 1,26 1,43 
Non-vacc-cha 
(PBS) 
0,45 0,40 NA NA NA NA NA NA NA NA 
0,45 0,42 NA NA NA NA NA NA NA NA 
Non-cha-c 
(Placebo) 
0,31 0,30 0,32 0,33 0,32 0,31 0,31 0,33 0,33 0,32 
0,30 0,30 0,31 0,32 0,35 0,32 0,31 0,33 0,32 0,32 
1/800 
AMM3 0,40 1,08 0,36 0,67 0,43 0,56 0,85 0,42 0,44 0,53 0,42 1,08 0,37 0,68 0,43 0,60 0,87 0,41 0,48 0,58 
Trivalent 0,54 0,44 0,71 0,54 0,51 0,55 0,47 0,55 0,54 NA  0,54 0,41 0,74 0,56 0,50 0,54 0,47 0,56 0,58 NA  
Monovalent 0,61 0,48 0,43 0,53 0,41 0,43 1,06 0,43 0,64 0,88 0,61 0,52 0,42 0,54 0,42 0,43 1,04 0,43 0,67 0,87 
Non-vacc-cha 
(PBS) 
0,34 0,31 NA NA NA NA NA NA NA NA 
0,36 0,32 NA NA NA NA NA NA NA NA 
Non-cha-c 0,28 0,30 0,29 0,31 0,30 0,31 0,32 0,30 0,30 0,30 0,25 0,28 0,28 0,31 0,30 0,31 0,29 0,32 0,31 0,31 
Blank 
0,19 0,20 0,21 0,22 0,22 0,22 0,25 0,23 0,20 0,22 
0,20 0,22 0,20 0,20 0,19 0,20 0,19 0,21 0,21 0,21 
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Table C20. Antibody levels detected by ELISA in vaccinated fish 31 days post challenge 
with strain 8752 (V. anguillarum O1). 
 
Serum 
dilution Vaccine 
Sera samples  
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 
OD (492 nm) 
1/200 
Trivalent 0,72 0,84 0,64 0,71 1,13 0,57 1,14 0,85 0,85 0,93 0,72 0,83 0,64 0,70 1,14 0,57 1,12 0,84 0,86 0,96 
Monovalent 0,86 0,93 0,97 0,79 1,09 0,65 1,04 0,79 0,76 0,90 0,90 0,93 0,98 0,76 1,11 0,65 1,06 0,79 0,76 0,89 
Non-vacc-cha 
(PBS) 
0,39 0,37 0,42 0,44 0,50 0,46 0,60 0,47 0,41 0,44 
0,42 0,38 0,43 0,43 0,51 0,47 0,57 0,69 0,46 0,44 
Non-cha-c 
(Placebo) 
0,30 0,27 0,30 0,28 0,28 0,29 0,31 0,31 0,32 0,31 
0,29 0,25 0,30 0,30 0,27 0,29 0,28 0,33 0,31 0,31 
0,29 0,26 0,29 0,28 0,27 0,28 0,29 0,29 0,30 0,32 
0,29 0,28 0,29 0,30 0,28 0,29 0,30 0,30 0,31 0,32 
1/800 
Trivalent 0,40 0,42 0,32 0,39 0,62 0,33 0,56 0,36 0,45 0,57 0,41 0,43 0,32 0,38 0,61 0,35 0,56 0,38 0,45 0,58 
Monovalent 0,49 0,42 0,49 0,49 0,65 0,39 0,62 0,39 0,42 0,39 0,49 0,42 0,49 0,48 0,68 0,37 0,60 0,41 0,41 0,40 
Non-vacc-cha 
(PBS) 
0,34 0,30 0,32 0,33 0,35 0,34 0,37 0,32 0,34 0,33 
0,35 0,30 0,32 0,35 0,35 0,35 0,36 0,34 0,33 0,33 
Non-cha-c 
(Placebo) 
0,32 0,28 0,30 0,28 0,29 0,30 0,30 0,28 0,29 0,27 
0,30 0,28 0,29 0,28 0,28 0,23 0,30 0,27 0,28 0,29 
0,29 0,26 0,27 0,27 0,27 0,28 0,31 0,27 0,28 0,28 
0,28 0,26 0,26 0,28 0,28 0,28 0,29 0,28 0,28 0,28 
Blank 0,25 0,25 0,27 0,25 0,27 0,14 0,19 0,25 0,28 0,29 0,27 0,25 0,27 0,28 0,27 0,26 0,26 0,25 0,27 0,26 
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Table C21. Ring diameters for purified lumpfish IgM (ng/µl) determined by SRID at six 
different concentrations. 
 
IgM 
(ng/µl) 
Ring (precipitin) diameter (mm) with 11 replicates 
1 2 3 4 5 6 7 8 9 10 11 Mean (mm) 
160 11.5 11.3 11.4 11.0 10.7 9.6 11.0 10.9 10.7 11.9 11.9 11.1 
80 10.6 10.3 10.3 9.5 8.7 9.6 9.2 9.2 9.0 10.3 10.5 9.7 
40 9.4 9.3 9.3 7.6 6.2 6.2 7.9 7.8 7.4 8.8 8.8 8.1 
20 8.7 8.2 7.8 6.6 6.2 5.7 6.4 6.2 6.2 7.4 7.2 6.9 
10 6.5 6.6 6.4 5.4 5.5 5.4 5.5 5.8 5.3 5.9 5.9 5.8 
5 5.9 5.7 5.4 5.1 5.2 4.9 5.5 4.8 4.9 5.3 5.4 5.3 
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Table C22. Determination of total serum IgM (mg/ml) by SRID in the lumpfish two weeks 
post immunization. 
 
 
 
Group 
 
 
Fish 
Ring (precipitin) diameter (mm) 
with six replicates 
 
Total serum 
(mg/ml)   1      2     3     4   5   6 
8546 
F1 9.36 9.36 NA NA NA NA 1.28 
F2 8.63 8.62 NA NA NA NA 0.84 
F3 8.47 7.58 NA NA NA NA 0.59 
F4 7.88 7.58 NA NA NA NA 0.50 
F5 7.88 7.28 NA NA NA NA 0.46 
F6 9.32 9.38 NA NA NA NA 1.27 
F7 9.96 9.96 NA NA NA NA 1.82 
F8 8.34 7.94 NA NA NA NA 0.63 
F9 7.15 7.18 NA NA NA NA 0.36 
F10 6.88 6.71 NA NA NA NA 0.29 
AL20460 
F1 8.98 9.22 9.27 NA NA NA 1.14 
F2 8.48 8.57 8.32 NA NA NA 0.76 
F3 8.03 7.73 7.87 NA NA NA 0.54 
F4 9.04 8.89 8.60 NA NA NA 0.95 
F5 7.63 7.38 7.03 NA NA NA 0.40 
F6 9.04 8.61 8.75 NA NA NA 0.93 
F7 9.19 8.61 8.46 NA NA NA 0.90 
F8 8.46 8.34 7.29 NA NA NA 0.59 
F9 8.01 8.13 8.03 NA NA NA 0.60 
F10 8.05 8.11 8.21 NA NA NA 0.62 
AL122 
F1 9.35 7.76 9.53 NA NA NA 0.97 
F2 9.53 9.53 9.17 NA NA NA 1.32 
F3 7.76 7.76 7.59 NA NA NA 0.49 
F4 7.94 6.88 6.88 NA NA NA 0.37 
F5 7.59 7.41 7.41 NA NA NA 0.43 
F6 7.59 7.41 7.23 NA NA NA 0.41 
F7 10.76 10.76 10.23 NA NA NA 2.61 
F8 10.76 10.05 9.35 NA NA NA 1.92 
F9 8.11 7.59 7.06 NA NA NA 0.46 
F10 10.05 9.17 8.47 NA NA NA 1.19 
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Table C23. Determination of total serum IgM (mg/ml) by SRID in small non-immunized 
lumpfish.  
 
Fish Rig diameter (mm) Mean diameter (mm) IgM (mg/ml) 
F1 6,42 6,09 5,04 4,77 5,58 0,04 
F2 7,41 6,09 7,42 7,80 7,18 0,09 
F3 6,09 5,83 6,36 5,30 5,90 0,04 
F4 9,20 9,30 9,70 9,68 9,47 0,34 
F5 6,36 6,88 6,89 6,89 6,76 0,07 
F6 6,25 5,83 7,15 6,89 6,53 0,06 
F7 6,36 6,10 7,15 7,20 6,70 0,07 
F8 7,68 7,15 8,80 8,21 7,96 0,14 
F9 5,83 6,09 6,11 5,82 5,96 0,04 
F10 9,07 9,00 9,00 9,00 9,02 0,26 
F11 7,94 8,21 8,74 7,94 8,21 0,16 
F12 5,30 5,80 6,04 6,04 5,80 0,04 
F13 7,15 7,15 7,90 7,68 7,47 0,11 
F14 8,48 8,21 9,30 9,27 8,82 0,23 
F15 7,42 7,68 8,21 7,01 7,58 0,11 
F16 9,70 9,50 9,73 9,79 9,68 0,39 
F17 9,11 8,90 9,12 9,80 9,23 0,30 
F18 8,97 8,48 8,74 8,47 8,67 0,21 
F19 7,15 7,42 8,48 8,48 7,88 0,14 
F20 6,36 6,18 6,40 6,62 6,39 0,06 
F21 6,88 6,18 6,62 6,36 6,51 0,06 
F22 7,75 7,41 8,74 8,48 8,10 0,15 
F23 9,00 8,00 9,86 9,00 8,97 0,25 
F24 6,09 6,35 6,80 6,62 6,47 0,06 
F25 8,47 8,47 9,30 9,27 8,88 0,24 
F26 7,42 7,68 9,20 9,00 8,33 0,18 
F27 7,15 7,15 8,21 8,48 7,75 0,13 
F28 6,62 6,62 6,62 6,89 6,69 0,07 
Mean 7,59 ± 1,23 0,14 ± 0,10 
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10. APPENDIX D. List of figures of results 
 
Fig. D1. Purified lumpfish IgM at different concentrations used as a standard protein for 
making a standard curve to quantify total IgM in unknown serum samples by SRID.   
 
 
A, 160ng/ml; B, 80ng/ml; C, 40ng/ml; D, 20ng; E, 10ng/ml; 5ng/ml; 1 -11, replicates.  
 
Fig. D2. Quantification of lumpfish IgM by SRID two weeks post-immunization with 
formalin inactivated WB strains of 8546 (atypical A. salmonicida). Serum was diluted 1/20 
in PBS.  
 
 
 F1 – F10, individual sera samples induplicates. 
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Fig. D3. Quantification of lumpfish IgM by SRID two weeks post-immunization with 
formalin inactivated WB strains of AL20460 (atypical A. salmonicida).  Serum was 
diluted 1/20 in PBS.  
 
 
Fig. D4. Quantification of lumpfish IgM by SRID two weeks post-immunization with 
formalin inactivated WB strains of AL122 (V. anguillarum O2). Serum was diluted 1/20 in 
PBS. 
 
 
Fig. 5D. Quantification of lumpfish IgM by SRID two weeks post-immunization with 
formalin inactivated WB of Pasteurella - spp. Serum was diluted 1/20 in PBS.  
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Fig. D6. Quantification of lumpfish IgM by SRID post-immunization against formalin 
inactivated WB of 8657. Serum dilution, 1/20 in PBS.  
 
 
Fig. D7. Quantification of total serum IgM in non-immunized lumpfish by SRID. Serum 
dilution, 1/20 in PBS.  
 
C1 – C2, sera samples in duplicates from non-immunized group; 1 – 3, replicates; b, blank.  
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Fig D8. Quantification of total serum IgM by SRID in small non – immunized lumpfish. 
Serum diluted 1/5 in PBS. F1 – F28 represent for individual sera samples in four 
replicates. 
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A B S T R A C T
The innate immune responses in lumpﬁsh (Cyclopterus lumpus L.) have been shown to be functional, but
little is currently known about the B cells, immunoglobulins or adaptive immune responses in this species.
We have used anti-IgM antiserum to isolate B cells and compared them morphologically and function-
ally with other cell types. The fraction of IgM+ cells among isolated peripheral blood leukocytes (PBL),
head kidney leukocytes (HKL) and spleen leukocytes (SL) was in the range of 40%, 12% and 34%, respec-
tively. The IgM+ B cells had high phagocytic ability and were the predominant phagocytes in blood with
higher capacity than IgM+ B cells in HKL. Interestingly, among PBL, the most potent phagocytes were, in
addition to monocytes, some small agranular uncharacterized IgM− cells. The IgM+ B cells were positive
for acid phosphatases (AcP), but negative for myeloperoxidase (MPO). Neutrophils were positive for MPO,
while monocytes/macrophages and dendritic-like cells stained negatively. Monocytes/macrophages and
the small, agranular IgM− cells stained most strongly positive for AcP corresponding to their high phago-
cytic capacity. Further, the ability to produce speciﬁc antibodies upon immunization veriﬁed adaptive
immunity in the species.
The high proportion of phagocytic IgM+ B cells and their phagocytic ability indicate a signiﬁcant role
of phagocytic B cells in lumpﬁsh innate immunity. The present analyses also give strong indications that
vaccination and immunostimulation of farmed lumpﬁsh can be used to prevent disease and mortality
caused by pathogenic organisms.
© 2015 Elsevier Ltd. All rights reserved.
1. Introduction
In teleosts, three classes of immunoglobulins, IgM, IgD and IgT
(called IgZ in zebraﬁsh), have been identiﬁed. IgM is the predom-
inant isotype and specialized in systemic immunity. IgT, which is
present in low concentrations in serum, is an immunoglobulin spe-
cialized in gut mucosal immunity and is considered to be the
functional equivalent to IgA in mammals and birds (reviewed in
Zhang et al., 2011; Sunyer, 2013). The role of IgD in ﬁsh immunity
is still unclear, but it has been suggested that it might function as
an antigen binding receptor and play a role in immune responses
as a mediator of innate immunity (Edholm et al., 2010).
In ﬁsh, two mutually exclusive B cell lineages exist based on the
presence of either IgM or IgT (IgZ) (Zhang et al., 2010; reviewed in
Zhang et al., 2011). The third class of immunoglobulin in ﬁsh, IgD,
can be co-expressed with IgM on B cells, but not with IgT (Edholm
et al., 2011; Wilson et al., 1997). Different subsets of B cells have
been reported for different species: IgM+/IgD+/IgT−, IgM−/IgD+/IgT−
and IgM−/IgD−/IgT+ in rainbow trout (Castro et al., 2014;
Ramirez-Gomez et al., 2012; Zhang et al., 2010) and IgM+/IgD−,
IgM+/IgD+ and IgM−/IgD+ in channel catﬁsh (Edholm et al., 2010; re-
viewed in Salinas et al., 2011). Most ﬁsh species have IgT orthologs,
such as zebraﬁsh (Danilova et al., 2005), rainbow trout (Hansen et al.,
2005), fugu (Savan et al., 2005), carp (Ryo et al., 2010; Savan et al.,
2005; Xiao et al., 2010) and salmon (Tadiso et al., 2011). To date,
catﬁsh is the only species where an IgT equivalent has not been
identiﬁed.
The unexpected discovery of professional phagocytic B cells in
ﬁsh, amphibians and reptilians (Li et al., 2006; Øverland et al., 2010;
Zhang et al., 2010; Zimmerman et al., 2010) has broadened the
insight into B cell functions. Phagocytic B cells in ﬁsh (rainbow trout,
salmon, cod and catﬁsh) were identiﬁed by use of immunoglobu-
lin speciﬁc antibodies to identify IgM+ and IgT+ cells. The fraction
of IgM+ phagocytes among isolated blood leukocytes in trout and
salmon are higher compared with cod, but cod B cells have better
phagocytic capacity shown by uptake of more particles per cell (Li
et al., 2006; Øverland et al., 2010). In rainbow trout, the propor-
tions of phagocytic IgT+ cells, both from blood and head kidney, were
Abbreviations: MPO, myeloperoxidase; AcP, acid phosphatase; DC, dendritic-
like cells; PBL, peripheral blood leukocytes; HKL, head kidney leukocytes; SL, spleen
leukocytes; IgM, immunoglobulin M; SRID, single radial immunodiffusion.
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fax: +4755584450.
E-mail address: Gyri.Haugland@bio.uib.no (G.T. Haugland).
http://dx.doi.org/10.1016/j.dci.2015.05.010
0145-305X/© 2015 Elsevier Ltd. All rights reserved.
Developmental and Comparative Immunology 52 (2015) 132–143
Contents lists available at ScienceDirect
Developmental and Comparative Immunology
journal homepage: www.elsevier.com/ locate /dc i
similar to that of IgM+ cells, and up to seven beads were ingested
by IgT+ cells. The IgT+ cells also had bactericidal abilities and were
stimulated to proliferate and produce secreted Ig similarly to the
IgM+ cells upon bacteria encounter (Zhang et al., 2010). In ﬁsh, it
is striking that the phagocytic B cells are the predominant phago-
cytic cells in blood (Li et al., 2006; Øverland et al., 2010). Although
it has been reported that the professional phagocytic B cells in ﬁsh
also have potent bactericidal abilities (Li et al., 2006; Zhang et al.,
2010), their role in clearance of microorganisms and as antigen pre-
senting cells to activate T cell responses remain to be elucidated.
The fundamental understanding of the role of B cells is their
ability to be primed and activated to accomplish the adaptive spe-
ciﬁc immune response through immunoglobulin production. In
teleosts, antibodies of the IgM class predominate in serum (Solem
and Stenvik, 2006; Warr, 1997), but serum IgT and IgD have also
been reported (reviewed in Sunyer, 2013). Secretory ﬁsh IgM is te-
trameric, although a monomeric IgM has been reported in some
species (Warr, 1995). The serum concentration of IgM varies between
ﬁsh species (about 0.6–20mgml−1), and depends on factors like de-
velopmental stage of the species, variations between individuals,
environmental conditions and stress (Solem and Stenvik, 2006). For
example, in cod (Gadhus morhua L.), IgM can constitute up to 50–70%
of the total serum proteins in the range of 2–20 mgml−1 and the
amount of IgM in cod is high comparedwith salmon (Israelsson et al.,
1991; Magnadottir, 1998; Magnadottir et al., 1999, 2009; Melingen
andWergeland, 2000). The understanding of the role of the natural
IgM antibodies in ﬁsh is in its infancy, but in goldﬁsh and trout
natural antibodies have shown to be involved in defense against both
viral and bacterial infections (Castro et al., 2013). Natural antibod-
ies in cod have also broad speciﬁcity (Gonzalez et al., 1989;
Magnadottir et al., 2009; Sinyakov et al., 2002). In rainbow trout,
IgT in serum is present as a monomer while the molecular weight
indicated a tetramer when isolated frommucus (Zhang et al., 2010).
At protein level, IgD has only been described in two teleost species,
catﬁsh and trout, where it is monomeric (Edholm et al., 2011;
Ramirez-Gomez et al., 2012). The ability of teleosts to produce spe-
ciﬁc antibodies upon vaccination varies. This is exempliﬁed by
Atlantic salmon demonstrating a high speciﬁc antibody response
upon vaccination while cod has a low response, possibly due to the
lack of MHC II (Pilstrøm et al., 2005; Star et al., 2011).
Professional phagocytic B cells have so far been shown in four
ﬁsh species, belonging to Salmoniformes, Gadiformes and Siluriformes.
In the present study, B cells in an evolutionary distant group,
Scorpaeniformes, represented by lumpﬁsh (Cyclopterus lumpus L.),
have been characterized. We have analyzed the proportion of
lumpﬁsh IgM+ B cells and their phagocytic ability and capacity using
ﬂow cytometry. Phenotypic and morphological characterization of
sorted IgM+ B cells has been performed by cytochemical staining
and transmission electron microscopy (TEM) and the B cells were
compared with other leukocyte subsets. Further, serum IgM protein
has been characterized, and we have measured the concentration
of total IgM and speciﬁc antibodies in serum from immunized ﬁsh.
2. Materials and methods
2.1. Fish and rearing conditions
Farmed lumpﬁsh were provided by Fjord Forsk Sogn AS, Norway
and kept in a 500 l tank in the rearing facilities at the Industrial Lab-
oratory (ILAB) at Bergen High-Technology Centre under normal
optimal rearing conditions, with a temperature of 12 °C, salinity of
34 ‰ and a photoperiod light/dark of 12:12 hrs. The oxygen satu-
ration in the outlet water was a minimum of 77% air saturation. The
ﬁshwere fed with commercial dry feed Amber Neptune, marine feed
for gadoids, obtained from Skretting, Norway. There were no signs
of infection and no mortality among the ﬁsh. The average weight
and length of the ﬁsh were 13.2 ± 5 g and 5.7 ± 0.9 cm, respective-
ly. Immunized ﬁsh had an average weight of 300 g (see Section 2.5).
2.2. Puriﬁcation of lumpﬁsh IgM
Puriﬁcation of IgM from lumpﬁsh serum was performed by gel-
ﬁltration and anion exchange chromatography using the Pharmacia
FPLC chromatographic system (Pharmacia). The serum was ob-
tained from wild caught ﬁsh with an approximate weight of 1 kg.
2.3. Production of rabbit anti-lumpﬁsh IgM serum
Rabbit immune serum (anti-IgM) was produced by a Speedy
28-day protocol with four immunizations (Eurogentec, Belgium).
Serum sampled from the rabbits before immunization is hereafter
termed pre-serum. Speciﬁcity of the rabbit antisera were veriﬁed
by ELISA and immunoblotting (Supplementary Fig. S1), in addi-
tion to immunostaining of isolated leukocytes from peripheral blood.
2.4. ELISA for evaluation of the reactivity of rabbit anti-lumpﬁsh IgM
sera
The reactivity of rabbit anti-lumpﬁsh IgM serawas tested by ELISA
using puriﬁed lumpﬁsh IgM as antigen. Immunoplates (F96Maxisorp,
Nunc) were coated with 1 μg ml−1 puriﬁed IgM diluted in PBS by
adding 150 μl per well. Wells where PBS replaced serumwere used
as blank. Skimmedmilk (3% in PBS-T (PBS containing 0.05% Tween))
was used as blocking solution. The conjugate, horseradish peroxi-
dase conjugated polyclonal goat anti-rabbit Ig (Dako, Denmark), was
diluted 1:2000 in PBS-T. The OD was read at 492 nm in a Sunrise
microplate reader (Tecan Group Ltd.) using Magellan software. Two
parallels were performed for all dilutions.
2.5. Production of polyclonal antisera in lumpﬁsh against lumpﬁsh
bacterial pathogens
For production of anti-bacteria immune sera, farmed lumpﬁsh
were kept at ILAB under the same rearing conditions and feed as
described earlier. There were no signs of infection and no mortal-
ity among the ﬁsh. Antisera against the bacteria Vibrio ordalii, V.
anguillarum, two strains of atypical Aeromonas salmonicida, and a
Pasteurella-like bacteria (all bacteria isolated from outbreaks of
disease in lumpﬁsh), were prepared in ten lumpﬁsh for each bac-
terial strain. For immunization 100 μl formalin-inactivated bacterial
suspensions were harvested in the late exponential growth phase
and were injected intraperitoneally. All ﬁsh were immunized three
times. Non-immunized controls were ﬁsh injected with PBS. For the
ﬁrst injection the antigens were emulsiﬁed in Freud’s incomplete
adjuvant. For the following injections the antigens were diluted 1:2
in PBS 4 and 8 weeks after the ﬁrst injection. The lumpﬁsh were
bled 2 weeks after the ﬁnal injection. Sera fractions were collect-
ed and stored at −20 °C.
2.6. ELISA for detection of lumpﬁsh antibodies to bacteria
Sera from lumpﬁsh immunized with bacteria were analyzed by
ELISA using bacteria as antigen. Immunoplates (F96Maxisorp, Nunc)
were coated with 10 μg ml−1 of bacteria diluted in PBS by adding
150 μl per well. Wells where PBS replaced serumwere used as blank.
Sera, diluted 1:50–1:25,600, were used as primary antibody. As no
commercial anti-lumpﬁsh conjugates exist, a secondary antibody
was included. The secondary antibody used was rabbit anti-
lumpﬁsh IgM (diluted 1:1000) described in Section 2.3. The conjugate
was peroxidase conjugated polyclonal goat anti-rabbit Ig (Dako
Denmark) diluted 1:1000 in PBS-T. The OD was read at 492 nm in
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a Sunrise microplate reader (Tecan Group Ltd.) using Magellan soft-
ware. Two parallels were performed for all dilutions.
2.7. Determination of IgM in plasma by single radial
immunodiffusion (SRID) assay
The concentration of total IgM from non-immunized and im-
munized ﬁsh was determined by SRID assay, also called the Mancini
method, as described previously (Melingen and Wergeland, 2000)
using three parallels for each dilution. Puriﬁed IgMwas used tomake
the standard curve.
2.8. Size determination of serum IgM by gel ﬁltration
One milliliter serum was applied to a 26/60 GE Healthcare gel
ﬁltration column in-house packed with superpose 6 prep grade
media (Pharmacia LKB, Biotechnology AB) pre-equilibrated with
buffer containing 50mMBis–Tris, pH 6.4 and 0.1MNaCl. The column
was run at 20 °C. Gel ﬁltration HMW calibration kit (GE Health-
care) was used to make the standard curve. Fractions of 1 ml were
collected and analyzed by SDS–PAGE and immunoblotting.
2.9. SDS–polyacrylamide gel electrophoresis (PAGE) and
immunoblotting
Puriﬁed IgM and PBL were fractioned on a 10 or 12% SDS–
polyacrylamide gel using a Mini Protean Tetra Cell (Bio-Rad) and
were heat-treated (96 °C for 5 min) in sample-buffer containing
β-mercaptoethanol. For the oligomer analysis, serum fractions and
puriﬁed IgM were heat-treated as earlier, but under non-reducing
conditions (absence of β-mercaptoethanol). Samples of 10 μl (5 × 105
cells) were loaded onto each well, electrophoresed at 190 V for
45 min, followed by staining of proteins using Silver Stain Plus kit
(Bio-Rad) or electroblotting onto 0.45 μm nitrocellulose mem-
branes (Bio-Rad). Puriﬁed IgM from lumpﬁsh was included as a
positive control. Immunoblot analyses were performed using rabbit
anti-lumpﬁsh IgM serum (1:1000), polyclonal goat anti-rabbit
immunoglobulins/HRP (Dako) (1:2000), developed with HRP
Conjugate substrate kit (Bio-Rad) or Clarity Western ECL substrate
(Bio-Rad) and visualized in Bio-Radmolecular image chemi Dic XRS+
Imaging system. Pre-serum as primary antibody was included as
a negative control. The molecular weight of the heavy and light
chains of IgMwas calculated in Image lab software version 5.1 BETA
(Bio-Rad) using precision plus protein Kaleidoscope prestained stan-
dard (Bio-Rad) as a molecular marker.
2.10. Tissue sampling and isolation of leukocytes
The ﬁsh were quickly netted and killed by a sharp blow to the
head. Leukocytes were isolated from peripheral blood, head kidney
and spleen using discontinuous Percoll gradients as described pre-
viously (Haugland et al., 2012a). Isolated leukocytes were counted
in a CASY-TT Cell CounterTM (Innovatis AG) and viability and aggre-
gation factors were determined for all samples.
2.11. Cytochemistry
Cytospin preparations were prepared by centrifugation of 100 μl
of cell suspension (1–1.5 × 106 cells ml−1) at 1000 rpm for 3 min in
a Shandon Cytospin 3 cytocentrifuge (Shandon Scientiﬁc Ltd.). The
samples were air dried for 20 hrs at room temperature prior to cy-
tochemical and immunoﬂuorescence staining. The preparations of
cells were stained using Colorrapid (Lucerna-Chem AG) according
to the manufacturer’s instructions.
2.11.1. Myeloperoxidase (MPO)
Staining was performed as described previously (Haugland et al.,
2012a) by use of SIGMAFAST DAB tablets (Sigma-Aldrich) accord-
ing to the manufacturer’s instructions.
2.11.2. Acid phosphatase (AcP)
Staining of leukocytes on cytospun slides was performed using
acid phosphatase kit (Sigma-Aldrich) according to the manufactu-
rer’s instructions. Two staining solutions were prepared, one with
and one without added tartrate.
2.12. Immunoﬂuorescence staining of cytospun leukocytes
Cytospin slides were ﬁxed in acetone:methanol (1:1) for 90 s,
washed once in PBS, pH 7.3 bath and incubated in a humidity
chamber in the dark with PBS, pH 7.3, containing 0.5% (w/v) BSA
for 30 min to block background staining. The slides were incu-
bated for 1 h in a humidity chamber in the dark with primary
antibody, rabbit anti-lumpﬁsh IgM, diluted 1:1000 in PBS contain-
ing 0.5% (w/v) BSA, and washed twice in PBS, pH 7.3 bath, prior to
incubation with Alexa Fluor® 488 F(ab′)2 fragments of goat anti-
rabbit IgG (5 μg ml−1) (Invitrogen) for 45 min and 3 washes in PBS
bath. The slides were cover slipped with ProLong® Gold antifade
reagent with DAPI (Invitrogen). For negative control, the rabbit pre-
serum was used as primary antibody (1:1000).
2.13. Flow cytometry of leukocytes labeled with rabbit anti-lumpﬁsh
IgM serum
Peripheral blood leukocytes (PBL), spleen leukocytes (SL) and head
kidney leukocytes (HKL) were labeled with rabbit anti-lumpﬁsh IgM
serum (1:10,000). Cells incubated without antibodies were used as
control for auto-ﬂuorescence and cells incubatedwith conjugate only
were included to detect any non-speciﬁc binding. Pre-serum as
primary antibody was included as a negative control for all leuko-
cyte samples and used to deﬁne positive cells (2%). Alexa Fluor® 647
F(ab′)2 fragments of goat anti-rabbit IgG (5 μgml−1) (Invitrogen, Mo-
lecular Probes) (1:400) was used as secondary antibody and 10,000
cells were recorded in each sample. Cells were analyzed for forward
scatter (FSC) and sideward scatter (SSC) patterns, representing the
size and granularity of the cells, respectively, and for red ﬂuores-
cence (FL4, long pass ﬁlter 670). Gating of the cells, deﬁned by
propidium iodide (PI, Sigma), was performed to exclude dead cells
and debris from subsequent analyses. Staining with PI was per-
formed according to the manufacturer’s instructions and measured
in FL2 (yellow–orange ﬂuorescence, band pass ﬁlter 585/42). The
analyses were performed on a BD FACSCalibur ﬂow cytometer (BD
Biosciences) equipped with a 488 nm argon laser and a 635 nm red
diode laser using Cell Quest version 3.1 software (Becton Dickin-
son). Further data analyses were performed using FCS express 3 (De
Novo Software).
2.14. Phagocytosis and labeling of IgM+ cells
In the phagocytic assay, isolated leukocytes from peripheral blood
and head kidney (5 × 106) cells in a total volume of 0.5 ml
L-15 + medium in 24 well culture plates (Nunc) were incubated with
ﬂuoresbrite carboxylate YG 1.0 micron microspheres (Polysciences)
as described previously (Haugland et al., 2012a), but with a cell/bead
ratio of 1:20 and incubation for 5 hrs at 15 °C. Negative controls were
wells containing leukocytes, but no beads. Following incubation, non-
adherent cell suspension were collected and mixed with adherent
cells that were carefully loosened using trypsin–EDTA (Lonza
BioWhittaker). Non-ingested beads were removed by placing the
cell-bead suspension at the top of a glucose-cushion consisting of
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3 ml PBS, pH 7.3 with 3% (w/v) BSA and 4.5% (w/v) D-glucose and
centrifugation at 84 × g for 10 min at 4 °C. The cell pellets were re-
suspended in 500 μl L-15 +medium. The leukocyte suspensions were
left over night at 4 °C prior to immunolabeling allowing the cells
to recover after phagocytosis.
Further, the resuspended cells were labeled using polyclonal anti-
IgM serum (1:10,000) as primary antibody and Alexa Fluor® 647
F(ab′)2 fragments of goat anti-rabbit IgG (5 μgml−1) (Invitrogen, Mo-
lecular Probes) (1:400) as secondary antibody prior to analysis with
a BD FACSCalibur ﬂow cytometer or sorting with a BD FACS Aria II
ﬂow cytometer. Negative controls for phagocytosis were cell sus-
pensions incubated without beads while negative controls for IgM
were cell suspensions incubated with rabbit pre-serum instead of
primary antibody. Cells were analyzed for forward scatter (FSC) and
sideward scatter (SSC) patterns, representing the size and granu-
larity of the cells, respectively, for yellow–green bead ﬂuorescence
(FL1) and red ﬂuorescent (FL4) detecting IgM+ cells. The samples
were analyzed as described in Section 2.13.
2.15. Cell sorting of PBL
PBL was labeled with rabbit polyclonal anti-IgM serum as de-
scribed earlier and sorted in a BD FACS Aria II ﬂow cytometer (Becton
Dickinson).Three fractions were collected; IgM+ cells, small IgM− cells
and large IgM− cells. Following phagocytosis and IgM labeling, IgM+
and IgM− phagocytes from blood were sorted, cytospun and stained
with Colorrapid.
2.16. Transmission electron microscopy (TEM)
FACS sorted cell fractions (IgM+, large and small IgM− cells from
blood and IgM+ and IgM− phagocytes from blood and head kidney)
were prepared for TEM atMIC, UiB. The samples were ﬁxed in 1.5–2%
glutaraldehyde in 0.1 M sodium cacodylate buffer and post-ﬁxated
in 1% osmium tetraoxide prior to embedding in Agar 100 resin. Thin
sections (50–60 nm) were stained with uranyl and lead. The prepa-
rations were analyzed at MIC, UiB, using the transmission electron
microscope Joel JEM-1230.
2.17. Digital imaging and image processing
All cytospin slides were examined in a Zeiss Axioskop 2 plus mi-
croscope (Carl Zeiss) and photographs of the cells were captured
using a Nikon DS camera Head DS-5M. The pictures were pro-
cessed in Adobe Photoshop CS5 (Adobe Systems Incorporated).
2.18. Statistics
Two-tailed unpaired t tests were performed for all analyses using
GraphPad Prism 5. The results were considered signiﬁcant when
P < 0.05. In Prism 5, P > 0.05 = n.s., *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.
3. Results
3.1. IgM in serum is a tetramer
In order to characterize lumpﬁsh IgM at the protein level, IgM,
puriﬁed from serum, was applied to SDS–PAGE. TheMw of the heavy
and light chain was determined to be 80.8 kDa and 25.8 kDa, re-
spectively (Fig. 1A). To determine if IgM is an oligomer, puriﬁed
serum IgMwas boiled under non-reducing conditions prior to elec-
trophoresis to avoid breaking of inter-monomeric bonds. IgM had
high Mw, showing that it is not a monomer (Fig. 1A). The oligo-
meric form of IgM in serumwas determined with gel ﬁltration using
HMW calibration kit (Fig. 1B). IgM, detected by rabbit anti-lumpﬁsh
IgM polyclonal serum, eluted with a peak at 49 ml, corresponding
to a Mw of approximately 760 kDa, suggests that serum IgM is a
tetramer (Fig. 1B).
3.2. IgM+ B cells are most abundant among peripheral blood and
spleen leukocytes
The rabbit anti-lumpﬁsh IgM polyclonal serum also reacted with
leukocytes in immunoblotting (Supplementary Fig. S1B, C) and with
live cells in ﬂow cytometer. The percentage of IgM+ B cells among
isolated leukocytes from peripheral blood, head kidney and spleen
could thus be determined using ﬂow cytometry. The IgM+ B cells,
Fig. 1. Lumpﬁsh serum IgM is a tetramer. (A) 12% SDS–PAGE of IgM puriﬁed from serum. Lane 1, IgM boiled under reducing conditions prior to SDS–PAGE; lane 2, kalei-
doscope prestained marker; lane 3, IgM boiled under non-reducing conditions (absence of β-mercaptoethanol) prior to SDS–PAGE. Arrows = heavy and light chain of
immunoglobulin, arrowhead = polymeric immunoglobulin. (B) Elution proﬁle of lumpﬁsh serum in gel ﬁltration column. Left panel: The elution volumes for the proteins in
the calibration kit are shown and the sizes of the proteins are given in the parentheses. Ovalbumin (Ova), Conalbumin (Con), Aldolase (Ald), Ferritin (Fer) and Thyroglobu-
lin (Thy). Right panel: Two fractions from each peak of the serum-samples were resolved with 10% SDS–PAGE and immunoblotted using polyclonal anti-lumpﬁsh IgM serum.
The numbers below the immunoblot show the selected fractions. M = molecular marker. Arrowhead = polymeric IgM. The elution proﬁle is representative for four different
sera analyzed.
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shown as red dots in the scatterplots in Fig. 2A, were found in the
lymphocyte region consisting of small, agranular cells (Fig. 2A, upper
panels). Corresponding histograms are shown in Fig. 2A, lower panels.
The fraction of IgM+ B cells among PBL was 43.5 ± 13%, HKL
12.0 ± 2.5% and SL 37.1 ± 11.4% (Fig. 2B). The anti-IgM serum reacted
with both small and large B cells as shown by immunoﬂuores-
cence staining of cytospun leukocytes (Fig. 2C).
3.3. IgM+ B cells have high phagocytic activity
As a ﬁrst step to characterize IgM+ B cells in lumpﬁsh function-
ally, a phagocytosis assay was performed. PBL and HKL were
incubatedwith 1 μm green ﬂuorescent beads, labeledwith the rabbit
anti-lumpﬁsh IgM serum and analyzed in a ﬂow cytometer. A rep-
resentative PBL sample is shown in Fig. 3A. A set of controls were
included in the assay for each sample; PBL incubated with pre-
serumwithout beads (quadrant i), PBL labeled with anti-IgM serum
without beads (quadrant ii) and PBL incubated with pre-serumwith
beads (quadrant iii). Based on these controls, the IgM+ phagocytes
were deﬁned (quadrant iv, gate 7). The IgM+ B cells were found in
the lymphoid region in the scatter plot (shown as red dots in Fig. 3A,
gate 5), while the majority of the IgM− cells among PBL were small
agranular cells (shown as green dots in Fig. 3A, gate 6). The IgM+
phagocytes, shown in gate 7, had high phagocytic activity. Surpris-
ingly, some small IgM− cells (green dots, gate 8) had potent
phagocytic ability with greater phagocytic capacity than the IgM+
B cells. The identity of the small IgM− cells is currently not known.
A similar analysis of IgM+ phagocytic cells among HKL is shown
in Fig. 3B. IgM+ B cells, shown as red dots in Fig. 3B, gates 5 and 7,
were present in the lymphoid region, while the IgM− cells, shown
as green dots in Fig. 3B, gates 6 and 8, were present throughout the
scatterplot, representing cells within both the lymphoid and
granuloid/macrophage regions.
The IgM+ cells were the dominant phagocytic cells among PBL
constituting 65.1 ± 11% of total phagocytic cells (P < 0.0001), while
among HKL, the percentage of IgM+ B cells (9.8 ± 1.7%) of total phago-
cytic cells was signiﬁcantly lower than other phagocytes (P < 0.0001)
(Fig. 3C). The average percentage of phagocytic B cells of total B cells
was, however, lower among PBL than HKL, 43.2 ± 16.8% and
56.9 ± 11.7%, respectively (Fig. 3D). This was also observed for the
IgM− cells. The percentages of phagocytic IgM− cells of total IgM−
cells were lower among PBL than HKL, 25.1 ± 18.6% and 38.9 ± 9.5%,
respectively. The analysis also showed that the percentages of IgM−
phagocytes among total IgM− cells were signiﬁcantly lower than IgM+
Fig. 2. Flow cytometry analyses and immunostaining of isolated leukocytes using anti-lumpﬁsh IgM polyclonal serum. (A) Representative scatter plot of isolated leuko-
cytes from peripheral blood (PBL), head kidney (HKL) and spleen (SL) stained with rabbit anti-lumpﬁsh IgM serum (upper panels) and the corresponding histograms (lower
panels). In the scatter plots, which distribute cells according to granularity and size, IgM+ cells are visualized as red dots. The gates deﬁne live cells. In the histograms, IgM+
cells, labeled with Alexa Fluor 467, are deﬁned by the cursors. Red line = samples labeled with anti-IgM serum, black line = samples incubated with pre-serum and gray
ﬁlled histograms are samples incubated with conjugate only (no primary antibody). (B) Diagram showing the percentages of IgM+ B cells of the total leukocyte populations
PBL (n = 8), HKL (n = 8) and SL (n = 8). Means ± S.D. are shown. (C) Immunostaining using anti-IgM serum and Alexa Fluor 488 (IgM+ cells are green). Nuclei are stained blue
with DAPI. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 3. IgM+ cells have phagocytic activity. Isolated leukocytes were incubated with 1 μm yellow green ﬂuorescent beads at a cell:bead ratio of 1:20 and incubated at 15 °C
for 5 hours. (A) Representative PBL and (B) HKL sample. Panel i: Quadrant plot of leukocytes incubated without green ﬂuorescent beads and with pre-serum (negative control).
Panel ii: Quadrant plot of leukocytes incubated with anti-IgM serumwithout beads. The IgM+ (gate 5, red dots) and IgM− cells (gate 6, green dots) are shown in the scatterplots
to the right. Panel iii: Quadrant plot of leukocytes incubated with pre-serum in the presence of beads. Panel iv: quadrant plots of leukocytes incubated with anti-IgM serum
and beads. Phagocytic IgM+ cells (gate 7) are shown as red dots in the scatterplot to the left while the IgM− phagocytes (gate 8) are shown as green dots. AF647 = Alexa
Fluor 647. (C) Diagram with the percentages of IgM+ (black bars) and IgM− phagocytes (gray bars) of the total number of phagocytic cells among PBL (n = 9) and HKL (n = 9).
Means ± S.D. are shown. (D) The percentage of phagocytic IgM+ positive cells of total IgM+ population (black dots) and the fraction of IgM− phagocytes among the total IgM−
leukocytes (gray squares) among PBL and HKL. Means are shown. Statistical signiﬁcance: P > 0.05 = n.s., *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001. The experiment was performed
three times with different batches of ﬁsh. All experiments gave similar results. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of this article.)
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phagocytes among total IgM+ cells in both PBL (P = 0.040) and HKL
(P = 0.003) (Fig. 3D).
3.4. IgM+ cells have high phagocytic ability
To compare the phagocytic capacity of IgM+ B cells with other
phagocytes, we investigated the cells’ ability to ingest 1, 2, 3–8 and
9+ beads (Fig. 4). Unexpectedly, the PBL samples from the ana-
lyzed ﬁsh were clearly grouped into two groups, PBL group 1 (PBL1)
containing leukocyte samples with a signiﬁcant number of granu-
locytes (Fig. 4A) and group 2 (PBL2) where the granulocytes were
low in numbers and the majority of the cells were small agranular
cells (Fig. 4B). IgM+ B cells in both PBL groups had a high phago-
cytic capacity (Fig. 4D, left panel). The majority of the B cells had
ingested 3–8 beads and the percentages of IgM+ B cells had phago-
cytized more than 3–8 beads were signiﬁcantly higher than
phagocytes with only 1 bead (P = 0.001 for PBL 1 and P = 0.0001 for
PBL2). Among HKL, a signiﬁcantly higher percentage of the IgM+ B
cells had ingested only 1 bead compared to IgM+ B cells in blood
(P = 0.024 in PBL1 and P < 0.001 in PBL2). The fraction of IgM+ B cells
with high capacity (9 or more beads) was signiﬁcantly lower among
HKL IgM+ B cells than IgM+ B cells in blood (P = 0.021 in PBL1 and
P = 0.001 in PBL2) (Fig. 4D left diagram). Different from PBL, the per-
centage of IgM+ cells among HKL with 9 or more beads was
signiﬁcantly lower (P = 0.0001) than those with 1 bead. The IgM−
cells and their phagocytic capacity were different between PBL group
1 and group 2 (Fig. 4D, right diagram). The IgM− cells in PBL2 con-
sisted mainly of small agranular cells (Fig. 4B) with remarkable high
phagocytic capacity despite their small size. Most of the cells had
ingestedmore than 3 beads and some of them could havemore than
50 beads as the cell pictured in Fig. 4B. In PBL2, but not in PBL1, the
percentage of cells with 9 or more beads was signiﬁcantly higher
than those with 3–8 beads (P < 0.0001). The phagocytic IgM− cells
in PBL1 were granulocytes with lower phagocytic capacity (with 1
or 2 beads, and only a few had more than 5 ingested beads). Among
PBL, the cell types with highest phagocytic capacity among the IgM−
cells were the small agranular cells and monocytes. Similar to IgM+
cells in HKL, the percentages of IgM− cells that have ingested 9 or
more beads were signiﬁcantly lower than those with 1 bead
(p = 0.003) and 3–8 beads (p = 0.0001). Among IgM− cells in HKL,
macrophages had the highest capacity to ingest beads (Fig. 4C).
Phagocytic cells were cytospun and stained with colorrapid to vi-
sualize cell morphology (Fig. 4A, B, C).
3.5. Phenotypic characterization of sorted IgM+ B cells
To further characterize the IgM+ B cells in lumpﬁsh, PBL were
sorted into IgM+ B cells, small IgM− cells and large IgM− cells (Fig. 5A).
Post-sort analyses showed that the IgM+ cells were isolated to a purity
of 87–92%. The IgM+ cells stained negatively for myeloperoxidase
(MPO), but were positive for acid phosphatase (AcP) (Fig. 5B). The
small IgM− cells were mononuclear leukocytes of lymphocyte size
or smaller and stained negative for MPO similar to the IgM+ cells.
The smallest cells in this fraction stained most intensely for AcP
(Figs. 5B and 6) which indicate the presence of a high number
enzymes and/or high enzymatic activity. The large IgM− cells con-
sisted mainly of neutrophilic granulocytes, but monocytes were also
present. The neutrophils stained positively for MPOwhile themono-
cytes were negative. Both cell types stained positive for AcP (Fig. 5B).
To investigate the ultrastructure of the sorted cells, the different frac-
tions were prepared for TEM (Fig. 5C). The IgM+ cells contained a
few cytoplasmic vacuoles while vacuoles were more abundant in
the small IgM− cells. Among the large IgM− cells were the neutro-
phils containing different types of granules and monocytes with
internal vesicles and ribosomes in the cytoplasm.
For a more detailed comparison with regards to morphology and
cytochemical staining of IgM+ cells with other cell-types observed
among isolated leukocytes, representative single cells of different
subtypes are shown in Fig. 6. Among the IgM− cell-types we iden-
tiﬁed cells with high nucleus to cytoplasm ratio, similar to the B
cells, that are likely T cells and we observed three subsets of neu-
trophils with bilobed, bean-shaped and rounded nucleus. Many of
the neutrophils contained a large cytoplasm and had irregular cell
morphology. All the neutrophils were positive for MPO. Basophils
were identiﬁed, but MPO staining of the basophils was not deter-
mined due to the low abundance of these cells. Monocytes,
macrophages and cells resembling dendritic cells were observed.
These cells were all negative for MPO (Fig. 6). The cell subsets with
highest AcP activity were monocytes/macrophages and some of the
smallest IgM− cells that might be precursor cells or immature cells.
All cell types had tartrate resistant acid phosphatases.
3.6. Speciﬁc antibodies are produced upon immunization
Single radial immunodiffusion (SRID) assay was performed to de-
termine the total IgM concentration in serum of normal ﬁsh and
upon immunization. In small, non-treated ﬁsh the concentrationwas
0.140 ± 0.099 mgml−1 (n = 27) (Supplementary Fig. S2).
The SRID assay was also applied to serum from ﬁsh immu-
nized with different bacteria, 2 isolates of atypical Aeromonas
salmonicidae, Vibrio anguillarum (also known as Listonella), V. ordalii
and a Pasturella-like bacteria, all isolated from lumpﬁsh. As shown
in Fig. 7B, the level of total IgM in serumwas not signiﬁcantly higher
in the immunized ﬁsh compared with the controls. However, the
levels of speciﬁc antibodies, measured with ELISA, were signiﬁ-
cantly higher in the immunized ﬁsh, except those immunized with
V. ordalii (Fig. 7D). The production of speciﬁc antibodies veriﬁes adap-
tive immunity in lumpﬁsh.
4. Discussion
We have characterized IgM+ B cells in lumpﬁsh and compared
these B cells with other cell types morphologically, phenotypi-
cally and functionally. Analysis of serum immunoglobulin showed
that it is a tetramer of IgM type, based on molecular weight anal-
yses of non-reduced and reduced isolated immunoglobulin and
rabbit anti-lumpﬁsh IgM serum. The IgM isotype is the dominat-
ing serum immunoglobulin also in other ﬁsh species (Sunyer, 2013).
The produced rabbit antiserum to lumpﬁsh IgM reacted with both
heavy and light chains of puriﬁed IgM and, although weakly, with
bands of corresponding size in the PBL samples (Supplementary
Fig. S1). The weak reaction with PBLmight be because of the number
of cells in the leukocyte sample loaded on the gel or amount of IgM
per cell. Further, the antiserum reacted with leukocytes consis-
tent with lymphocyte morphology and size as shown by ﬂow
cytometry, staining of sorted cells and by immunoﬂuorescence. Ac-
cordingly, this antiserum could be used to identify and isolate IgM+
cells.
The percentages of IgM+ cells among PBL, HKL and SL are com-
parable to those found in other ﬁsh species like trout (Abos et al.,
2013) and Atlantic salmon (Øverland et al., 2010; Pettersen et al.,
2000; Supplementary Fig. S3). In Atlantic cod, the percentages of
B cells among PBL are lower compared with those of salmonids and
lumpﬁsh, while the level of cod B cells among isolated leucocytes
from spleen is higher in cod (Rønneseth et al., 2007). In humans,
the main population among PBL is neutrophils being about 70% of
the leukocytes, while in ﬁsh the IgM+ B cells seem to be the domi-
nating leukocyte population in blood. The immunological signiﬁcance
of the high levels of B cells among PBL in ﬁsh is not known, but the
high level, in addition to their high phagocytic ability, suggests that
B cells in ﬁsh are a major part of the teleost innate immune defense
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Fig. 4. IgM+ cells have high phagocytic capacity. Isolated leukocytes were incubated with 1 μm yellow green ﬂuorescent beads at a cell:bead ratio of 1:20 and incubated at
15 °C for 5 hours. The PBL samples divided into group 1 with several neutrophils and group 2 with few neutrophils. (A) PBL, group 1 (n = 4) and (B) PBL, group 2 (n = 4) and
(C) HKL (n = 8). Left panels: Scatterplots showing the phagocytic cells. R1 = lymphoid region, R2 = granuloid region. Red dots = cells with 1 bead, blue = cells with two beads,
green = cells with 3–8 beads and purple = 9 or more beads. The gates deﬁne live cells. Second left panels: quadrant plots showing IgM+ and IgM− phagocytes. AF647 = Alexa
Fluor 647. Second right panels: Distribution of IgM+ and IgM− phagocytes in scatter plots. Right panels: Histograms showing the number of beads ingested by phagocytic
cells. The peaks deﬁne different numbers of beads ingested. Colorrapid staining of representative phagocytes are shown. Scale bar = 5 μm. The red circle in the histogram to
the right in (B) show the IgM− cells with extremely high phagocytic capacity despite their small size. (D) Diagrams of phagocytic IgM+ (left diagram) and IgM− cells (right
diagram) among PBL group 1, PBL group 2 and HKL. The colors of the bars represent various numbers of beads as indicated in the key. Means ± S.D. are shown. Statistical
signiﬁcance: P > 0.05 = n.s., *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.
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Fig. 5. Cytochemical staining and ultrastructural analyses of IgM+ cells, small IgM− cells and large IgM− sorted from PBL. (A) Cell sorting and post sort analysis. Left panel:
Scatterplot of a representative PBL sample. The gate deﬁnes live single cells. Second left panel: Scatterplot showing IgM+ AF647 versus size. The squares deﬁne sorted cells;
IgM+ cells, small IgM− cells and large IgM− cells. The two plots to the right show post sort analysis of IgM+ cells. (B) Colorrapid (CR) and cytochemical staining of sorted cells.
MPO = myeloperoxidase, AcP = acid phosphatase, N = neutrophil and M = monocytes. Note that RBC stain positive in the MPO staining and thus function as a positive control
for the staining procedure. Scale bar = 5 μm. (C) Ultrastructure of IgM+ (left picture), IgM− small (middle picture) and IgM− large cells (right picture). Representative cells are
shown. The magniﬁcation are shown as numbers in the upper right corner of each picture, K = 1000. Scale bar = 1 μm.
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mechanisms. In this study we have identiﬁed and characterized the
lumpﬁsh IgM+ B cell linage. Other immunoglobulin isotypes are not
yet identiﬁed in lumpﬁsh, although IgT+ cells and free IgT immu-
noglobulin, which are shown to be important for mucosal immunity
in other ﬁsh species like trout (Castro et al., 2013; Zhang et al., 2010),
may be present in this species.
For analyses of lumpﬁsh B cell functions, we performed a phago-
cytosis assay using ﬂuorescent beads. The ﬂow cytometry analyses
showed that IgM+ B cells in lumpﬁsh had high phagocytic ability
and capacity. Among PBL, the IgM+ cells constitute the main frac-
tion of the phagocytic cells (65.1 ± 11%), while the IgM+ cells isolated
from head kidney constituted only about 10% of the phagocytes. The
high difference between the proportions of IgM+ phagocytes of the
total phagocytic population in PBL and HKL is similar to trout (Abos
et al., 2013) and expected due to the different abundance of IgM+
B cells among the isolated cells. Although the fraction of IgM+ phago-
cytes of total IgM+ cells in PBL was highly variable, varied from 25
to 74%, in average, the fraction of phagocytic IgM+ cells is higher
among HKL than PBL, 56.9 ± 11.7% and 43.2 ± 16.8%, respectively. In-
terestingly, the IgM+ cells in blood have higher phagocytic capacity
than those isolated from head kidney, indicating that factors like
maturation may affect cell function. The high phagocytic capacity
of the IgM+ B cells with ability to ingest more than 9 beads was un-
expected. Also, in a previous study, we reported that leukocytes
isolated from large wild caught lumpﬁsh have high phagocytic ability
(Haugland et al., 2012a), suggesting that the innate immunemecha-
nisms in lumpﬁsh are very effective, involving phagocytes like
monocytes/macrophages, small agranular cells, B cells and
neutrophils.
A striking observation was that IgM− cells of equal or smaller size
as the IgM+ cells had very high phagocytic capacity. These small
mononuclear cells, which had ingested numerous beads, were easily
observed in ﬂow cytometry analysis and colorrapid staining of
phagocytic cells from PBL. The nature of these cells is currently not
known, but similar cells have been reported from trout (Li et al.,
2006), Atlantic salmon (Haugland et al., 2012b) andwrasse (Haugland
et al., 2014). We have earlier suggested for salmon and wrasse that
these cells may be precursor cells or immature cells (Haugland et al.,
2012a, 2014). They stain strongly positive for AcP and theymay pos-
sibly belong to the myeloid linage, be a DC or B cell precursor. If
they are B cell precursors this can support a relation between B cells
and myeloid cells as suggested previously (Li et al., 2006). As phago-
cytic activity of B cells also have been reported from the evolutionary
distant teleost species, rainbow trout and Atlantic salmon (order
Salmoniformes), Atlantic cod (order Gadiformes) and catﬁsh (order
Siluriformes). The ability of B cells to be highly phagocytic seems
to be a rather general feature of evolutionary distant teleosts, but
variations exist as zebraﬁsh IgM+ B cells were not particularly phago-
cytic (Parra et al., 2012). Onemust, however, keep inmind that about
40,000 known ﬁsh species represent a considerable phylogenetic
diversity. The current knowledge showing similarities and differ-
ences in immunity within the teleosts and to mammals are based
on studies of a few ﬁsh species and new ﬁndings extending the
present knowledge are expected as more species are investigated.
Phagocytic B cells have also been reported from amphibians (Li et al.,
2006) and reptiles (Zimmerman et al., 2010). In addition, in mice,
phagocytic B-1 cell subset has now been identiﬁed and was found
to dominate in the peritoneal cavity. The phagocytosis was per-
formed independent of the B cell receptor (BCR), but the cells
presented antigen to CD4+ cells (Gao et al., 2012; Parra et al., 2012).
Also mouse liver B cells have been shown to have high propor-
tions of phagocytic B cells compared to the spleen cells (Nakashima
et al., 2012). Both the ﬁsh phagocytic B cells and the B-1 cells have
microbicidal abilities (reviewed in Sunyer, 2012). It has been hy-
pothesized that the ﬁsh phagocytic B cells and the mammalian B-1
cells may be the most evolutionarily ancient B cell linage (Sunyer,
2013). It is well-known that ﬁsh B cells have MHC II and thus ability
to present antigens, however, the mechanisms underlying the ability
of ﬁsh B cells to present antigens to T cells is not clear. As there are
teleost species, like Atlantic cod (Pilstrøm et al., 2005; Star et al.,
2011), lacking MHC II, it will be interesting to investigate whether
lumpﬁsh have MHCII and if so, its presence on B cells.
To further investigate the B cell function, we performed cyto-
chemical staining of sorted cells, which give valuable information
about enzymes involved in degradation of microbes. One such
enzyme is MPO which is part of an oxygen-dependent killing
Fig. 6. Morphologic and phenotypic comparison of IgM+ cells with different cell types. CR = colorrapid, MPO = myeloperoxidase, AcP = acid phosphatase, AcP + T = acid phos-
phatase + tartrate, Pre = possible precursor cells, L = lymphocyte, Baso = basophil, neutrophils include cells with bilobed, kidney shaped and rounded nuclei, M = monocytes,
Mϕ = macrophage, DC = dendritic-like cell, RBC = red blood cell. n.d. = not determined (due to the low number/absence of cells observed). Pictures are captured with 63×
objective and representative cells are shown. Scale bar 10 μm.
141A. Rønneseth et al./Developmental and Comparative Immunology 52 (2015) 132–143
mechanism. We found that IgM+ B cells stain negatively for this
enzyme. This is similar to B cells in other teleosts and mammals.
It has to be noted that RBC stain positive in the MPO procedure. The
only MPO positive leukocytes were neutrophils observed in frac-
tion of large IgM− sorted cells. The monocytes/macrophages were
negative for MPO.
We have earlier shown that innate immune mechanisms of
lumpﬁsh are eﬃcient (Haugland et al., 2012a), but knowledge of
the lumpﬁsh’s adaptive immunity is largely unexplored. There-
fore, as a ﬁrst step, we measured the concentration of total IgM in
serum and determined the presence of speciﬁc antigens in immu-
nized ﬁsh. Although there were no signiﬁcant differences in total
IgM level upon immunization, the presence of speciﬁc antibodies
was signiﬁcantly higher in the immunized ﬁsh (with the excep-
tion of those immunized with V. ordalii). The result is as expected
since the speciﬁc antibodies constitute only a minor fraction of the
total IgM. Production of speciﬁc antibodies was measured by ELISA
verifying adaptive immunity, but, further studies are needed to iden-
tify the magnitude of the adaptive immune-responses in lumpﬁsh
with regard to the protective immunity to pathogens upon vacci-
nation and to fully understand the underlying mechanisms.
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Fig. 7. Determination of total IgM and level of speciﬁc antibodies upon immunization determined by SRID and ELISA. (A) SRID standard curve of puriﬁed IgM. (B) Diagram
showing total [IgM] in serum (mgml−1) in ﬁsh immunized with bacteria measured with the SRID method. AtypAs = atypical Aeromonas salmonicida, two different isolates,
Past = Pasteurella-like bacteria, V. ang = Vibrio anguillarum, V. ord = V. ordalii, C = non-immunized controls. Average with standard deviation is shown. (C) ELISA. Dilution curve
of sera from ﬁsh immunized with bacteria (each spot is the average value from the 10 ﬁsh within each group, except for the non-immunized controls were n = 2). (D) ELISA
diagram showing the individual measurements within each group at serum dilution 1:400. Statistical signiﬁcance: P > 0.05 = n.s., *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.
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